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Abstract 
 
Traditionally separate disciplines of a large and broad chemical spectrum, synthetic 
organic chemistry and biochemistry have found in the last two decades a fertile common 
ground in the area pertaining to the biosynthesis of natural products.  Both disciplines 
remain indispensable in providing unique solutions on numerous questions populating the 
field.  Our contributions to this interdisciplinary pursuit have been confined to the 
biosynthesis of polyketides, a therapeutically and structurally diverse class of natural 
products, where we employed both synthetic chemistry and biochemical techniques to 
validate complex metabolic processes.  One such example pertained to the uncertainty 
surrounding the regiochemistry of dehydration and cyclization in the biosynthetic 
pathway of the marine polyketide spiculoic acid A.  The molecule's key intramolecular 
cyclization was proposed to occur through a linear chain containing an abnormally 
dehydrated polyene system.  We synthesized a putative advanced polyketide intermediate 
and tested its viability to undergo a mild chemical transformation to spiculoic acid A.  In 
addition, we applied a synthetic and biochemical approach to elucidate the biosynthetic 
details of thioesterase-catalyzed macrocyclizations in polyketide natural products.  The 
outcome of the enzyme's activity is divided between hydrolysis and macrocyclization and 
limited information is currently available pertaining to its selectivity.  We synthesized 
four enantioenriched NAC-thioester analogs and assayed them with overexpressed DEBS 
TE, the canonical thioesterase of polyketide natural products, to gain insight into the 
effect key structural and stereochemical elements of the polyketide substrate have in the 
macrocyclization selectivity and regioselectivity of the enzyme. 
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Chapter 1. Synthetic chemistry, biochemistry and the biosynthetic discovery: an 
essential feedback loop at the interface of chemistry and biology 
"I can no longer, so to speak, hold my chemical water 
and must tell you that I can make urea without needing a kidney, 
whether of man or dog; the ammonium salt of cyanic acid is urea." 
 
Excerpt from Friedrich Wöhler's 
letter to his mentor Jöns Jacob Berzelius1 
22 February 1828 
1.1.  Introduction 
The development of modern synthetic chemistry, through both rationally designed 
and serendipitous discoveries, has been inexorably linked to the understanding of the 
chemical processes of organisms.  This connection however was not born of a natural 
progression but of the separate growth of the fields of organic chemistry and 
biochemistry from pioneering works of 19th century scientists such as Friedrich Wöhler 
and Eduard Buchner.2  Their discoveries regarding the synthesis of urea3 and cell-free 
fermentations,4, 5 respectively, had profound repercussions to the established view of 
vitalism and its élan vital so championed by the likes of Berzelius and Pasteur.6, 7 
It was these momentous scientific developments that set the tone and laid the 
foundation for research endeavors in the 20th century to gradually develop free from the 
confines of doctrine.  For the chemical and biochemical disciplines this path would allow 
for a gradual yet certain establishment of their interconnectedness, as exemplified by the 
eventual work by Hans Krebs and Kurt Henseleit to identify the metabolic origins and 
mechanism of the urea cycle.8 
The maturation of the synthetic chemistry discipline owes to the isolation and 
characterization of compounds of therapeutic value and/or as commodity chemicals from 
both prokaryote and eukaryote natural sources.  Limited access to sufficient quantities of 
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compound from their biological sources, and the associated difficulties in providing 
sustainable growing and culturing conditions in the laboratory have historically been the 
motivation for the development of synthetic routes and scale up methodologies for 
structure determination, research and industrial production.  Nevertheless the tacit 
underlying motivation amongst synthetic chemists has been the remarkable creative 
potential provided by the enormous structural diversity found within the various 
subclasses of natural products. 
Recent developments in the understanding of metabolic pathways and their 
relationship with the biosynthesis of natural products has opened new avenues for 
exploration by the synthetic chemist.  This chapter will review some notable strategies 
and contributions synthetic chemists have had on the advancement of the biosynthetic 
field with a particular focus on the formulation and testing of biosynthetic hypotheses and 
the development of biosynthetic precursors for the in depth study of individual enzymatic 
mechanisms. 
1.2.  Synthesis and the biosynthetic study of secondary metabolites 
Whereas the isolation, analysis and characterization of the biosynthetic machinery of 
natural products is the ideal path to take to decipher their assembly, realistically the 
process is time consuming and complex endeavor.  Given this, the unavailability of a 
natural product's biosynthetic gene cluster has not hampered the attuned chemist from 
proposing reasonable steps to rationalize its origins.  It is the purpose of this section to 
highlight the complementary role synthetic experiments and/or chemical hypotheses have 
had on the understanding of natural product biosynthesis. 
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1.2.1.  Alkaloids 
 
FIGURE 1.1.  Structural diversity of the alkaloid class of natural products. 
Alkaloids are a large, medicinally significant class of nitrogen-containing natural 
products.  Generally viewed as the products of eukaryotic organisms, plants in particular, 
these compounds are widespread in Nature.  Their biosynthesis is known to involve 
diverse pathways, unique building blocks, and a plethora of strategies9, each tailored to 
produce exquisitely complex structures (Figure 1.1).  The origin of nitrogen incorporation 
in these compounds is a consequence of their amino acid origins or from a PLP-mediated 
transamination.10 
1.2.1.1.  Daphniphyllum alkaloids 
 
FIGURE 1.2.  Daphniphyllum alkaloids. 
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Daphniphyllum alkaloids11-17 are structurally related compounds isolated from the 
plant family Daphniphyllaceaea (Figure 1.2).  Suzuki et al. were first to scrutinize the 
origins of their carbon skeleton by incorporation experiments of racemic [2-14C]-
mevalonic acid.18  They proposed from observed scintillation measurements that 
daphniphylline and its congeners likely share triterpene squalene as a biosynthetic 
precursor.  Beyond this however they were unable to provide a satisfactory hypothesis to 
explain the steps leading to the formation of its characteristic polycyclic scaffold. 
This challenge was seized 15 years later by the Heathcock laboratory.19-23  With the 
initial intent to design an efficient synthetic route to daphniphyllum alkaloids, they 
sought inspiration from the elegant simplicity of Nature.  They reasoned a pathway from 
squalene consisting of a combination of biosynthetically precedented and chemically 
intuitive steps (Figure 1.3).  They hypothesized a dioxidation of squalene to key 
dialdehyde 1.1, which would undergo the formation of azadiene 1.2 by amination with 
common cofactor pyridoxamine phosphate.  The azadiene intermediate's conjugate 
cyclization to the dihydropyran-containing compound 1.5 is preceded by strategic 
imine/enamine tautomerizations and azadiene deconjugation, proposed to occur with an 
amino acid residue localized in the enzyme's active site, to yield the reactive and 
nucleophilic enamine species 1.4. 
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FIGURE 1.3.  Proposed biosynthetic hypothesis of daphniphyllum alkaloids. 
Known to synthetic chemists as effective nucleophiles in conjugate addition 
reactions24, compounds such as enamine 1.4 may undergo conversion to 1.5, after which 
an aminal hydrolysis and rearrangement of the bicycle leads to key azadiene 1.7.  This 
bicyclic intermediate is proposed to undergo a regio- and stereoselective cyclization 
cascade to form the pentacyclic secodaphniphylline core.  The sequence consists of an 
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aza Diels-Alder followed by an aza Prins carbocyclization and generation, by proton 
transfer, of isopropenyl-containing 1.9, which they proposed to be the precursor to other 
structural motifs in the compound class.  The biosynthetic hypothesis informed and 
served as a blueprint for the design of a synthetic strategy.  Their approach was simplified 
by the employment of dihydrosqualene aldehyde 1.10 as a starting material (Figure 1.4).  
The decision would permit direct access to a reactive enamine, eliminating the 
intermediate tautomerization steps and setting the stage for the ensuing intramolecular 
cyclization cascade.  Noteworthy was their chance discovery of the contrasting effects an 
alkylamine and ammonia showed in the mechanism leading to the structure of the 
isopropenyl side chain.  Whereas with ammonia a 1,5 proton transfer resulted in the 
expected isopropenyl side chain of 1.11, methyl amine however resulted in the isolation 
of product containing a saturated isopropyl moiety 1.12, suggesting a 1,5-hydride shift 
mechanism to be operative. 
 
FIGURE 1.4.  Synthesis of secodaphniphylline alkaloids 1.11 and 1.12. 
Heathcock's hypothesis remains biosynthetically unverified as the genes responsible 
for daphniphyllum biosynthesis have not yet been isolated and characterized, yet the 
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sound mechanistic insight and elegance in design that resulted from these studies will be 
hard to ignore and will likely remain as the point of reference for future analyses. 
1.2.2.  Terpenoids 
Terpenoids9 are an enormous and highly varied family of natural products that have 
traditionally been associated with multicellular organisms including plants and animals.  
These compounds are not only of great interest to researchers for their physiologically 
active properties but for the tremendous complexity produced from the cationic 
rearrangement of simple dimethyl allyl pyrophosphate (DMAPP) and its regioisomer 
isopentenyl pyrophosphate (IPP).  In animals these key metabolites are the products of 
the mevalonic acid pathway (Figure 1.5). 
 
FIGURE 1.5.  Mevalonic acid pathway and the biosynthesis of terpenoid natural products. 
1.2.2.1.  Furanocembranoids 
An exceptional example of the use of chemical techniques to initiate the 
rationalization of a natural product's biosynthetic origins is that of the conversion of 
bipinnatin J and intricarene by the Trauner laboratory.25, 26  The work perfectly illustrates 
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the "screening hypothesis" concept,27-31 developed to explain the underpinnings of why 
and how organisms generate enormous structural diversity and complexity through 
choice modifications of key metabolites.  The strategy is proposed to yield a few reactive 
intermediates that, either enzymatically or spontaneously, undergo drastic restructuring of 
their scaffold to lead to increased production of structurally diverse congeners (Figure 
1.6). 
 
FIGURE 1.6.  The furanocembranoid terpenoids. 
Bipinnatin J (1.13) and intricarene (1.14) are examples of a large family of 
structurally related macrocyclic diterpenoids isolated from gorgonian corals of the genus 
Pseudopterogorgia.  The representative furanocembranoid macrocycle, exemplified by 
1.13, owes its origins to an enzyme-catalyzed stereoselective cationic intramolecular 
cyclization of geranylgeranyl diphosphate, followed by a putative series of P450-
dependent oxygenations of the carbon skeleton (Figure 1.7).32, 33 
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FIGURE 1.7.  Proposed biosynthesis of furanocembranoid terpenoids. 
However, the rearrangement of the tricyclic furanocembranoid archetype to a 
molecule of such complexity as intricarene, which contains a trispiropentacyclic core 
remained an elusive, unexplored topic.  That is until the elegant work of Trauner and co-
workers showed their relationship to be the product of an Achmatowicz reaction34-[3+2] 
dipolar cycloaddition35 cascade (Figure 1.8). 
 
FIGURE 1.8.  Biomimetic conversion of 1.13 to 1.14 by an Achmatowicz-[3+2] dipolar cycloaddition 
sequence. 
To test their hypothesis they subjected their synthetic sample of 1.1326 to a 
regioselective epoxidation of the furan with mCPBA mediated by the adjacent furfuryl 
alcohol to produce hydroxypyranone 1.15.  Acetylation to 1.16 followed by elimination 
grants access to oxidopyrillium dipole 1.17 which, by heating to 150 °C, initiates the 
expected [3+2] dipolar cycloaddition thus granting access to 1.14 in 26% yield.  The high 
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temperatures necessary to effect cyclization suggest an enzyme must be involved to 
regulate the energetics of the reaction. 
1.2.3.  Polyketides 
 
FIGURE 1.9.  Polyketide natural products are complex and structurally diverse. 
Polyketide natural products are a structurally diverse group of highly oxygenated 
secondary metabolites (Figure 1.9) biosynthesized by a complex collection of enzymes 
known as a polyketide synthase (PKS). 36  Several varieties of PKSs have been identified, 
however, the standard biosynthetic model of assembly is that exemplified by a modular 
type I polyketide synthase (Figure 1.10) operative in the assembly of macrolide 
antibiotics and polyether biotoxins to name a few.  The process takes place by iterative 
thio-Claisen condensations of malonyl-CoA and/or its derivatives37, 38 in a manner 
analogous to fatty acid biosynthesis39 to produce β-keto thioester intermediates.  The 
basic enzymatic mechanism of modular PKSs involves three indisspensable catalytic 
domains arranged into repetitive units or modules: ketosynthase (KS), acyl transferase 
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(AT) and acyl carrier protein (ACP); the number of modules present in the PKS dictates 
the length of the carbon chain of the end product.  In addition, the modules may also 
possess tailoring domains arranged in various configurations that facilitate access to β-
hydroxy units (ketoreductase – KR); conjugated E alkenes (dehydratase – DH); and fully 
saturated products (enoyl reductase – ER).  Release from the enzyme complex is 
mediated by a terminal thioesterase domain (TE) that, depending on the intra- or 
intermolecular availability of a nucleophile, may yield macrolactones or seco-acids 
respectively. 
 
FIGURE 1.10.  PKS chain elongation of a malonyl-CoA derivative displaying the consensus mechanism for 
the essential KS-AT-ACP catalytic triad. 
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1.2.3.1.  Polyether biotoxins 
The biosynthetic hypotheses discussed thus far have provided a glimpse of 
chemically reasonable pathways that have gone without independent corroboration from 
molecular genetics and/or enzymology experiments.  However, when controversies occur 
among experimentally supported hypotheses, the best and only solution in discriminating 
between these is the characterization of the natural product's biosynthetic pathway.  This 
scenario unfolded with two proposals of polyether biosynthesis: the Cane-Celmer-
Westley40 and Townsend-Basak-McDonald41 hypotheses. 
The Cane-Celmer-Westley hypothesis (Figure 1.11-A) was proposed to explain the 
biosynthesis of polyether biotoxins such as monensin A (1.18).  It attempted to 
rationalize the molecule's origins as the product of an elegant intramolecular epoxide ring 
opening cascade set in motion by a P450 monoxygenation of putative E,E,E-premonensin 
polyketide intermediate (1.19).  Key to its recognition as a viable and compelling 
biosynthetic step is its application in the facile synthesis of complex polyether natural 
products in accordance with Baldwin's ring-closure rules.42  Conversely, the Townsend-
Basak-McDonald hypothesis (Figure 1.11-B) predicts the polyether scaffold to form by 
sequential intramolecular syn-oxidative additions of a metal-oxo species owing to a [2+2] 
metallaoxetane-reductive elimination mechanism.  By this logic, the stereochemistry of 
intermediate 1.18 was recognized to necessitate the hemiketal of key polyketide 
intermediate Z,Z,Z-premonensin (1.20).  McDonald and coworkers explored and 
confirmed the potential of their proposed step to the synthesis of 1.18 by employing PCC 
as the oxidant of short Z,Z-hydroxydienes.43 
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FIGURE 1.11.  Biosynthetic proposals for the origins of polyether biotoxins (e.g. monensin A (1.18)). (A) 
Cane-Celmer-Westley and (B) Townsend-Basak-McDonald hypotheses. 
Refutal of one of these hypotheses required the isolation, sequence and expression of 
a polyether gene cluster and the piecemeal spectroscopic analysis of multiple 
intermediates in the pathway.  Work by Leadlay and coworkers44 provided the first 
evidence of the stereochemical nature of premonensin's triene system.  They generated a 
mutant of the monensin biosynthetic gene cluster by fusing an erythromycin thioesterase 
domain downstream of module 4.  In this manner, they effectively suppressed monensin 
production, yet isolated and characterized a truncated metabolite containing an olefin 
with an (E)-stereochemistry.  Further molecular genetic studies of various mutants of the 
monensin biosynthetic cluster confirmed the accumulation of an E,E,E-premomensin 
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derivative in the pathway, effectively confirming the Cane-Celmer-Westley hypothesis as 
the key model in the biosynthesis of polyether natural products. 
1.3.  Precursor and analog design for enzymology of polyketide natural products 
Another key area in the field of biosynthesis where synthetic chemists have made 
profound contributions has been that of enzymology and the understanding of the 
molecular underpinnings of biosynthetic pathways.  These studies deal with available 
biosynthetic enzymes and attempt to answer questions as varied as those regarding 
substrate specificity, regio- and stereochemical characteristics of products, enzyme 
kinetics, substrate-enzyme complex inhibitors and the development of novel compounds.  
The high point of the application of the experimental possibilities has been reached with 
the enormous polyketide class of natural products. 
1.3.1.  Precursor directed biosynthetic studies 
As was succinctly described by Boddy and coworkers: "precursor-directed 
biosynthesis provides a powerful method to introduce non-native starting materials into 
biosynthetic pathways.".45  Aside from the obvious goal of this concept which is to 
chemoenzymatically generate a diverse set of chemical congeners with novel therapeutic 
profiles, a fascinating consequence is the exploration and elucidation of the specificity 
and selectivity of steps in individual pathways towards non-native structural motifs. 
1.3.1.1.  Precursor-directed biosynthesis of erythromycin analogs 
One of the first examples of precursor-directed biosynthesis of polyketide natural 
products was designed by the Khosla group in 1997.46  Employing the canonical 
erythromycin PKS pathway, they generated a null mutant by deleting the ketosynthase 
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domain of module 1 (KS1), rendering the pathway dependent on the exogenous supply of 
synthetic substrates (Figure 1.12).47 
 
FIGURE 1.12.  Precursor directed biosynthesis of erythromycin analogs. 
The study served to underline the capacity of the pathway to accept and produce 
interesting analogs, and moreover to reveal the tolerance of downstream enzymatic steps 
to marked steric and structural differences in the substrate. 
1.3.2.  Domain-level studies in PKS pathways 
The enzymology of polyketide biosynthetic domains has been fundamental in 
creating a normative understanding and model of their mechanistic underpinnings.  The 
advent of sequencing technology and heterologous expression systems have had a 
tremendous impact on the researchers availability and investigation of biosynthetic genes 
and their products.  Chemical synthesis is an excellent tool in the elucidation of these 
processes and interactions. 
1.3.2.1.  Decarboxylative chain termination in curacin A biosynthesis 
The terminal step in the biosynthesis of polyketide natural products is catalyzed by a 
thioesterase domain (TE).  These catalytic domains mediate the cleavage of the thioester 
bond of the upstream ACP-bound mature polyketide and concomitantly produce either a 
macrocyclic or hydrolytic product.  This model mechanism is not applicable when 
analyzing the anticancer cyanobacterial metabolite curacin A (1.21) as it is characterized 
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by a terminal olefin moiety in place of the canonical seco-acid (Figure 1.13).  The 
molecule's gene cluster was isolated and sequenced by Gerwick and coworkers to reveal 
a termination module containing a putative sulfotransferase domain (ST) among the ACP 
and TE domains.48 
 
FIGURE 1.13.  CurM, the termination module of the curacin A PKS, contains a sulfotransferase domain 
(ST) flanked by an ACP and a TE domain 
From analysis of the predicted mature polyketide the ST was hypothesized to act on 
an ACP-bound β-hydroxythioester intermediate.  The precise sequence of events leading 
to formation of 1.21 however, remained unclear.  To determine ST domain's role and its 
timing within the termination of the mature polyketide leading to 1.21, Sherman and 
coworkers synthesized a simple ACP-bound heptaketide analog (1.22) containing the 
requisite β-hydroxythioester moiety (Figure 1.14).49  Individual and combined 
biochemical analyses of 1.22 with recombinant ST and TE domains ratified the sequence 
of events to 1.23.  The ACP-bound β-hydroxythioester polyketide is shown to be sulfated 
prior to the action of the thioesterase domain which catalyzes a hydrolysis reaction and 
mediates the acid's decarboxylative β-elimination to yield 1.23. 
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FIGURE 1.14.  Substrate studies of curacin A's sulfotransferase (ST) and thioesterase domains. 
These results demonstrated an unprecedented mechanism of polyketide termination 
by decarboxylative elimination of a β-sulfate containing advanced intermediate and 
represents a potential new and useful tool for the inclusion of terminal olefins in 
engineered polyketide pathways. 
1.3.2.2.  High resolution structural studies of the pikromycin thioesterase domain 
Synthetic chemistry has been fundamental in the elucidation of key structural 
substrate-enzyme interactions and the mechanistic underpinnings of catalysis.50-53  To 
gain structural information that would guide their desired rational engineering of a PKS 
thioesterase domain, Fecik and coworkers designed 1.25 a non-hydrolysable pentaketide 
phosphonate-based inhibitor structurally analogous to the mature heptaketide native to 
the pikromycin biosynthetic pathway 1.24 (Figure 1.15).54, 55 
 
FIGURE 1.15.  Synthesis of phosphonate 1.25, an irreversible inhibitor of the pikromycin thioesterase 
domain. 
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The structural characteristics of the enzyme that stabilize the substrate in the channel 
remained unclear.  Initially thought to be due to various hydrophilic residues lining the 
channel, Fecik et al. obtained an X-ray crystal structure of co-crystallized 1.25-PIKS TE 
(Figure 1.16) where they observed that the co-crystallized phosphonate inhibitor made 
few specific contacts with the channel, suggestive of hydrophobic interactions being key 
for the stabilization of the substrate-enzyme intermediate.  Furthermore, a weak barrier of 
water molecules in the channel's exit was suggested to be the underlying cause of the 
enzyme's macrocyclization mechanism, as it was observed to direct the substrate's O-
nucleophile towards the enzyme active site. 
 
FIGURE 1.16.  Crystal structure of phosphonate 1.25 (circled) bound to the active site of the pikromycin 
thioesterase domain. 
1.4.  Conclusion 
Natural product biosynthetic studies have experienced enormous growth in the last 20 
years by the swift technological advances and invaluable contributions of the synthetic 
chemistry and biochemistry disciplines.  These, have been employed effectively in the 
development and testing of biosynthetic hypotheses, and as probes of the underlying 
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mechanistic underpinnings of enzymatic processes.  Presented herein are our efforts to 
showcase the seamless relationship the chemical sciences, whether synthetic chemistry or 
biochemistry, have had in comprehending the biosynthetic origins of polyketide natural 
product spiculoic acid A, a prospective antitumor therapeutic, in addition to the substrate 
specificity and mechanism of the DEBS-TE, the thioesterase involved in the cyclization 
of macrolide polyketide erythromycin. 
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CHAPTER 2.  Investigating the cyclization of an alternate biomimetically-inspired 
 linear intermediate of spiculoic acid A 
2.1.  Introduction 
The Diels-Alder reaction, discovered by Otto Diels and Kurt Alder in the early 20th 
century,1 has become a powerful tool in the synthetic chemist's collection of reactions.  
Characterized by the coupling of a conjugated diene and an olefin (dienophile), the 
reaction's value resides in its ability to predictably yield potentially complex 
cyclohexene-containing products with superb regio- and stereochemical control. 
 
FIGURE 2.1.  A) Diels-Alder reaction B1) Orbital correlation diagram of a normal electron demand Diels-
Alder reaction.  B2) Orbital correlation diagram of a inverse electron demand Diels-Alder reaction.  The 
orbitals in red represent the frontier molecular orbitals. C1) Diastereo- and regioselectivity of a normal 
electron demand Diels-Alder reaction.  C2) Diastereo- and regioselectivity of an inverse electron demand 
Diels-Alder reaction. 
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Since its discovery, the Diels-Alder reaction underwent a series of theoretical 
breakthroughs which laid down the sophisticated mechanistic foundation necessary for its 
application in numerous natural product syntheses.2  Formally a pericyclic [4+2] reaction, 
the Diels-Alder is typified by a cyclic transition state where, in a single concerted step, 
three π bonds are broken concomitantly forming two σ bonds and a π bond (Figure 2.1-
A).  The key orbital interactions involving the reaction's components are their highest 
occupied and lowest unoccupied molecular orbitals (HOMO and LUMO respectively) as 
predicted by frontier molecular orbital theory (FMO)3 and symmetry conservation 
considerations (Figure 2.1-B).4, 5  If the HOMO-LUMO energy gap decreases, the 
reactivity of the system increases.  This phenomenon can be modulated by inclusion of 
polarizing functionalities (electron donating and withdrawing) on one or both 
components of the reaction. 
Perturbation of the diene-dienophile by inclusion of electron rich or poor substituents 
changes the energetic landscape of the reaction as regio- and stereoselective pathways to 
product become available (Figure 2.1-C).  Fortunately an analysis of stabilizing 
electronic effects in the transition state effectively eliminates the majority of these 
putative pathways.  On account of the reaction being concerted and stereospecific, only 
two major pathways are operative in explaining the reaction's diastereoselection.  
Formation of the kinetically favored endo transition state is rationalized by invoking 
secondary orbital bonding interactions between the reaction components.  The 
thermodynamically controlled product, obtained from an exo transition state, may be also 
isolated owing to favorable steric interactions of reactants.  Of note is also the marked 
effect the polarizing substituents have on the orbital coefficients of the reaction's 
27 
 
 
components and thus its regiochemical outcome.  This effect creates geometric 
asymmetries in the key frontier molecular orbitals which affect the synchronicity of bond 
formation at the transition state.6  The favored transition state will then be that which 
arises from complementing orbital coefficients of the diene-dienophile pair. 
The flow of electrons determines how the Diels Alder reaction is classified.  A 
normal-electron-demand Diels-Alder is characterized by a reaction between an electron-
rich diene and an electron-poor dienophile and, as expected, the HOMO of the diene and 
the LUMO of the dienophile are its key frontier molecular orbital interactors (Figure 2.1-
B1 and C1).  The opposite polarization is also applicable and the reaction is known as an 
inverse-electron-demand Diels-Alder reaction7, 8 (Figure 2.1-B2 and C2). 
Shown in Figure 2.2, are a few relevant cases where a Diels-Alder cycloaddition 
figures prominently as a key transformation in the synthetic route to a natural product's 
framework.  Moreover they are examples of intramolecular Diels-Alder reactions 
(IMDA), a common synthetic cyclization strategy increasingly associated with the 
biosynthetic origins of various secondary metabolites.9-12 
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FIGURE 2.2.  Total syntheses of natural products featuring the versatility of the Diels-Alder reaction. 
2.1.1.  The enzymatic Diels-Alder in the biosynthesis of polyketide natural products 
Examples abound in secondary metabolism of intramolecular cyclizations reminiscent 
of a Diels-Alder reaction13-19 (Figure 2.3).  The isolation of cyclic natural products 
containing the familiar scaffold set in motion the intense search for the enzymatic step 
believed to be involved in each individual pathway.  The few results thus far have been 
subject to intense debate.  In vitro assays with enzyme preparations (crude or otherwise) 
and NAC-thioester intermediates of polyketide synthase (PKS) systems such as the 
macrophomate and lovastatin synthases, have shown product mixtures consistent with a 
stepwise mechanism of catalysis.11, 20 
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FIGURE 2.3.  Polyketide natural products with cyclic elements derived from a putative Diels-Alder reaction. 
Most recently, a study on the cyclization of the polyketide spinosyn A led by Liu et 
al. successfully cloned and isolated gene product SpnF, a putative Diels-Alderase that 
catalyzes an exclusive transannular cyclization of 2.7 in vitro (Figure 2.4) and produced a 
single trans-hydrindane diastereomer (2.8).21 
 
FIGURE 2.4.  SpnF is the first example of a putative Diels-Alderase that exclusively yields a single 
diastereomer. 
The clear implication of this discovery is that a concerted reaction mechanism may be 
taking place.  Carefully crafted mechanistic studies and high resolution structural data 
will be necessary to verify the fundamental mechanism of action of this enzyme.  If 
indeed the the mechanism is found to be pericyclic, the often-quoted enzyme catalysis 
paradigm of stabilization of the transition state by electrostatic interactions in the active 
site22 may likely undergo a period of intense debate. 
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2.1.2.  trans-Hydrindane polyketides: the product of a Diels-Alderase? 
The trans-hydrindane (bicyclo[4.3.0]nonane) contained in some polyketide natural 
products is a rare scaffold biosynthesized by diverse microbial species isolated from 
evolutionarily distinct populations (Figure 2.5).23, 24 
 
FIGURE 2.5.  trans-Hydrindane polyketides. 
Largely regarded to be the product of an enzyme-catalyzed Diels-Alder 
cycloaddition11, mechanistic insight on its origin remains inconclusive and an active 
source of speculation and debate 20, 25-29.  Although the biosynthetic gene clusters of the 
ionophore antibiotic indanomycin has been isolated,30-32 its study has yet to shed light on 
the chemistry involved in trans-hydrindane formation from the putative linear polyketide 
precursor. 
An important example of this class of scaffold is found in spiculoic acid A (2.11, 
Figure 2.6), a natural product isolated from tissue extracts of the Caribbean sponge 
Plakortis angulospiculatus; it possesses modest activity as a chemotherapeutic33.  The 
molecule is characterized by a highly congested trans-hydrindane framework, displaying 
six stereocenters, of which two are adjacent, strained quaternary centers. 
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FIGURE 2.6.  Spiculoic Acid A (2.11). 
The biosynthetic origin of the compound’s elaborate carbocyclic framework is likely 
due to an intramolecular Diels-Alder (IMDA) cycloaddition of a linear polyketide 
product33.  The nature of this enzyme-bound linear chain remains a subject of debate 
since its biosynthetic gene cluster has yet to be isolated, sequenced and characterized; the 
complexity of both the sponge microbiome and the concomitant metagenomic mining 
studies the likely culprit. 
2.1.3.  Spiculoic acid A is putatively biosynthesized by a type I PKS 
The linear chain of 2.11 is hypothesized33 to be the product of a type I PKS chain 
extension of phenylacetyl-CoA starting unit34-36 by a sequential condensation of ethyl and 
methyl malonyl-CoA extender units (Figure 2.7). 
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FIGURE 2.7.  Spiculoic acid A linear chain and PKS extender unit framework.  Thioesterase (TE) hydrolysis 
is hypothesized to be followed by an intramolecular Diels-Alder cycloaddition. 
The timing of the cyclization leading to spiculoic acid A remains unknown.  This step 
is thought to be mediated by a putative Diels-Alderase37-41 enzyme, following the 
enzymatic hydrolysis of the polyketide intermediate.  However, examples of 
intramolecular cyclizations42, 43 of PKS-bound intermediates poses the question of 
whether this step may take place while bound to the PKS enzyme.  In this case, the lower 
energy LUMO of the conjugated thioester found in the enzyme-bound intermediate 
would be more reactive in a Diels-Alder reaction than the seco-acid of the hydrolyzed 
product (Figure 2.8). 
33 
 
 
 
FIGURE 2.8.  Spiculoic acid A IMDA cyclization may take place during polyketide chain extension. 
The double bond regiochemistry of the enzyme-bound linear polyketide remains an 
issue of considerable interest.  The dehydration mechanism of DH domains44-46 in type I 
polyketides and fatty acids is known to consistently produce double bonds in conjugation 
with the acyl-enzyme intermediate.  If this logic is applied to the biosynthesis of the 
acyclic intermediate of 2.11, an additional regisomerization of the triene olefins would be 
necessary to form a diene conformation reactive towards a Diels-Alder reaction.  Despite 
this, Huang et al have justified the feasibility of the intermediate's intramolecular 
cyclization through a sequence of abnormal β,γ dehydrations during the biosynthesis of 
2.11 (Figure 2.9-A).  The HOMOdiene-LUMOdienophile energy gap of the mature enzyme-
bound intermediate suggest a cyclization at milder, physiologically relevant conditions 
would require a Diels-Alderase47-49. 
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FIGURE 2.9.  Hypothetical biosynthetic routes: A) Abnormal PKS-bound dehydration. B) Normal 
dehydrated product catalyzed by canonical DH domains. 
Consistent with this view have been the elevated temperature employed to effect the 
IMDA in the synthetic studies and total syntheses of 2.1150-53 (Figure 2.10).  Baldwin et 
al. showed that under the reaction conditions selected to install the molecule's dienophile 
(100 °C), their advanced intermediate spontaneously undergoes an IMDA.  Matsumura et 
al. successfully isolated an IMDA-capable aldehyde intermediate however, it was slow to 
react at elevated temperatures (70 °C).  These studies suggest a couple of interpretations: 
either the HOMOdiene-LUMOdienophile energy gap54 of the intermediate is too large to 
allow for a spontaneous IMDA and/or the energy of activation of the IMDA is 
exceedingly high given the entropic and enthalpic cost of organizing the sterically 
crowded intermediate into a reactive conformation. 
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FIGURE 2.10.  Synthetic strategies employed for the formation of spiculoic acid A’s trans-hydrindane 
framework.50 
We propose an appealing alternative biosynthetic hypothesis where the sequence of 
DH-mediated dehydrations occurs normally as shown in Figure 2.9-B.  As a 
consequence, we expect the intermediate to remain unreactive towards the IMDA.  The 
olefins defining the conjugated diene in the system would have to undergo a 
regioisomerization step which we predict to be facilitated by an acid/base residue either 
contained in the putative cyclase or in the active site of a non-canonical PKS domain 
(Figure 2.11).55-58 
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FIGURE 2.11.  An intermediate regioisomerization step may take place prior to cyclization by a putative 
cyclase. 
The prospect of a mild, spontaneous IMDA cyclization may be directly facilitated by 
the favorable electronics of the extended enol or enolate intermediate.  The increased 
electron density of the diene provided by the extended conjugation of the enol moiety 
will decrease the HOMOdiene-LUMOdienophile energy gap54 of the system. 
Guided by our biosynthetic rationale and understanding of polyketide pathways, 
herein we describe our efforts in the development and synthesis of a novel biomimetic 
acyclic polyketide intermediate of 2.11 and its ability to undergo an IMDA under a 
variety of reaction conditions. 
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2.2.  RESULTS AND DISCUSSION 
2.2.1.  Computational analysis 
To predict the favored stereochemical outcome of the linear intermediate of 2.11 
under IMDA reaction conditions, we employed gas-phase ab initio density functional 
theory (DFT) computational methods at the B3LYP/6-31G(d,p) level of theory.  We 
envisioned the results would provide insight into the equilibrium conformation energies 
of putative key intermediates and stereoisomers populating the potential energy surface 
of the reaction coordinate to 2.11.  Unlike the single concerted step to product shown in 
Figure 2.12-A, we anticipated the path from linear intermediate 2.18 to cyclic 2.11 to go 
through a transient cyclic enol such as 2.19, which in route to product would require an 
equilibration step to set the molecule’s stereochemistry at C6 (Figure 2.12-B). 
 
FIGURE 2.12.  Steps involved in the conversion of linear polyketide chains to 2.11. A) IMDA reaction of 
putative intermediate 2.17 directly yields 2.11. B) IMDA reaction of 2.18 may produce an enol 
intermediate 2.19 that after equilibration may yield product 2.11. 
In addition, the outcome of the IMDA reaction will be biased by the endo vs. exo 
selectivity and facial approach of the molecule's dienophile.  Synthetic precedence50, 51, 53 
suggests that the cyclization will take place preferentially through an endo transition state 
produced by a β-face approach of the dienophile on the diene.  Assuming our acyclic 
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analog 2.39 (see Scheme 2.4) displays similar endo selectivity, we hypothesize that the 
facial approach will be dictated by the energy profile of the reaction's transition state 
conformation.  The congested structure of the cyclic enol stereoisomers, suggests a late 
transition state.  Thus, we expect key steric interactions present in the products to reflect 
key steric interactions in the transition state.59 
We have modeled and optimized the endo cyclic enol products of the IMDA reaction 
of 2.18 (Figure 2.13) and the products from their C6 tautomerization.  The energies of the 
putative products are shown relative to the energy of spiculoic acid A.  Unexpectedly 
2.21 was lower in energy by 2.4 kcal/mol relative to 2.19, implying the potential presence 
of a cyclase to guide the stereochemical outcome of cyclization.  Likewise, this result 
may be a reflection of the molecules’ relaxation to its equilibrium pseudo-chair 
conformation from the more strained boat conformation required for the IMDA 
cyclization, necessitating a closer inspection by direct computation of their transition 
state energies.  Analysis of the structures resulting from tautomerization of C6 show the 
anti epimer 2.11 to be 9.2 kcal/mol lower than the syn epimer 2.20, likely due to the 
absence of the 1,3 diaxial interaction between the alkyl groups at C4 and C6.  On the 
contrary, the epimers originating from 2.21 show a great degree of strain from 1,3-diaxial 
interactions between the C2 and C4 ethyl side chains.  Noteworthy from these separate 
processes is the evident interrelatedness of all four diastereomeric products through an 
additional tautomerization step at C4 to yield enantiomers.  Encouragingly, the lowest 
energy C4 and C6 anti product, which act as a thermodynamic sink, corresponds with the 
relative stereochemical configuration of 2.11. 
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FIGURE 2.13.  Cyclic endo products from the IMDA cycloaddition of 2.18.  Dienophile-diene facial 
selectivity has the potential of producing two diastereomers which are expected to undergo an enol-keto 
tautomerization to products. 
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2.2.2  Retrosyntheses 
2.2.2.1.  Strategy I 
Our initial strategy was centered on synthesizing 2.11 by an enantioselective route 
that would emulate our hypothetic biosynthetic pathway of PKS-mediated linear chain 
extension.  The corresponding retrosynthetic analysis is summarized in Scheme 2.1. 
SCHEME 2.1.  Strategy I: Chiral retrosynthetic strategy to 2.11. 
 
Esterification and disconnection between C2-C10 and C3-C7 of 1 reveals chiral 
tetraene 2.46, the route’s key linear target.  Upon the retrosynthetic reduction and 
silylation of the secondary alcohol at C5, the disassembly of compound 2.46 can begin by 
cleavage at the C2-C3 olefin.  The step reveals chiral β-hydroxy aldehyde 2.45; related in 
the synthetic sense by the employment of a Horner-Wadsworth-Emmons olefination.  
The rationale of this methodology lies in our desire to obtain an intermediate that, by 
control of the oxidation state at C5, would enable us to test various IMDA conditions to 
efficiently access the scaffold of 2.11.  The syn relationship between the C4 and C5 
substituents in 2.45 leads our analysis to β-hydroxy intermediate 2.44, in which either an 
Evans or Crimmins asymmetric aldol methodology60, 61 has been employed to obtain 
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selectivity.  Disconnection between C4-C5 of 2.44 yields key trienal 2.43.  This 
intermediate may be disassembled by an oxidoreduction sequence of the conjugated 
aldehyde to the carboxylic acid oxidation state, followed by an olefin cleavage.  This 
sequence revealed commercially available phenylacetaldehyde (2.24), an analog of 
spiculoic acid A’s biosynthetic starter unit62.  In the forward sense, the aldehydes may be 
olefinated by reaction with stabilized phosphorus ylides. 
Regrettably, at the crux of our strategy, the Evans aldol reaction failed to provide 
reproducible results.  In addition, by switching to a Crimmins methodology we found a 
proclivity of 2.43 to enolize under the reaction conditions, which prevented us entry to 
the chiral β-hydroxy target in the manner proposed.  The results, which will be discussed 
in detail in Section 2.2.3.1, forced us to re-evaluate our synthetic strategy. 
2.2.2.2.  Strategy II 
Given the successful diastereoselective synthesis of 2.1150, and the setbacks 
experienced while implementing our initial strategy, the design was simplified to include 
construction of rac-2.46 (Scheme 2.2).  We envisioned 2.11 to arise directly from the 
acid-catalyzed deprotection of ketal intermediate 2.54.  It was hoped that the ketalization 
of the C5 ketone would permit the isolation and spectroscopic characterization of the 
IMDA precursor.  In keeping with the linear theme of Strategy I, disconnection of 2.54 at 
the C2-C3 olefin exposes aldehyde 2.53 accessible by oxidation of the alcohol derived 
from reduction of the C3 ester of 2.50.  Formation of the C4-C5 bond in ester 2.50 was 
designed to arise from a Reformatsky addition63 of an α-bromoester on aldehyde 2.43, the 
common link amongst strategies. 
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SCHEME 2.2.  Strategy II: Achiral retrosynthetic strategy to 2.11. 
 
During this synthesis, ketalization of the C5 ketone that resulted from the oxidization 
of 2.50 proved difficult, as described in section Section 2.2.3.2.  Despite a series of 
attempts to circumvent this obstacle, the chemistry remained uncooperative and forced us 
again to redesign the route. 
2.2.2.3.  Strategy III 
A convergent approach was chosen that would incorporate and recycle some elements 
of our prior designs.  As per Scheme 2.3, retrosynthetic bond cleavage of the C6-C7 
trisubstituted olefin in rac-2.46 yields dienal 2.30 and the novel phosphonate 2.59 which 
may be crafted from the addition of commercial diethyl ethylphosphonate (2.31) to the 
acyl chloride64-66 of acid 2.57.  Disassembly of this fragment can be accomplished by 
cleavage of the C2-C3 olefin and modification of the oxidation state of C5.  This acid is 
likely to be accessible from a Wittig olefination, C5 desylilation of the hydroxyester 
intermediate and the Jones oxidation 67of β-hydroxyaldehyde 2.34, an intermediate 
suggestive of commercially available diethyl ethylmalonate (2.31). 
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SCHEME 2.3.  Strategy III: Convergent and achiral retrosynthetic strategy to 2.11. 
 
The synthesis of fragment 2.59 was smoothly carried out from 2.34, however, we 
discovered that under a number of conditions (Masamune-Roush68, KOH, NaH and 
pyridine/heat) and temperature profiles, the fragment rapidly decomposed, as detailed in 
section Section 2.2.3.3.  Based on these results, we once again redesigned our synthesis 
to follow a similar strategy while avoiding the unstable phosphonate coupling partner. 
2.2.2.4.  Strategy IV 
Our final route relied on the use of an aldol coupling to access a similar olefination 
product as envisioned in the prior strategy.  This route also exploited the symmetry 
element of malonate 2.31 (Scheme 2.4).  The strategy's most salient feature, however, 
was the incorporation of the C6-C7 double bond of fragment 2.39 by a Lewis acid-
mediated aldol condensation-dehydration sequence of aldehyde 2.30 and enone 2.37, in 
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which stereocontrol of the C5 hydroxyl group was not necessary. 
SCHEME 2.4.  Strategy IV: Redesigned convergent and achiral retrosynthetic strategy to 2.11. 
 
The C5-C6 bond can be formed from a Grignard alkylation of conjugated Weinreb 
amide 2.36, in turn formed from a nucleophilic displacement of the conjugated ester 
produced by the olefination of protected β-hydroxyaldehyde 2.34 (Section 2.2.3.4).  This 
sequence would provide us with our most advanced intermediate, and enable us to test 
our Diels-Alder hypothesis. 
2.2.3.  Syntheses of 2.39, the putative polyketide intermediate of spiculoic acid A 
2.2.3.1.  Strategy I 
Scheme 2.5 outlines the synthesis of aldehyde 2.43 starting with commercially 
available phenylacetaldehyde (2.24). 
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SCHEME 2.5.  Synthesis of aldehyde 2.43.a 
 
a Reagents and conditions: (a) 2.40, toluene, reflux, overnight; (b) DIBAL-H, CH2Cl2, 0°C (or toluene, -
78°C), 1hr; (c) IBX, DMSO, r.t., 1.5hrs; (d) 2.47, benzene, reflux, overnight. 
The sequence began with the olefination of aldehyde 2.24 with known ylide 2.4069, 70 
in refluxing toluene.  The resulting conjugated ester 2.25 was obtained in 77% yield with 
excellent E selectivity (E/Z = 17:1 by 1H NMR).  The stereoselectivity of this step has 
been discussed in the literature; the authors rationalize the result through analysis of the 
oxaphosphetane dissociation step.69  The build-up of double bond character in the 
transition state is stabilized to a greater extent by conjugation with the carbonyl's π 
orbital, the expected scenario when the oxaphosphetane's bulkiest groups are anti with 
respect to each other.  Reduction of ester 2.25 by dropwise addition of DIBAL-H carried 
out in an ice-cold solution of DCM furnished alcohol 2.26 in 100% yield.  Oxidation of 
alcohol 2.26 to aldehyde 2.27 was attempted using a variety of methods including PCC71, 
TCCA/TEMPO72, manganese dioxide73 and IBX74.  Aldehyde 2.27 (97% yield) was 
obtained by oxidation with a solution of IBX in DMSO at room temperature (r.t.).  To 
limit decomposition63, aldehyde 2.27 was immediately olefinated with ylide 2.40 in 
refluxing benzene to yield a 1:2 mixture of chromatographically inseparable dienyl esters 
2.28 and 2.28a respectively in 33% yield (Figure 2.14), as well as unreacted starting 
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material 2.27 (22% recovery). 
 
FIGURE 2.14.  Chromatographically inseparable isomers of dienyl compounds 2.28-2.30 were identified by 
1D and 2D NMR spectroscopy. 
Ester mixture 2.28 and 2.28a was reduced with DIBAL-H at 0°C in DCM to furnish 
chromatographically inseparable alcohol isomers 2.29 and 2.29a as a 1:1 ratio (52% 
yield).  Oxidation of this mixture with IBX in DMSO at room temperature to aldehydes 
2.30 and 2.30a (1:1 ratio, 93% yield), followed by immediate olefination with 
commercially available ylide 2.47 provided trienyl esters 2.41 and 2.41a as a 1:1 mixture 
(89% yield).  The terminal carbonyl in 2.41 and 2.41a was reduced with DIBAL-H at -
78°C in toluene to alcohols 2.42 and 2.42a (1:1 ratio, 87% yield), which in turn were 
oxidized with IBX in DMSO to aldehydes 2.43 and 2.43a (1:1 ratio, 81% yield).  Notable 
among compounds 2.28-2.30 and 2.41-2.43 was the presence of a double bond pattern 
analogous to that of dienyl ester mixture 2.28 and 2.28a.  Although the increased length 
of the polyene chain would suggest an increased number of regioisomers in solution, 
NMR data confirmed the mixtures consisted only of two isomers (Figure 2.15). 
 
FIGURE 2.15.  Chromatographically inseparable isomers of trienyl compounds 2.41-2.43 were identified by 
1D and 2D NMR spectroscopy. 
The C4-C5 coupling and chain extension proved to be problematic when an 
asymmetric methodology was attempted (Scheme 2.6). 
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SCHEME 2.6.  Asymmetric methodologies employed in forming the C4-C5 bond with aldehyde 2.43.a 
 
a Reagents and conditions: (a) 2.48, nBu2BOTf, iPr2NEt, CH2Cl2, -78°C; (b) TBSOTf, 2,6-lutidine, THF, 
0°C; (c) Auxiliary cleavage – DIBAL-H; HN(Me)OMe; LiOH; (d) 2.49, TiCl4, (-)-Sparteine, CH2Cl2, -
78°C. 
Initially, an Evans chiral auxiliary (2.48) was employed and, to our delight, it 
furnished alcohol 2.44 in 62% yield.  Unfortunately, after alcohol silylation, the amide 
proved to be unreactive towards cleavage under hydrolysis, aminolysis, and reduction 
conditions.  Attempts to scale up the chiral aldol for further analysis proved challenging, 
as the aldol reaction was highly irreproducible, leading us to examine the Crimmins61 
(2.49) chiral aldol reaction.  Regrettably, under the reaction conditions, 2.43 remained 
unreactive, allowing for its full recovery upon quenching.  We believe the combination of 
a highly oxophilic Lewis acid (TiCl4) and an enolization-prone aldehyde such as 2.43 
quickly led to suppression of the C5 electrophilic center prior to its reaction with the 
preformed chiral enolate of 2.49. 
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2.2.3.2.  Strategy II 
We shifted our focus towards synthesizing the linear chain in a non-selective manner 
(Scheme 2.7). 
SCHEME 2.7.  Synthetic studies towards the C3 chain extension of aldehyde 2.43.a 
 
a Reagents and conditions: (a) 2.55, Zn°, benzene, reflux, 4hrs; (f) LAH, Et2O, 0°C, 1hr;  (g) PivCl, Et3N, 
DMAP. CH2Cl2, -78°C, 5 h; (h) TBSOTf, 2,6-lutidine, CH2Cl2, 0°C, 5 min. 
A Reformatsky reaction75 coupled ethyl 2-bromobutyrate (2.55) and aldehyde 2.43 to 
effectively yield syn and anti β-hydroxy esters 2.50a/b, and their respective olefin 
regioisomers, in a combined 78% yield (45% and 33% yield respectively).  The expected 
loss of the C5 stereocenter by oxidation at a later stage allowed us to bypass the 
assignment of the products’ relative stereochemistry.  We anticipated that a simple series 
of protecting group manipulations and modifications in the oxidation state of key carbon 
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atoms on 2.50a/b would permit access to rac-2.46.  Yet the molecule remained 
unreactive upon the multiple attempts to reach our goal.  Our initial plan was to protect 
C5 at the keto oxidation state, a move that would subsequently allow us to extend the 
chain at C3.  Oxidation of 2.50a with IBX followed by ethylene glycol ketalization under 
acidic and refluxing conditions (Scheme 2.7-A) failed to yield product.  Access to the C3 
electrophile was again denied after silylation of 2.50a and 2.50b (Scheme 2.7-B).  As 
with TBS-protected 2.44, and likely due to steric crowding, the molecule proved 
unreactive toward reduction with DIBAL-H or LiBH4, hydrolysis with KOH, or 
amidation with the Weinreb amine.  Treatment with LAH effectively reduced C3, but 
also removed the alcohol's TBS protection. 
A secondary protecting group sequence employed the reduced products of β-hydroxy 
esters 2.50a/b with LAH: 1,3 diols 2.51a/b (Scheme 2.7-C1).  The sequence, attempted 
on diol 2.51a, involved pivalate acylation and silylation of the primary and secondary 
hydroxyl groups, respectively, furnishing differentially dprotected intermediate 2.52a in a 
combined 32% yield.  If a selective pivalate deprotection was successful, oxidation of C3 
and olefination would effectively lead to the protected dihydro-2.52 and to the route’s 
completion.  Several pivalate deprotection methodologies involving hydrolysis, 
nucleophilic attack, and reduction were attempted, and the moiety was either unreactive, 
or a concomitant removal of the TBS group was observed. 
As a last resort, and by taking into consideration the differential electrophilicity of 
aldehydes and ketones, we hoped that double oxidation of diols 2.51a/b followed by an 
olefination reaction might lead to target rac-2.46 (Scheme 2.7-C2).  Oxidation of diol 13a 
with 2 equivalents of IBX quickly led to formation of the enone, but left the primary 
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alcohol untouched.  Addition of an extra 2 equivalents of IBX led to substrate 
decomposition. 
2.2.3.3.  Strategy III 
The route was redesigned to include the synthetic convergence by a HWE olefination 
of the previously employed mixture of aldehydes 2.30/2.30a and phosphonate 2.59 
(Scheme 2.8).  Synthesis of 2.59 began with the hydride reduction of commercially 
available diethyl ethylmalonate (2.31) in refluxing THF to produce 2.32 in 82% yield.  
Desymmetrization and monoprotection of diol 2.32 was necessary to extend the 
molecule’s carbon skeleton.  We employed a methodology developed by our lab where 
diol 2.32 and TBSCl were dissolved in a binary solvent system comprised of hexanes and 
acetonitrile, and vigorously stirred overnight to furnish monoprotected diol 2.33 (56% 
yield).  Oxidation of alcohol 2.33 under Swern conditions76 furnished aldehyde 2.34 in 
64% yield, which was easily converted via a Wittig reaction and deprotection to ester 
2.56 in 39% yield over two steps. 
SCHEME 2.8.  Synthesis of carboxylic acid 2.57.a 
 
a Reagents and conditions: (a) LAH, THF, r.t. to reflux, 36 h, 82%; (b) TBDPSCl, 1:4 MeCN-Hexanes, 
Et3N, r.t., 72 h, 56%; (c) (COCl)2, DMSO, Et3N, -60 to -78°C to r.t., 5 h, 64%; (d) 32, benzene, reflux, 
overnight; 10%HCl/MeOH, r.t., 3h, 39% over two steps; (e) K2Cr2O7, H2SO4, Acetone, 0°C, 2.5 h, 27%; 
(f) 32, benzene, reflux, overnight, 74%. 
Jones oxidation77 of alcohol 2.56 to converted it to carboxylic acid 2.57 in 27% yield.  
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Initially, several attempts to access phosphonate 2.59 were met with inconsistent results 
and side reactions.  However, careful study of the reaction conditions of alkyl 
phosphonate addition and the later substitution of the electrophile in the reaction to ester 
2.35 resulted in phosphonate 2.61 in good yield (Scheme 2.9). 
SCHEME 2.9.  Synthesis of advanced intermediates to employ for the olefination of 2.30.a 
 
a Reagents and conditions: (a) 2.60, n-BuLi, THF, -78°C to -40°C, 3 h, 60%. 
As was previously touched upon, the conditions employed for the HWE reaction 
failed to yield the expected linear chain.  It was observed that the phosphonate, under the 
reaction conditions and in the absence of an electrophile, produced the same 
uncharacterized mixture (by 1H NMR) as that found for the HWE reaction, suggesting 
decomposition of the phosphonate. 
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Heathcock et al. used a similar approach and phosphonate 2.66 towards the synthesis 
of the halichlorine family of natural products.64  They reported difficulty with the HWE 
olefination; their best yield (27%) was achieved under the Masamune-Roush conditions.  
Without additional insight into the basis of their results, they replaced the phosphonate 
2.66 with the phosphorane equivalent 2.67 (Figure 2.16) and found an increase in yield 
(66%). 
 
FIGURE 2.16.  Key olefination strategies in the synthesis of pinnaic acid. 
We attempted a similar approach by the basic hydrolysis of ester 2.35; conversion to 
the pivaloyl mixed anhydride and nucleophilic addition of ethylenetriphenylphosphorane.  
The latter step proved ineffective in the synthesis of our system, precipitating our 
decision to adjust our route. 
2.2.3.4.  Strategy IV 
Our fourth and final strategy was conceived to circumvent our setback in strategy 3 
and retain the simplicity of the route (Scheme 2.10).  The feature of our scheme is the 
Lewis acid-mediated aldol reaction between dienal 2.30 and ketone 2.37.  We converted 
ester 2.35 to Weinreb amide 2.36 by a nucleophilic addition of the deprotonated Wenreib 
amine in THF (61%).  The product was treated with ethyl Grignard to smoothly furnish 
ketone 2.37 in 62% and unreacted 2.36.  With both key fragments in hand, we proceeded 
to couple them using an aldol methodology.  Generation of the enolate was effected by 
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complexation of 2.37 at -78°C in DCM with TiCl4, followed by deprotonation of the 
activated intermediate with Hunig's base.  Dienal 2.30 was diluted in DCM and slowly 
added by syringe pump overnight to produce the β-hydroxyketone adduct, which was 
treated with MsCl/Et3N in THF to form the C6-C7 olefin, and immediately followed by 
deprotection of the C1 silyl ether with TBAF in THF to isolate the stable hydroxyketone 
tetraene 2.38 as a mixture of diastereomers (6% over three steps). 
SCHEME 2.10.  Synthesis of 2.39.a 
 
a Reagents and conditions: (a) i-PrMgCl, HCl·HN(OMe)Me, THF, -20°C, 2 h, 61%; (b) EtMgBr, THF, 
0°C, 2 h, 62%; (c) TiCl4, (i-Pr)2NEt, CH2Cl2, -78°C, overnight; MsCl, Et3N, 0°C, overnight; TBAF, THF, 
r.t., overnight, 6% over three steps; (d) (COCl)2, DMSO, Et3N, -78°C, overnight, 100%. 
The end game towards the synthesis of 2.11 began with the oxidation of alcohol 
mixture 2.38 using the Swern conditions which furnished tetraene aldehyde 2.39 as a 
mixture of diastereomers.  Gratifyingly, the C3-C4 double bond from conjugation with 
the C5 ketone to conjugation with the newly formed C1 aldehyde was unambiguously 
confirmed by 1H NMR; its signal was a singlet at 9.38 ppm. 
To test the viability of aldehyde 2.39 as a hypothetical intermediate in the 
biosynthesis of 2.11, we explored reaction conditions that we predicted would promote 
double bond regioisomerization (Scheme 2.11).  We considered MacMillan's catalyst78 an 
attractive method to mimic an enzyme's strategy for dienophile activation at mild 
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temperature conditions.  With the addition of stoichiometric amount of a Brønsted acid 
(p-TSOH) in CDCl3, we expected proton transfer and the concomitant enolization to lead 
to product.  The 1H NMR showed full conversion to the iminium ion upon treatment with 
the catalyst.  After five days and slow heating from room temperature to reflux, the 
aldehyde slowly decomposed.  To introduce greater polarization of the dienophile and 
increase the reactivity of the acyclic intermediate, we opted to employ MeAlCl2, a strong 
Lewis acid common in Diels-Alder reactions.79-81  The acyclic intermediate 2.39 was 
treated with the Lewis acid at -78°C in DCM and was slowly warmed up to room 
temperature overnight.  After aqueous workup, we were surprised to discover the intact, 
unreacted starting material. 
SCHEME 2.11.  Conditions attempted for the IMDA cyclization of aldehyde 2.39 to 2.11.a  The molecule’s 
equilibrium will be dominated by the presence of its Z or E enolate tautomers.  Only the E enolate will be 
reactive towards an IMDA.  Formation of the bicyclic IMDA adduct depends on accessing the conjugated 
E enol, as this conformation will favor the intramolecular approach of the reactive moieties. 
 
a Reagents and conditions: (1) p-TSOH, MacMillan's catalyst, r.t. to reflux, 5 d; (2) MeAlCl2, CH2Cl2, -
78°C to r.t., overnight; (3) H2O, d-DMSO, 80°C, 5 d. 
Lastly, we considered the inclusion of water in the reaction as it is known to cause an 
acceleration by promoting a minimization of the substrate's surface area exposed to the 
solvent, and consequently the enforcement of self-stabilizing hydrophobic interactions.82-
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86  The substrate was dissolved in d-DMSO and 10% H2O, and heated to 80°C for five 
days.  The use of water as a co-solvent was favored over its deuterated counterpart to 
prevent proton exchange and better follow formation of precedented bicyclic aldehyde 
2.69 by 1H NMR.53  However, intermediate 2.39 remained unreactive under the reaction 
conditions; no enolization or IMDA was observed. 
2.3.  Conclusions 
Through our synthesis of linear intermediate 2.39, we set to rationalize the 
biosynthesis of the polyketide chain and its relationship with the trans-hydrindane 
scaffold of spiculoic acid A.  We were concerned that the initial biosynthetic hypothesis 
of spiculoic acid A33 did not adequately address the double bond regiochemistry in the 
nascent polyketide.  Consequently, we developed an alternative hypothesis, and set to 
confirm it by the synthesis of a linear polyketide polyene consistent with the canon of 
PKS dehydration, with the belief it might under mild, enzyme free conditions, grant 
access to the spiculoic acid A framework.  Our convergent route was effective in 
generating the full carbon skeleton of our linear putative biomimetic intermediate.  
However, we were unable to coax the linear precursor to cyclize under either mild or 
harsh reaction conditions. 
2.3.1.  A spontaneous cycloaddition reaction is not operative 
Our hypothesis for formation of the trans-hydrindane scaffold under mild reaction 
conditions did not prove correct.  We have rationalized our results by analyzing the 
orbital coefficients of the reactive centers in our linear enol precursor to spiculoic acid A.  
We expect coefficient overlap of the reactants at the transition state to lead to the 
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preferred route to products7.  For our analysis we designed, modeled and optimized two 
simplified cyclic analogs of our enol intermediate, each representing an individual 
component of the IMDA reaction.  The A semi-empirical extended Hückel method was 
employed to generate the frontier molecular orbitals of each analog.  Our goal was to 
extract from the frontier orbitals calculated a qualitative description of the influence the 
polarizing groups would have on the coefficients and, consequently, on the 
asynchronicity of the reaction7.  Our results clearly show the incompatibility of the 
analog's orbital coefficients (Figure 2.17).  Although we did not observe enolization 
experimentally, we believe our analysis is sufficiently broad to extend to the 
cycloaddition of (E)-2.68. 
 
FIGURE 2.17.  Modeled analogs employed for the orbital coefficient analysis of the IMDA of linear 
precursor (E)-2.68 in route to spiculoic acid A. 
In addition, the stability of 2.39 under the various reaction conditions employed was 
surprising.  The absence of a mixture of aldehyde regioisomers in solution suggests a 
high barrier for enolization, likely due to a buildup of 1,3-allylic strain.  Accordingly, we 
set to understand the energy landscape and key structural characteristics of the steps 
involved in the conversion of 2.39 to 2.70, the compounds involved in the reaction 
coordinate of a putative regioisomerization step.  The results of our ab initio 
computational study are summarized in Figure 2.18. 
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FIGURE 2.18.  Ab initio analysis of regioisomerization of linear precursor 2.39.  The C10 proton (blue) is 
coplanar to the C8-C9 and C11-C12 olefins, which results in its decreased acidity and likely prevents the 
regioisomerization of the molecule's olefin system. 
In the optimized, lowest energy structure of 2.39, the coplanarity of the C10 proton to 
the C8-C9 and C11-C12 olefins's π system would minimize its acidity and clearly prevent 
the molecule's regioisomerization to a conformation favorable towards a Diels-Alder 
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cycloaddition.  Moreover, the high equilibrium energy difference between (Z)-2.68 
(+10.8 kcal/mol) and 2.39 may explain the reason for the latter's stability in solution.  
Interestingly, the (E)-2.68 necessary for an IMDA failed to converge in our attempts to 
find its energy minimum.  The structure appeared to have been caught oscillating 
between two energy minima, a telling result that strengthens the likelihood the structure 
is not viable, at least in the gas phase. 
The tacit biosynthetic implications of our analyses are two-fold: a non-canonical 
enzymatic regioisomerization step is indispensable to produce a viable compound for an 
IMDA, and likely a protein is involved in the cyclization of spiculoic acid A. 
2.3.2.  A non-canonical domain is likely responsible for the olefin regioisomerization 
The general mechanism of incorporation of double bonds in the biosynthesis of 
polyketides is shown in Figure 2.19.  The mechanism of dehydration proceeds by an 
E1cb syn elimination promoted by the catalytic histidine contained in the enzyme's 
signature HX3GX3P motif.  The acidic pro-S α-proton is transferred to the general base 
histidine, forming an intermediate thioester enolate which promptly undergoes 
elimination of the β-hydronium ion, a step that ensures that conjugation with the ACP-
thioester is preordained.87, 88 
 
FIGURE 2.19.  Canonical mechanism of dehydration in PKS DH domains. 
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Given this, an unusual non-canonical step must take place to regioisomerize the 
olefins of our linear polyketide on its way to spiculoic acid A.  Biosynthetic gene clusters 
have recently been identified of a novel class of polyketide natural products containing 
uncharacteristic domains capable of effecting a plethora of non-canonical structural 
modifications during the assembly of the linear chain.55, 58  For example, modules 7 and 9 
of the rhizoxin D's biosynthetic pathway (Figure 2.20) contain abnormal DH domains 
that isomerize the α,β-olefins to a β,γ conformation by entirely different mechanisms55, a 
model we predict to be also present during the assembly of spiculoic acid A. 
 
FIGURE 2.20.  Modules 7 and 9 from the rhizoxin D biosynthetic pathway. 
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2.5.  Experimental section 
2.5.1.  General methods 
Reactions were carried out under an argon atmosphere with dry solvents and oven-
dried glassware under anhydrous conditions unless specified otherwise.  All reactions 
were carried out under an inert argon atmosphere with dry tetrahydrofuran, diethyl ether, 
and DCM solvents by passing them through activated alumina columns.  Toluene, 
benzene, and triethylamine were freshly distilled over calcium hydride.  Reagents were 
purchased at the highest commercial quality and used without further purification, unless 
otherwise stated.  Ethyl 2-(triphenylphosphoranylidene)butyrate (2.40), and 2-
iodoxybenzoic acid (IBX) were prepared by literature methods.1, 2  Yields refer to 
chromatographically and spectroscopically (1H NMR) homogeneous materials. 
Reactions were monitored by analytical thin-layer chromatography (TLC) and carried 
out on 0.25 mm E. Merck silica gel plates (60F-254) using UV light as a visualizing 
agent and/or ceric ammonium molybdate (CAM), p-anisaldehyde (PA), and potassium 
permanganate (KMnO4) staining solutions.  Flash column chromatography was 
performed with E. Merck silica gel (60, particle size 0.040-0.063 mm).  Preparative thin-
layer chromatography (PTLC) separations were carried out on 0.25 mm E. Merck silica 
gel plates (60F-254). 
1H NMR, 13C NMR, COSY, HSQC, HMQC and HMBC spectra were recorded on the 
Bruker DPX-300 or AMX-300, AMX-400, DRX-500, and Varian Inova 500 
spectrometers and calibrated using residual undeuterated solvent as an internal reference.  
Data are reported as follows: chemical shifts in ppm (δ); multiplicities are indicated by 
the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, dd 
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= doublet of doublets, dt = doublet of triplets, td = triplet of doublets, ddd = doublet of 
doublet of doublets, m = multiplet, b = broad; coupling constants in Hz (J).  Infrared 
spectra (IR) were obtained on NaCl discs on a Nicolet IR200 series FT-IR spectrometer.  
Low resolution atmospheric pressure chemical ionization (APCI) mass spectra were 
obtained on a Shimadzu LCMS-2010A quadrupole ion trap mass spectrometer.  HRMS 
were obtained on a Kratos Analytical Concept instrument (University of Ottawa Mass 
Spectrum Centre). 
2.5.2.  Experimental procedures 
2-Ethyl-4-phenyl-but-2-enoic acid ethyl ester (2.25)a 
O
O
2.25
1
6
10
11
13
3
O
2.24  
Phenylacetaldehyde (2.24, +90% purity) (2.87 mL, 23.0 mmol) and ylide 2.40 (10.6 
g, 28.2 mmol, 1.1 equiv) were dissolved in toluene (20 mL) and gently refluxed for 10 h.  
The reaction mixture was purified directly and without work-up by silica gel 
chromatography (3% EtOAc-hexanes) affording ester 2.25 (5.02 g, 23.0 mmol, 100%) as 
a yellow oil. 
Analytical data for 2.25 
M.W.: 218.29 
TLC (Rf): 0.62 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.30 (m, 5 H, PhH), 6.95 (t, J = 7.5 Hz, 1 H, H3), 4.25 (q, J = 7.2 Hz, 2 H, 
H13), 3.56 (d, J = 7.5 Hz, 2 H, H4), 2.50 (q, J = 7.5 Hz, 2 H, H11), 1.32 
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(t, J = 7.2 Hz, 3 H, H14), 1.14 (t, J = 7.5 Hz, 3 H, H12) 
13C NMR: (75 MHz, CDCl3) 
168.1 (C(1)), 140.0 (C(Ph)), 137.6 (C(2)), 135.1 (C(3)), 129.0 (C(Ph)), 
128.9 (C(Ph)), 126.8 (C(Ph)), 60.8 (C(13)), 34.9 (C(4)), 20.5 (C(11)), 14.6 
(C(14)), 14.4 (C(12)) 
LRMS: (APCI) m/z calcd for C14H19O2 [(M+H)+] 219.13, found 219.00 
Reference: Tanaka, T.; Hiramatsu, K.; Kobayashi, Y.; Ohno, H., Chemo- and 
stereoselectivity in titanium-mediated regioselective ring-opening reaction 
of epoxides at the more substituted carbon. Tetrahedron 2005, 61 (28), 
6726-6742 
a Ester 3 was identical to its previously reported spectroscopic values 
2-Ethyl-4-phenyl-but-2-en-1-ol (2.26)a 
OH
2.26
1
6
10
11
3O
O
2.25  
Ester 2.25 (4.09 g, 18.7 mmol) was dissolved in dry dichloromethane (DCM, 20 mL) 
and cooled to 0 °C while vigorously stirring under argon.  Diisobutylaluminum hydride 
(DIBAL-H, 1.0 M in toluene, 37.5 mL, 37.5 mmol, 2.0 equiv) was added dropwise over 5 
min.  The mixture was slowly warmed-up to room temperature and stirred for 1 h.  Upon 
completion (as per TLC) the reaction was cooled to 0°C and quenched by the slow, 
stepwise addition of water (1.52 mL), aqueous 15% NaOH solution (1.52 mL), and water 
(3.8 mL).  The white, gel-like precipitate was filtered and the mother liquor extracted 
with ethyl acetate (EtOAc, 3 × 100 mL).  The organic layers were combined and washed 
with brine (150 mL), dried over Na2SO4 and filtered.  The solvent was removed in vacuo 
and the residue was purified by silica gel chromatography (10% EtOAc-hexanes) 
affording alcohol 2.26 (3.30 g, 100%) as a colorless oil. 
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Analytical data for 2.26 
M.W.: 176.25 
TLC (Rf): 0.22 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.30 (m, 5 H, PhH), 5.60 (t, J = 7.5 Hz, 1 H, H3), 4.11 (d, J = 0.9 Hz, 2 H, 
H1), 3.48 (d, J = 7.5 Hz, 2 H, H4), 2.28 (q, J = 7.5 Hz, 2 H, H11), 1.13 (t, J 
= 7.5 Hz, 3 H, H12) 
13C NMR: (75 MHz, CDCl3) 
141.7 (C(2)), 141.2 (C(Ph)), 128.7 (C(Ph)), 128.5 (C(Ph)), 124.6 (C(Ph)), 
66.0 (C(1)), 33.8 (C(4)), 21.3 (C(11)), 13.5 (C(12)) 
LRMS: (APCI) m/z calcd for C12H15 [(M+H)+-H2O] 159.12, found 159.00 
Reference: Tanaka, T.; Hiramatsu, K.; Kobayashi, Y.; Ohno, H., Chemo- and 
stereoselectivity in titanium-mediated regioselective ring-opening reaction 
of epoxides at the more substituted carbon. Tetrahedron 2005, 61 (28), 
6726-6742 
a Alcohol 2.26 was identical to its previously reported spectroscopic values. 
2-Ethyl-4-phenyl-but-2-enal (2.27)a 
O
2.27
1
3
6
10
11
H
OH
2.26  
Alcohol 2.26 (1.54 g, 8.68 mmol) and iodoxybenzoic acid (IBX, 4.87 g, 17.4 mmol, 
2.0 equiv) were dissolved in dimethylsulfoxide (DMSO, 22 mL) by vigorously stirring at 
room temperature for 1 h 20 min.  Upon completion, the mixture was purified without 
work-up by silica gel chromatography (10% EtOAc-hexanes) affording aldehyde 2.27 
(1.46 g, 8.38 mmol, 97%) as a colorless oil. 
Analytical data for 2.27 
M.W.: 174.10 
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TLC (Rf): 0.60 (20% EtOAc-hexanes) 
IR: (Film) 
2970, 1691, 1493, 1454, 1376, 1224, 1065, 796, 745, 699, 519 
1H NMR: (300 MHz, CDCl3) 
9.41 (s, 1 H, H1), 7.29 (m, 5 H, PhH), 6.57 (t, J = 7.5 Hz, 1 H, H3), 3.71 
(d, J = 7.5 Hz, 2 H, H4), 2.40 (q, J = 7.5 Hz, 2 H, H11), 1.05 (t, J = 7.5 Hz, 
3 H, H12) 
13C NMR: (75 MHz, CDCl3) 
195.1 (C(1)), 152.1 (C(2)), 145.5 (C(3)), 138.4 (C(Ph)), 129.0 (C(Ph)), 
128.6 (C(Ph)), 126.9 (C(Ph)), 35.0 (C(4)), 17.5 (C(11)), 13.6 (C(12)) 
LRMS: (APCI) m/z calcd for C12H16O [(M+H)+] 175.12, found 175.00 
Reference: Bruch, A.; Gebert, A.; Breit, B., Tandem-directed regioselective 
hydroformylation/beta -elimination: a practical method for the synthesis of 
enals. Synthesis 2008, (14), 2169-2176 
a Aldehyde 2.27 was identical to its previously reported spectroscopic values. 
2,4-Diethyl-6-phenyl-hexa-2,4-dienoic acid ethyl ester (2.28) 
2,4-Diethyl-6-phenyl-hexa-2,5-dienoic acid ethyl ester (2.28a) 
O
O
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2.27  
Aldehyde 2.27 (1.46 g, 8.38 mmol) and ylide 2.40 (5.04 g, 13.4 mmol, 1.6 equiv) 
were dissolved in benzene (21 mL), and the pale yellow solution was refluxed for 20 h.  
Purification was performed directly without work-up by silica gel chromatography (4% 
EtOAc-hexanes) affording an inseparable mixture of ester isomers 2.28 and 2.28a (400 
mg, 1.47 mmol, 37%) as well as unreacted starting material (470 mg, 2.7 mmol, 32%) 
that was re-subjected to the above conditions. 
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Analytical data for 2.28 
M.W.: 272.38 
TLC (Rf): 0.51 (10% EtOAc-hexanes). 
IR: (Film) 
3027, 2968, 2934, 2875, 1711, 1640, 1494, 1236, 1128, 746, 698 
1H NMR: (500 MHz, CDCl3) 
7.38-7.34 (m, 5 H, PhH), 7.27 (s, 1 H, H3), 5.82 (t, J = 7.5 Hz, 1 H, H5), 
4.45-4.35 (q, J = 7 Hz, 2 H, H17), 3.67 (d, J = 7.5 Hz, 2 H, H6), 2.61 (q, J 
= 7.5 Hz, 2 H, H15), 2.46 (q, J = 7.5 Hz, 2 H, H13), 1.46 (t, J = 7 Hz, 3 H, 
H18), 1.23-1.17 (m, 6 H, H14 & H16) 
13C NMR: (125 MHz, CDCl3) 
168.62 (C(1)), 141.27 (C(3)), 140.68 (C(4)), 138.88 (C(Ph)), 136.07 (C(2)), 
129.88 (C(5)), 129.36 (C(Ph)), 128.70 (C(Ph)), 126.26 (C(Ph)), 60.61 
(C(17)), 34.33 (C(6)), 23.72 (C(13)), 21.17 (C(15)), 14.49 (C(18)), 14.06 
(C(16)), 13.57 (C(14)) 
HRMS: (EI) m/z calcd for C18H24O2 [(M)+] 272.1776, found 272.1770 
Analytical data for 2.28a 
M.W.: 272.38 
TLC (Rf): 0.51 (10% EtOAc-hexanes). 
IR: (Film) 
3027, 2968, 2934, 2875, 1711, 1640, 1494, 1236, 1128, 746, 698 
1H NMR: (500 MHz, CDCl3) 
7.47-7.44 (m, 5 H, PhH), 6.78 (d, J = 10 Hz, 1 H, H3), 6.53 (d, J = 16 Hz, 1 
H, H6), 6.25 (dd, J = 15.5, 7.5 Hz, 1 H, H5), 4.44-4.36 (q, J = 7 Hz, 2 H, 
H17), 3.30 (m, 1 H, H4), 2.54 (q, J = 7.5 Hz, 2 H, H13), 1.80-1.67 (m, 2 H, 
H15), 1.46 (t, J = 7 Hz 3 H, H18), 1.23-1.17 (m, 3 H, H14), 1.10 (t, J = 7.5 
Hz, 3 H, H16) 
13C NMR: (125 MHz, CDCl3) 
168.48 (C(1)), 143.26 (C(3)), 135.24 (C(Ph)), 134.02 (C(2)), 131.67 (C(5)), 
130.20 (C(6)), 128.62 (C(Ph)), 128.46 (C(Ph)), 126.26 (C(Ph)), 60.88 
(C(17)), 44.17 (C(4)), 28.43 (C(15)), 21.00 (C(13)), 14.49 (C(18)), 14.73 
(C(14)), 12.03 (C(16)) 
HRMS: (EI) m/z calcd for C18H24O2 [(M)+] 272.1776, found 272.1770 
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2,4-Diethyl-6-phenyl-hexa-2,4-dien-1-ol (2.29) 
2,4-Diethyl-6-phenyl-hexa-2,5-dien-1-ol (2.29a) 
OH
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Esters 2.28 and 2.28a (1.35 g, 4.96 mmol) were dissolved in toluene (25 mL) and 
cooled in an acetone-dry ice bath to -78 °C under argon.  DIBAL-H (1.0 M in toluene, 
19.8 mL, 19.8 mmol, 4.0 equiv) was added by syringe over 15 min.  The solution was 
warmed up slowly to room temperature and stirred for 1 h.  Quenched the mixture by the 
slow, stepwise addition of water (0.79 mL), aqueous 15% NaOH solution (0.79 mL), and 
water (1.98 mL).  The gel-like precipitate was filtered and the mother liquor extracted 
with ethyl acetate (EtOAc, 2 × 20 mL), washed with brine (20 mL), dried over Na2SO4 
and filtered.  The solvent was removed in vacuo and the residue purified by silica gel 
chromatography (10% EtOAc-hexanes) affording an inseparable mixture of alcohols 2.29 
and 2.29a (1.14 g, 100%) as a colorless oil. 
Analytical data for 2.29 
M.W.: 230.35 
TLC (Rf): 0.39 (30% EtOAc-hexanes). 
IR: (Film) 
3315, 3026, 2964, 2873, 1494, 1454, 1029, 744, 695 
1H NMR: (500 MHz, CDCl3) 
7.20-7.00 (m, 5 H, PhH), 5.74 (s, 1 H, H3), 5.30 (t, J = 7.5 Hz, 1 H, H5), 
3.95 (s, 2 H, H1), 3.31 (d, J = 7.5 Hz, 2 H, H6), 2.17-1.99 (m, 4 H, H13 & 
H15), 0.98-0.84 (m, 6 H, H14 & H16) 
13C NMR: (125 MHz, CDCl3) 
142.03 (C(4)), 141.43 (C(2)), 139.13 (C(Ph)), 128.75 (C(Ph)), 128.45 
(C(Ph)), 127.65 (C(3)), 126.17 (C(5)), 125.99 (C(Ph)), 66.62 (C(1)), 34.22 
(C(6)), 24.23 (C(15)), 21.98 (C(13)), 13.71 (C(14)), 13.52 (C(16)) 
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HRMS: (EI) m/z calcd for C16H22O [(M)+] 230.1671, found 230.1665 
Analytical data for 2.29a 
M.W.: 230.35 
TLC (Rf): 0.39 (30% EtOAc-hexanes) 
IR: (Film) 
3315, 3026, 2964, 2873, 1494, 1454, 1029, 744, 695 
1H NMR: (500 MHz, CDCl3) 
7.20-7.00 (m, 5 H, PhH), 6.20 (d, J = 16 Hz, 1 H, H6), 5.95 (dd, J = 16, 7.5 
Hz, 1 H, H5), 5.14 (d, J = 9.5 Hz, 1 H, H3), 3.93 (s, 2 H, H1), 2.90 (m, 1 H, 
H4), 2.17-1.99 (m, 2 H, H13), 1.50-1.20 (m, 2 H, H15), 0.98-0.84 (m, 3 H, 
H14), 0.77 (t, J = 7.5 Hz, 3 H, H16) 
13C NMR: (125 MHz, CDCl3) 
141.11 (C(2)), 137.90 (C(Ph)), 133.76 (C(5)), 128.91 (C(6)), 128.61 
(C(Ph)), 128.35 (C(Ph)), 128.20 (C(3)), 126.61 (C(Ph)), 66.71 (C(1)), 43.03 
(C(4)), 28.87 (C(15)), 21.53 (C(13)), 13.39 (C(14)), 12.02 (C(16)) 
HRMS: (EI) m/z calcd for C16H22O [(M)+] 230.1671, found 230.1665 
2,4-Diethyl-6-phenyl-hexa-2,4-dienal (2.30) 
2,4-Diethyl-6-phenyl-hexa-2,5-dienal (2.30a) 
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Alcohols 2.29 and 2.29a (790 mg, 3.43 mmol) and IBX (1.92 g, 6.86 mmol, 2.0 
equiv) were dissolved in DMSO (9 mL) by vigorously stirring at room temperature for 1 
h and 20 min.  Purified the mixture directly and without prior work-up by silica gel 
chromatography (10% EtOAc-hexanes) affording inseparable aldehydes 2.30 and 2.30a 
(760 mg, 3.33 mmol, 97%) as a colorless oil. 
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Analytical data for 2.30 
M.W.: 228.33 
TLC (Rf): 0.67 (30% EtOAc-hexanes) 
IR: (Film) 
3027, 2968, 2875, 2711, 1685, 1613, 1454, 1377, 1189, 1060, 967, 910, 
793, 747, 697 
1H NMR: (500 MHz, CDCl3) 
9.40 (s, 1H, H1), 7.39-7.23 (m, 5 H, PhH), 6.72 (s, 1 H, H3), 5.94 (t, J = 7.5 
Hz, 1 H, H5), 3.59 (d, J = 7.5 Hz, 2 H, H6), 2.48-2.37 (m, 4 H, H13 & 
H15), 1.12-1.03 (m, 6 H, H14 & H16) 
13C NMR: (125 MHz, CDCl3) 
195.26 (C(1)), 152.98 (C(3)), 145.03 (C(4)), 143.51 (C(2)), 139.02 (C(7)), 
134.53 (C(5)), 128.89 (C(Ph)), 127.71 (C(Ph)), 126.38 (C(Ph)), 34.59 
(C(6)), 23.25 (C(15)), 18.35 (C(13)), 13.92 (C(14)), 13.68 (C(16)) 
HRMS: (EI) m/z calcd for C16H20O [(M+)] 228.1514, found 228.1497 
Analytical data for 2.30a 
M.W.: 228.33 
TLC (Rf): 0.67 (30% EtOAc-hexanes) 
IR: (Film) 
3027, 2968, 2875, 2711, 1685, 1613, 1454, 1377, 1189, 1060, 967, 910, 
793, 747, 697 
1H NMR: (500 MHz, CDCl3) 
9.44 ( s, 1 H, H1), 7.39-7.23 (m, 5 H, PhH), 6.45 (d, J = 16 Hz 1 H, H6), 
6.33 (d, J = 10 Hz, 1 H, H3), 6.13 (dd, J = 16, 7.5 Hz, 1 H, H5), 3.36 (m, 1 
H, H4), 2.36-2.31 (m, 2 H, H13), 1.74-1.61 (m, 2 H, H15), 1.12-1.03 (m, 3 
H, H14), 0.98 (t, J = 7.5 Hz, 3H, H16) 
13C NMR: (125 MHz, CDCl3) 
196.04 (C(1)), 155.54 (C(3)), 152.08 (C(2)), 137.30 (C(7)), 130.97 (C(6)), 
130.62 (C(5)), 128.81 (C(Ph)), 128.54 (C(Ph)), 126.53 (C(Ph)), 44.30 
(C(4)), 28.33 (C(15)), 17.84 (C(13)), 13.84 (C(14)), 11.92 (C(16)) 
HRMS: (EI) m/z calcd for C16H20O [(M+)] 228.1514, found 228.1497 
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4,6-Diethyl-2-methyl-8-phenyl-octa-2,4,6-trienoic acid ethyl ester (2.41) 
4,6-Diethyl-2-methyl-8-phenyl-octa-2,4,7-trienoic acid ethyl ester (2.41a) 
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Aldehydes 2.30 and 2.30a (760 mg, 3.33 mmol) and ylide 2.47 (3.02 g, 8.33 mmol, 
2.5 equiv) were dissolved in benzene (20 mL) and refluxed overnight.  The mixture was 
directly purified without work-up by silica gel chromatography (4% EtOAc-hexanes) 
affording a mixture of inseparable esters 2.41 and 2.41a (880 mg, 2.82 mmol, 85%) as a 
pale yellow oil. 
Analytical data for 2.41 
M.W.: 312.45 
TLC (Rf): 0.70 (20% EtOAc-hexanes) 
IR: (Film) 
3061, 3026, 2964, 2874, 1713, 1631, 1453, 1367, 1248, 1114, 1031, 964, 
912, 746, 696 
1H NMR: (500 MHz, CDCl3) 
7.20-7.00 (m, 5 H, PhH), 6.96 (s, 1 H, H3), 5.72 (s, 1H, H5), 5.36 (t, J = 7.5 
Hz, 1 H, H7), 4.04 (q, J = 7.5 Hz, 2 H, H20), 3.33 (d, J = 7.5 Hz, 2 H, H8), 
2.10-2.05 (m, 4 H, H16 & H18), 1.83 (d, J = 1.5 Hz, 3 H, H15), 1.15 (t, J = 
7.5 Hz, 3 H, H21), 0.88-0.76 (m, 6 H, H17 & H19) 
13C NMR: (125 MHz, CDCl3) 
169.13 (C1)), 142.27 (C(3)), 142.05 (C(4)), 139.19 (C(6)), 138.35 (C(Ph)) 
134.29 (C(5)), 131.55 (C(2)), 128.52 (C(Ph)), 127.25 (C(7)), 126.26 
(C(Ph)), 60.81 (C(20)), 34.40 (C(8)), 24.31 (C(16)), 24.04 (C(18)), 14.53 
(C(21), 14.34 (C(15)), 14.18 (C(17)), 13.46 (C(19)) 
LRMS: (APCI) m/z calcd for C21H29O2 [(M+H)+] 313.22, found 313.05 
Analytical data for 2.41a 
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M.W.: 312.45 
TLC (Rf): 0.70 (20% EtOAc-hexanes) 
IR: (Film) 
3061, 3026, 2964, 2874, 1713, 1631, 1453, 1367, 1248, 1114, 1031, 964, 
912, 746, 696 
1H NMR: (500 MHz, CDCl3) 
7.20-7.00 (m, 5 H, PhH), 6.96 (s, 1 H, H3), 6.20 (d, J = 16 Hz, 1 H, H8), 
5.94 (dd, J = 16, 7.5 Hz,  1 H, H7), 5.18 (d, J = 10 Hz, 1 H, H5), 4.04 (q, J 
= 7.5 Hz, 2 H, H20), 2.96 (m, 1 H, H6), 2.15 (q, J = 7.5 Hz, 2 H, H16), 1.82 
(d, J = 1.5 Hz, 3 H, H15), 1.47-1.30 (m, 2 H, H18), 1.15 (t, J = 7.5 Hz, 3 H, 
H21), 0.88-0.76 (m, 6H, H17 & H19) 
13C NMR: (125 MHz, CDCl3) 
169.06 (C(1)), 141.87 (C(3)), 141.25 (C(4)), 137.86 (C(Ph)), 135.29 (C(5)), 
133.16 (C(7)), 131.38 (C(2)), 129.35 (C(8)), 128.97 (C(Ph)), 128.70 
(C(Ph)), 126.14 (C(Ph)), 60.81 (C(20)), 43.67 (C(6)), 28.90 (C(18)), 24.76 
(C(16)), 14.53 (C(21)), 14.29 (C(15)), 13.69 (C(17)), 12.14 (C(19)) 
LRMS: (APCI) m/z calcd for C21H29O2 [(M+H)+] 313.22, found 313.05 
4,6-Diethyl-2-methyl-8-phenyl-octa-2,4,6-trien-1-ol (2.42) 
4,6-Diethyl-2-methyl-8-phenyl-octa-2,4,7-trien-1-ol (2.42a) 
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Esters 2.41 and 2.41a (880 mg, 2.82 mmol) were dissolved by vigorously stirring in 
toluene (5 mL) and cooled in an acetone-dry ice bath to -78 °C under argon.  DIBAL-H 
(1.0 M in toluene, 26.3 mL, 26.3 mmol, 9.0 equiv) was added dropwise over 15 min.  The 
reaction was warmed-up to room temperature and stirred an additional 2.5 h.  The 
reaction was quenched by the slow, stepwise addition of water (0.6 mL), aqueous 15% 
NaOH solution (0.6 mL), and water (1.5 mL).  The precipitate was filtered and the 
mother liquor washed with brine (15 mL), dried over Na2SO4 and filtered.  The solvent 
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was removed in vacuo and the residue purified by silica gel chromatography (10% 
EtOAc-hexanes) affording alcohols 2.42 and 2.42a (662 mg, 2.45 mmol, 87%) as a 
colorless oil. 
Analytical data for 2.42 
M.W.: 270.41 
TLC (Rf): 0.22 (20% EtOAc-hexanes) 
IR: (Film) 
3323, 3025, 2963, 1494, 1452, 1376, 1070, 963, 908, 745, 695 
1H NMR: (500 MHz, CDCl3) 
7.20-7.00 (m, 5 H, PhH), 5.70 (s, 1 H, H3), 5.57 (s, 1 H, H5), 5.32 (t, J = 
7.5 Hz, 1 H, H7), 3.91 (s, 2 H, H1), 3.32 (d, J = 7.5 Hz, 2 H, H8), 2.11-1.98 
(m, 4 H, H16 & H18), 1.65 (d, J = 1.5 Hz, 3 H, H15), 0.89-0.77 (m, 6 H, 
H17 & H19) 
13C NMR: (125 MHz, CDCl3) 
139.63 (C(6)), 139.51 (C(4)), 138.53 (C(2)), 136.44 (C(Ph)), 130.76 (C(5)), 
128.55 (C(Ph)), 127.73 (C(3)), 126.13 (C(Ph)), 125.93 (C(7)), 125.80 
(C(Ph)), 69.10 (C(1)), 34.28 (C(8)), 25.10 (C(18)), 24.49 (C(16)), 15.48 
(C(15)), 13.98 (C(19)), 13.44 (C(17)) 
LRMS: (APCI) m/z calcd for C19H25 [(M+H)+-H2O] 253.20, found 253.05 
Analytical data for 2.42a 
M.W.: 270.41 
TLC (Rf): 0.22 (20% EtOAc-hexanes) 
IR: (Film) 
3323, 3025, 2963, 1494, 1452, 1376, 1070, 963, 908, 745, 695 
1H NMR: (500 MHz, CDCl3) 
7.20-7.00 (m, 5 H, PhH), 6.21 (d, J = 16 Hz, 1 H, H8), 5.99 (dd, J = 16, 7 
Hz, 1 H, H7), 5.75 (s, 1 H, H3), 4.99 (d, J = 7 Hz, 1 H, H5), 3.91 (s, 2 H, 
H1), 2.94 (m, 1 H, H6), 2.11-1.98 (m, 2 H, H16), 1.67 (d, J = 1.5 Hz, 3 H, 
H15), 1.50-1.35 (m, 2 H, H18), 0.89-0.77 (m, 6 H, H17 & H19) 
13C NMR: (125 MHz, CDCl3) 
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1441.48 (C(4)), 137.99 (C(2)), 135.93 (C(Ph)), 133.95 (C(7)), 131.10 
(C(5)), 128.74 (C(8)), 128.55 (C(Ph)), 127.44 (C(Ph)), 127.96 (C(3)), 
126.97 (C(Ph)), 69.10 (C(1)), 43.47 (C(6)), 28.97 (C(18)), 24.39 (C(16)), 
15.48 (C(15)), 13.39 (C(17)), 12.10 (C(19)) 
LRMS: (APCI) m/z calcd for C19H25 [(M+H)+-H2O] 253.20, found 253.05 
Calcd: 271.21 
Found: 253.05 (C12H15+ (M-18)+) 
4,6-Diethyl-2-methyl-8-phenyl-octa-2,4,6-trienal (2.43) 
4,6-Diethyl-2-methyl-8-phenyl-octa-2,4,7-trienal (2.43a) 
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Alcohols 2.42 and 2.42a (662 mg, 2.45 mmol) and IBX (1.37 g, 4.90 mmol, 2.0 
equiv) were dissolved in DMSO (22 mL) and vigorously stirred at room temperature for 
45 min.  The mixture was purified directly and without prior work-up by silica gel 
chromatography (10% EtOAc-hexanes) affording an inseparable mixture of aldehydes 
2.43 and 2.43a (536 mg, 2.0 mmol, 82%) as a yellow oil. 
Analytical data for 2.43 
M.W.: 268.39 
TLC (Rf): 0.59 (20% EtOAc-hexanes) 
IR: (Film) 
3341, 2963, 2710, 1686, 1494, 1378, 1198, 1014, 912, 746 
1H NMR: (500 MHz, CDCl3) 
9.27 (s, 1 H, H1), 7.20-6.99 (m, 5 H, PhH), 6.58 (s, 1 H, H3), 5.99 (s, 1 H, 
H5), 5.44 (t, J = 7.5 Hz, 1 H, H7), 3.34 (d, J = 7.5 Hz, 2 H, H8), 2.29 (q, J 
= 7.5 Hz, 2 H, H18), 2.12 (q, J = 7.5 Hz, 2 H, H16), 1.77 (d, J = 1.5 Hz, 3 
H, H15),  0.93-0.79 (m, 6 H, H17 & H19) 
13C NMR: (125 MHz, CDCl3) 
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195.99 (C(1)), 153.95 (C(3)), 139.19 (C(2)), 138.91 (C(6)), 138.62 (C(4)), 
138.05 (C(5)), 137.02 (C(Ph)), 128.70 (C(Ph)), 128.49 (C(7) & (C(Ph))), 
126.26 (C(Ph)), 34.43 (C(8)), 24.20 (C(16) & C(18)), 14.48 (C(17)), 13.50 
(C(19)), 11.06 (C(15)) 
LRMS: (APCI) m/z calcd for C19H25O [(M+H)+] 269.19, found 269.05 
Analytical data for 2.43a 
M.W.: 268.39 
TLC (Rf): 0.59 (20% EtOAc-hexanes) 
IR: (Film) 
3341, 2963, 2710, 1686, 1494, 1378, 1198, 1014, 912, 746 
1H NMR: (500 MHz, CDCl3) 
9.28 ( s, 1 H, H1), 7.39-7.23 (m, 5 H, PhH), 6.59 (s, 1 H, H3), 6.22 (d, J = 
16 Hz 1 H, H8), 5.94 (dd, J = 16, 7.5 Hz, 1 H, H7), 5.47 (d, J = 9.5 Hz, 1 H, 
H5), 3.02 (m, 1 H, H6), 2.21 (q, J = 7.5 Hz, 2 H, H16), 1.78 (d, J = 1.5 Hz, 
3 H, H15), 1.48-1.36 (m, 2 H, H18), 0.93-0.79 (m, 6 H, H17 & H19) 
13C NMR: (125 MHz, CDCl3) 
196.00 (C(1)), 153.58 (C(3)), 140.91 (C(2)), 139.73 (C(5)), 137.64 (C(Ph)), 
137.49 (C(4)), 132.38 (C(7)), 129.85 (C(8)), 128.70 (C(Ph)), 128.49 
(C(Ph)), 126.26 (C(Ph)), 43.91 (C(6)), 28.81 (C(18)), 23.53 (C(16)), 13.99 
(C(17)), 12.06 (C(19)), 10.96 (C(15)) 
LRMS: (APCI) m/z calcd for C19H25O [(M+H)+] 269.19, found 269.05 
(4E,6E,8E)-Ethyl 2,6,8-triethyl-3-hydroxy-4-methyl-10-phenyldeca-4,6,8-trienoate 
(2.44) 
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To a well stirred solution of aldehyde 2.43 and 2.43a (107 mg, 0.40 mmol) in 
benzene (0.40 mL), zinc metal (29 mg, 0.44 mmol, 1.1 equiv) and 2-3 crystals of iodine 
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were added.  Ethyl 2-bromobutyrate (2.55, 62 μL, 1.05 equiv) was added over 5 minutes 
and heated mixture to reflux.  After 10 minutes, dark green solution had turned ochre.  
Continued to reflux for a total of 3 hours and solution was then cooled to room 
temperature.  Once cool, quenched reaction with 10% aqueous H2SO4 (1 mL) and 
extracted with EtOAc (3 x 1 mL), dried organic phase over Na2SO4 and filtered.  
Evaporated solvent in vacuo and purified residue by silica gel chromatography (10% 
EtOAc-hexanes) affording alcohols 2.50 (68 mg, 0.18 mmol, 45%) and 2.50a (51 mg, 
0.13 mmol, 33%) as pale yellow oils. 
Analytical data for 2.50 (two regioisomers) 
M.W.: 384.27 
TLC (Rf): 0.33 (20% EtOAc-hexanes) 
IR: (Film) 
3462, 2965, 2930, 1731, 1459, 1375, 1262, 1179, 1031, 746, 696 
1H NMR: (500 MHz, CDCl3) - Regioisomer I 
7.18-6.97 (m, 5 H), 5.76 (s, 1 H), 5.49 (s, 1 H), 5.26 (t, 1 H), 4.07 (d, J = 
6.5 Hz, 1 H), 4.03-3.92 (m, 2 H), 3.30 (d, J = 7.5 Hz, 2H), 2.40 (m, 1 H), 
2.40 (m, 1 H), 2.06-1.93 (m, 2 H), 1.60 (s, 3 H), 1.56-1.27 (m, 4 H), 1.11-
1.01 (m, 3 H), 0.85-0.66 (m, 9 H) 
1H NMR: (500 MHz, CDCl3) - Regioisomer II 
7.18-6.97 (m, 5 H), 6.18 (dd, J = 15.5, 7,5 Hz, 1 H), 5.94 (m, 1 H), 5.74 (s, 
1 H), 4.91 (d, J = 9.5 Hz, 1 H), 4.07 (d, J = 6.5 Hz, 1 H), 4.03-3.92 (m, 2 
H), 2.90 (quintet, J = 8.0 Hz, 1 H), 2.40 (m, 1 H), 2.06-1.93 (m, 2 H), 1.61 
(s, 3 H), 1.56-1.27 (m, 4 H), 1.11-1.01 (m, 3 H), 0.85-0.66 (m, 9 H) 
Analytical data for 2.50a (two regioisomers) 
M.W.: 384.27 
TLC (Rf): 0.25 (20% EtOAc-hexanes) 
IR: (Film) 
3461, 2964, 2931, 2874, 1733, 1459, 1376, 1267, 1178, 1028, 746, 695 
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1H NMR: (500 MHz, CDCl3) – Regioisomer I 
1H NMR of Regioisomer I is inconclusive. 
1H NMR: (500 MHz, CDCl3) – Regioisomer II 
7.17-7.00 (m, 5 H), 6.19 (dd, J = 16, 4.5 Hz, 1 H), 5.94 (ddd, J = 16, 4.5, 
2.0 Hz, 1 H), 5.72 (s, 1 H), 4.93 (d, J = 9.5 Hz, 1 H), 4.00 (m, 3 H), 2.90 
(quintet, J = 8.0 Hz, 1 H), 2.42 (m, 1 H), 2.08-1.93 (m, 2 H), 1.58 (s, 3 H), 
1.46-1.28 (m, 4 H), 1.12-1.07 (m, 3 H), 0.84-0.69 (m, 9 H) 
2-(Hydroxymethyl)butanol (2.32) 
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Diethyl ethylmalonate 2.31 (941 mg, 5.00 mmol) was added dropwise to a solution of 
lithium aluminum hydride (LAH, 285 mg, 7.53 mmol, 30.0 equiv) vigorously stirred in 
tetrahydrofuran (THF, 50 mL) at 0°C.  The resulting reaction was warmed up to r.t. and 
stirred overnight.  To bring the reaction to completion, solution was refluxed for an 
additional 24 h.  After cooling the mixture, it was quenched with 0.4 ml H2O, followed 
by 0.4 mL 15% NaOH(aq) and lastly 1.2 mL H2O.  Precipitated aluminum salts were 
filtered and the oil was purified by silica gel chromatography (30% EtOAc-hexanes) 
affording diol 2.32 (427 mg, 4.10 mmol, 82%) as a clear oil. 
Analytical data for 2.32a 
M.W.: 104.15 
TLC (Rf): 0.20 (40% Acetone-hexanes) 
1H NMR: (400 MHz, CDCl3) 
3.80 (dd, J = 12, 4 Hz, 2 H, H1' & H3'), 3.64 (dd, J = 12, 8 Hz, 2 H, H1'' & 
H3''), 1.66 (m, 1 H, H2), 1.44 (bs, 2 H, OH), 1.27 (quintet, J = 8 Hz, 2 H, 
H4), 0.93 (t, J = 8 Hz, 3 H, H5) 
13C NMR: (100 MHz, CDCl3) 
66.49 (C(1)), C(3)), 43.69 (C(2)), 20.61 (C(4)), 11.74 (C(5)) 
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Reference: Harabe, T.; Matsumoto, T.; Shioiri, T., Esters of 2,5-multisubstituted-1,3-
dioxane-2-carboxylic acid: their conformational analysis and selective 
hydrolysis. Tetrahedron 2009, 65 (20), 4044-4052 
a Diol 2.32 was identical to its previously reported spectroscopic values. 
2-((tert-Butyldiphenylsilyloxy)methyl)butan-1-ol (2.33) 
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Diol 2.32 (521 mg, 5.00 mmol) was dissolved in a 1:4 biphasic solution of 
acetonitrile and hexanes (10 mL and 40 mL respectively), to which triethylamine (Et3N, 
0.84 mL, 1.2 equiv) and finally tert-butyldiphenylsilyl chloride (TBDPSCl, 1.3 mL, 5.0 
mmol, 1.0 equiv) were added.  Stirred at r.t. for 72 h, quenched with a saturated NH4Cl 
solution, and extracted with EtOAc (3 x 20 mL), dried organic phase over Na2SO4 and 
filtered.   Solvent was evaporated in vacuo and the residual oil purified by silica gel 
chromatography (5% EtOAc-hexanes) affording monoprotected diol 2.33 (962 mg, 2.81 
mmol, 56%) as a colorless oils. 
Analytical data for 2.33a 
M.W.: 342.55 
TLC (Rf): 0.38 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.67-7.64 (m, 4 H, PhH), 7.45-7.36 (m, 6 H, PhH), 3.84-3.60 (m, 4 H, H1 
& H3), 1.73-1.64 (dd, J = 4.4, 2 Hz, 1 H, OH), 1.31-1.18 (m, 2 H, H4), 
1.04 (s, 9 H, H6), 0.83 (t, J = 7.6 Hz, 3 H, H5) 
13C NMR: (100 MHz, CDCl3) 
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135.61 (2 C, Ph), 135.60 (2 C, Ph'), 133.10 (C(Ph)), 133.08 (C(Ph')), 
129.83 (2 C, Ph, Ph'), 127.79 (2 C, Ph), 127.73 (2 C, Ph'), 67.22 (C(1)), 
65.93 (C(3)), 43.94 (C(2)) , 26.86 (3 C, C(6)), 20.55 (C(4)), 19.15 (C(7)), 
11.69 (C(5)) 
Reference: Schmittberger, T.; Uguen, D., A formal synthesis of brassinolide. 
Tetrahedron Lett. 1997, 38(16), 2837-2840 
a 2.33 was identical to its previously reported spectroscopic values. 
2-((tert-Butyldiphenylsilyloxy)methyl)butanal (2.34) 
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In a round bottomed flask (r.b.f.) oxalyl chloride ((COCl)2, 0.27 mL, 3.1 mmol, 3.5 
equiv) was dissolved in dichloromethane (5.8 mL) and cooled to -60°C.  
Dimethylsulfoxide (0.31 mL, 4.4 mmol, 5.0 equiv) was added dropwise at this 
temperature, and immediately upon addition gas generation was observed.  The solution 
was stirred for an additional 30 min at -60°C, at which point the temperature was lowered 
to -78°C.  A precooled (-78°C) solution of monoprotected diol 2.33 (300 mg, 0.88 mmol) 
in DCM (3 mL) was added dropwise by cannula and the white and opaque mixture was 
stirred for 1 h.  Triethylamine (1.22 mL, 8.8 mmol, 10 equiv) was added dropwise and 
the thick slurry was slowly warmed to r.t.  after which distilled water (3mL) was added to 
quench.  Extracted with EtOAc (3 x 10 mL), dried organic phase over Na2SO4 and 
filtered.  After evaporation of solvent the oil was purified by silica gel chromatography 
(5% EtOAc-hexanes) affording aldehyde 2.34 (192 mg, 0.56 mmol, 64%) as a clear oil. 
Analytical data for 2.34a 
M.W.: 340.53 
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TLC (Rf): 0.64 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
9.71 (d, J = 2.4 Hz, 1 H, H3), 7.63-7.61 (m, 4 H, PhH), 7.42-7.24 (m, 6 H, 
PhH), 3.86 (m, 2 H, H1), 2.34 (m, 1 H, H2), 1.74 (m, 1 H, H4'), 1.46 (m, 1 
H, H4''), 1.01 (s, 9 H, H6), 0.86 (t, J = 7.2 Hz, 3 H, H5) 
13C NMR: (100 MHz, CDCl3) 
204.6 (C(3)), 135.59 (4 C, Ph, Ph'), 133.19 (C(Ph)), 133.17 (C(Ph')), 
129.81 (2 C, Ph, Ph'), 127.76 (4 C, Ph, Ph'), 62.32 (C(1)), 55.85 (C(2)), 
26.76 (3 C, C(6)), 19.24 (C(7)), 18.51 (C(4)), 11.43 (C(5)) 
Reference: Smith, A. B., III; Cox, J. M.; Furuichi, N.; Kenesky, C. S.; Zheng, J.; 
Atasoylu, O.; Wuest, W. M., Total Synthesis of (−)-2-epi-Peloruside A. 
Org. Lett. 2008, 10(24), 5501-5504 
a Aldehyde 2.34 was identical to its previously reported spectroscopic values. 
(E)-Ethyl 4-((tert-butyldiphenylsilyloxy)methyl)-2-ethylhex-2-enoate (2.35) 
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Aldehyde 2.34 (670 mg, 1.96 mmol) and ylide 2.40 (1.5 g, 4.0 mmol, 2.0 equiv) were 
dissolved in benzene (20 mL, 0.1M) and stirred vigorously while it refluxed for 24 h.  
The mixture was cooled to r.t. and the solvent evaporated in vacuo.  The mixture was 
filtered without work-up through a silica gel plug (100% hexanes), and the residual oil 
was purified by column chromatography (10% EtOAc-hexanes) furnishing ester 2.35 
(635 mg, 1.45 mmol, 74%) as a clear oil. 
Analytical data for 2.35 
M.W.: 438.67 
TLC (Rf): 0.65 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
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7.81-7.61 (m, 4 H, PhH), 7.43-7.33 (m, 6 H, PhH), 6.51 (d, J = 10.5 Hz, 1 
H, H3), 4.18 (m, 2 H, H10), 3.55 (dq, J = 9.9, 3.7 Hz, 2 H, H1), 2.52 (m, 1 
H, H2), 2.25 (m, 2 H, H6), 1.67 (m, 1 H, H8'), 1.27 (m, 1 H, H8''), 1.27 (t, J 
= 7.1 Hz, 3 H, H11), 1.01 (s, 9 H, H12), 0.94 (t, J = 7.4 Hz, 3 H, H7), 0.83 
(t, J = 7.4 Hz, 3 H, H9) 
13C NMR: (100 MHz, CDCl3) 
167.83 (C(5)), 143.35 (C(3)), 135.65 (2 C, Ph), 135.63 (2 C, Ph'), 135.30 
(C4)), 133.66 (C(Ph)), 133.63 (C(Ph')), 129.62 (C(Ph)), 129.61 (C(Ph')), 
127.63 (4 C, Ph, Ph'), 66.58 (C(1)), 60.29 (C(10)), 43.13 (C(2)), 26.80 (3 C, 
C(12)), 24.11 (C(8)), 20.43 (C(6)), 19.26 (C(13)), 14.30 (C(11)), 14.29 
(C(7)) , 11.85 (C(9)) 
HRMS: (EI) m/z calcd for C23H29O3Si [(M-C4H9)+] 381.1880, found 381.1855 
(E)-Ethyl 2-ethyl-4-(hydroxymethyl)hex-2-enoate (2.56) 
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Ester 2.35 (327 mg, 0.96 mmol) was treated with a 10% HCl/MeOH (5 mL) solution 
and stirred at r.t. for 3 h.  The solution was slowly quenched with a saturated sodium 
bicarbonate solution, diluted with H2O and EtOAc and extracted thrice with EtOAc.  The 
organic layers were combined, dried with Na2SO4 and, after evaporation, the oil was 
purified by column chromatography (20% EtOAc-hexanes) furnishing alcohol 2.56 (67 
mg, 0.60 mmol, 39%) as a clear oil. 
Analytical data for 2.56 
M.W.: 200.27 
TLC (Rf): 0.23 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
6.42 (d, J = 10.4 Hz, 1 H, H3), 4.18 (q, J = 7.2 Hz, 2 H, H10), 3.61 (dd, J = 
5.6, 5.2 Hz, 1 H, H1'), 3.49 (dd, J = 7.6, 2.8 Hz, 1 H, H1''), 2.55 (m, 1 H, 
H2), 2.34 (dq, J = 7.2, 3.2 Hz, 2 H, H6), 1.55 (m, 2 H, H8' & OH), 1.28 (m, 
1 H, H8''), 1.28 (t, J = 7.2 Hz, 3 H, H11), 1.01 (t, J = 7.2 Hz, 3 H, H7), 0.87 
(t, J = 7.2 Hz, 3 H, H9) 
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13C NMR: (100 MHz, CDCl3) 
167.6 (C(5)), 142.4 (C(3)), 136.8 (C(4)), 65.8 (C(1)), 60.5 (C(10)), 43.4 
(C(2)), 24.0 (C(8)), 20.5 (C(6)), 14.3 (C(11)), 14.2 (C(7)), 11.8 (C(9)) 
(E)-4-(Ethoxycarbonyl)-2-ethylhex-3-enoic acid (2.57) 
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Alcohol 2.56 (67 mg, 0.33 mmol) was pre-dissolved in an acidic solvent system of 
aqueous 10% H2SO4 (0.3 mL) and acetone (3 mL) while stirring at 0°C under an argon 
atmosphere.  Prior to addition, the Jones reagent was freshly prepared by vigorously 
mixing in a vial potassium dichromate (294.8 mg, 1 mmol), conc. H2SO4 (0.2 mL) 
followed by distilled water (1 mL).  The bright orange mixture (0.43 mL, 0.36 mmol, 1.1 
equiv) was slowly syringed into the alcohol solution and stirred for 2.5 h at which time 
the chromium's oxidation state change was evidenced by a concomitant color change 
from bright orange to olive green.  Quenching was accomplished by addition of a 
saturated solution of NaHCO3 (4 mL) and dilution with EtOAc (1 mL).  The aqueous 
layer was acidified by an aqueous 0.1M HCl solution until the pH reached ~2.0.  After 
extraction with EtOAc (3x5 mL), drying of organic layers with Na2SO4 and evaporation 
solvent in vacuo, the oil was purified by column chromatography (20% EtOAc-hexanes) 
isolating acid 2.57 (19 mg, 0.089 mmol, 27%). 
Analytical data for 2.57 
M.W.: 214.26 
TLC (Rf): 0.23 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
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6.60 (d, J = 10.4 Hz, 1 H, H3), 4.18 (q, J = 7.2 Hz, 2 H, H10), 3.30 (dt, J = 
6.8, 3.6 Hz, 1 H, H2), 2.34 (m, 2 H, H6), 1.88 (m, 1 H, H8'), 1.63 (m, 1 H, 
H8''), 1.29 (t, J = 7.2 Hz, 3 H, H11), 1.02 (t, J = 7.6 Hz, 3 H, H7), 0.94 (t, J 
= 7.6 Hz, 3 H, H9) 
13C NMR: (100 MHz, CDCl3) 
177.8 (C(1)), 167.2 (C(5)), 137.0 (C(3) & C(4)), 60.7 (C(10)), 46.3 (C(2)), 
25.8 (C(8)), 20.5 (C(6)), 14.2 (C(11)), 14.0 (C(7)), 11.7 (C(9)) 
(E)-Diethyl 6-((tert-butyldiphenylsilyloxy)methyl)-4-ethyl-3-oxooct-4-en-2-
ylphosphonate (2.61) 
2.612.35
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Triethyl  ethylphosphonate 2.60 (100 µL, 0.62 mmol, 2.5 equiv) was dissolved in 
THF (1.5 mL) and cooled to -78°C while stirring under argon.  After 10 min n-BuLi (250 
µL, 0.63 mmol, 2.5 equiv) was added and warmed up to -40°C over 1.5 hrs.  Ester 2.35 
(109 mg, 0.25 mmol) dissolved in THF (1 mL) was cooled to -40°C and transferred by 
cannula to the phosphonate-containing solution.  Stirred overnight.  Quenched with HCl 
(1 mL, 10%), diluted with water (0.5 mL)  and extracted with EtOAc (3 x 2 mL).  Dried 
with MgSO4 and evaporated solvent in vacuo.  The viscous oil was purified by column 
chromatography (20% EtOAc-hexanes to 100% EtOAc) isolating inseparable mixture (a 
1.4:1 ratio) of phosphonate diastereomers 2.61 (84 mg, 0.15 mmol, 60%). 
Analytical data for 2.61 
M.W.: 558.76 
TLC (Rf): 0.09 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
89 
 
7.64-7.59 (m, 4 H), 7.42-7.33 (m, 6 H), 6.41 (d, J = 10.1 Hz, 1 H), 6.29 (d, 
J = 10.1 Hz, 1 H),  4.07 (m, 4 H), 3.83 (m, 1 H), 3.60 (m, 2 H), 2.62 (m, 1 
H), 2.26 (m, 1 H), 1.74 (m, 1 H), 1.31 (m, 1 H), 1.15 (t, J = 7.1 Hz, 3 H), 
1.03 (s, 9 H), 1.00 (s, 9 H), 0.85 (m, 6 H) 
13C NMR: (100 MHz, CDCl3) 
197.94, 197.89, 197.47, 197.43, 145.79, 144.31, 144.25, 144.22, 144.19, 
144.17, 135.59, 135.58, 135.54, 130.89, 129.775, 129.71, 129.58, 127.73, 
127.70, 127.61, 66.54, 66.14, 62.59, 62.57, 62.52, 62.50, 62.37, 62.31, 
62.26, 62.19, 43.69, 43.66, 40.63, 40.18, 39.29, 38.87, 36.49, 26.86, 26.79, 
24.29, 24.24, 19.66, 19.64, 19.27, 16.47, 16.45, 16.42, 16.37, 16.32, 14.07, 
13.97, 13.93, 13.12, 13.06, 12.81, 12.74, 11.85, 11.77 
(E)-4-((tert-Butyldiphenylsilyloxy)methyl)-2-ethyl-N-methoxy-N-methylhex-2-
enamide (2.36) 
2.362.35
O
O
NOTBDPS
O
EtO
O
1
8
2
9
4
6
710
11
5
Si
12
13
3
 
Ester 2.35 (343 mg, 0.78 mmol) and N,O-dimethylhydroxylamine hydrochloride (117 
mg, 1.2 mmol, 1.5 equiv) were stirred vigorously in THF (4 mL, 0.2M) and cooled under 
argon to -20°C.  i-PrMgCl (1.2 mL, 2.4 mmol, 3.0 equiv) was added over 10 minutes and 
warmed up to 0°C.  After 2 hrs, quenched with NH4Cl (2 mL) and extracted with EtOAc 
(2 x 5 mL).  Dried with MgSO4 and after evaporation of solvent in vacuo the crude was 
purified by column chromatography (20% EtOAc-hexanes) isolating amide 2.36 (214.6 
mg, 0.47 mmol, 61%) while also recovering unreacted ester 2.35 (130 mg, 0.30 mmol). 
Analytical data for 2.36 
M.W.: 453.69 
TLC (Rf): 0.21 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
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7.64-7.62 (m, 4 H, PhH), 7.43-7.32 (m, 6 H, PhH), 5.48 (d, J = 10.1 Hz, 1 
H, H3), 3.58 (s, 3 H, H10), 3.54 (d, J = 6.2 Hz, 2 H, H1), 3.20 (s, 3 H, 
H11), 2.46 (m, 1 H, H2), 2.67 (dq, J = 7.6, 0.9 Hz, 2 H, H6), 1.69 (m, 1 H, 
H8'), 1.23 (m, 1 H, H8''), 1.03 (s, 9 H, H12), 0.94 (t, J = 7.5 Hz, 3 H, H7), 
0.85 (t, J = 7.4 Hz, 3 H, H9) 
13C NMR: (75 MHz, CDCl3) 
171.96 (C(5)), 138.33 (C(3)), 135.59 (2 C, Ph), 135.57 (2 C, Ph'), 133.73 
(C(4)), 133.68 (C(Ph)), 133.62 (C(Ph')), 129.60 (C(Ph)), 129.58 (C(Ph')), 
127.61 (4 C, Ph, Ph'), 66.70 (C(1)), 60.82 (C(10)), 42.30 (C(2)), 34.13 
(C(11)), 26.84 (3 C, C(12)), 24.30 (C(8)) , 21.80 (C(6)), 19.23 (C(13)), 
13.21 (C(7)), 11.73 (C(9)) 
HRMS: (EI) m/z calcd for C23H30NO3Si [(M-C4H9)+] 396.1989, found 396.2013 
 
(E)-6-((tert-Butyldiphenylsilyloxy)methyl)-4-ethyloct-4-en-3-one (2.37) 
2.372.36
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Amide 2.36 (80 mg, 0.18 mmol) was dissolved by stirring in THF (1.8 mL, 0.1M) 
cooled under argon to 0°C.  After 10 min, EtMgBr (0.14 mL, 0.42 mmol, 3.0 equiv) were 
added  and the solution stirred for another 2 hrs at 0°C.  Quenched with NH4Cl (0.5 mL), 
diluted with water (0.3 mL) and extracted with EtOAc (3 x 2 mL).  Dried with MgSO4 
and after evaporation of solvent in vacuo the crude was purified by column 
chromatography (20% EtOAc-hexanes) isolating ketone 2.37 (47 mg, 0.11 mmol, 62%) 
while also recovering unreacted amide 2.36 (20 mg, 0.044 mmol). 
Analytical data for 2.37 
M.W.: 422.67 
TLC (Rf): 0.72 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
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7.64-7.60 (m, 4 H, PhH), 7.43-7.33 (m, 6 H, PhH), 6.33 (d, J = 10.2 Hz, 1 
H, H3), 3.63 (m, 2 H, H1), 2.60 (m, 3 H, H2, H10), 2.25 (dq, J = 7.4, 1.1 
Hz, 2 H, H6), 1.68 (m, 1 H, H8'), 1.23 (m, 1 H, H8''), 1.07 (t, J = 7.3 Hz, 3 
H, H11), 1.01 (s, 9 H, H12), 0.88 (t, J = 7.4 Hz, 3 H, H7), 0.84 (t, J = 7.5 
Hz, 3 H, H9) 
13C NMR: (100 MHz, CDCl3) 
202.36 (C(5)), 144.11 (C(4)), 143.36 (C(3)), 135.62 (2 C, Ph), 135.58 (2 C, 
Ph'), 133.56 (2 C, Ph, Ph'), 129.71 (C(Ph)), 129.68 (C(Ph')), 127.67 (4 C, 
Ph, Ph'), 66.59 (C(1)), 43,28 (C(2)), 30.60 (C(10)), 26.81 (3 C, C(12)), 
24.27 (C(8)), 19.38 (C(6)), 19.27 (C(13)), 14.25 (C(7)), 11.85 (C(9)), 8.94 
(C(11)) 
HRMS: (EI) m/z calcd for C23H29O2Si [(M-C4H9)+] 365.1931, found 365.1925 
(4E,7E,9E,12E)-5,9,11-Triethyl-3-(hydroxymethyl)-7-methyl-13-phenyltrideca-
4,7,9,12-tetraen-6-one (2.38) 
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Aldol.  Ketone 2.37 (386 mg, 0.92 mmol) was dissolved in DCM (15 mL, 0.03M) 
and cooled under argon to -78°C.  After stirring for 20 min, to the clear solution, titanium 
tetrachloride (TiCl4, 121 µL, 1.1 mmol, 1.2 equiv) was added dropwise over 15 min.  The 
light yellow solution was stirred for an additional 30 min at -78°C at which time N,N-
diisopropylethylamine (DIPEA, 192 µL, 1.1 mmol, 1.2 equiv) was added, immediately 
showing enolate formation by the solution's notable change of coloration to a dark 
red/purple hue.  Stirred the solution for 1 hr at -78°C, after which a solution of aldehyde 
2.30/2.30a (158 mg, 0.69 mmol, 0.75 equiv) dissolved in DCM (20 mL) was added by 
syringe pump (0.7 mL/hr) overnight.  Quenched with MeOH (10 mL), and slowly 
warmed up to r.t.  The solution was diluted with water (10 mL) and extracted with EtOAc 
(3 x 10 mL).  Dried the organic phase with MgSO4, evaporated solvent in vacuo, and 
partially purified the crude oil by column chromatography (5% EtOAc-hexanes) to obtain 
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β-hydroxy ketone (272 mg) which was mesylated without further purification.  
Mesylation-Elimination/Deprotection.  Crude β-hydroxy ketone  (243 mg, ~0.37 
mmol), DMAP (114 mg, 0.93 mmol, 2.5 equiv) were dissolved in DCM and cooled at -
20°C while stirring under argon.  Slowly added TEA (780 µL, 5.6 mmol, 15 equiv) 
followed by methanesulfonyl chloride (MsCl, 147 µL, 1.9 mmol, 5.0 equiv).  The 
solution was slowly warmed up to r.t. and stirred overnight.  Quenched with a saturated 
solution of NaHCO3 (5 mL), diluted with H2O (10 mL), and extracted with EtOAc (3 x 
10 mL).  Dried the organic phase with MgSO4, evaporated solvent in vacuo, and partially 
purified the crude oil by column chromatography (5% EtOAc-hexanes).  The oil obtained 
was deprotected by addition of TBAF (2 mL, 2.0 mmol, 5.5 equiv) to a solution in THF 
(10 mL) while stirring at r.t. under argon overnight.  Quenched by addition of H2O and 
extracted with EtOAc (3 x 5 mL).  The organic phase was dried with MgSO4, evaporated 
solvent in vacuo, and purified the crude oil by column chromatography (10% EtOAc-
hexanes) to furnish alcohol 2.38 (20 mg, 0.051 mmol, 6% over three steps) and its 
uncharacterized, minor diastereomer. 
Analytical data for 2.38 
M.W.: 394.59 
TLC (Rf): 0.28 (20% EtOAc-hexanes) 
1H NMR: (500 MHz, CDCl3) 
7.32-7.15 (m, 5 H, PhH), 6.65 (s, 1 H, H7), 6.36 (d, J = 15.8 Hz, 1 H, H12), 
6.09 (ddd, J = 15.9, 7.4, 2.6 Hz, 1 H, H11), 5.66 (d, J = 10.3 Hz, 1 H, H3), 
5.38 (dd, J = 9.6, 2.2 Hz, 1 H, H9), 3.60 (dd, J = 10.6, 5.6 Hz, 1 H), 3.48 
(dd, J = 10.9, 7.5 Hz, 1 H), 3.11 (p, J = 7.6 Hz, 1 H, H10), 2.61 (m, 1 H, 
H2), 2.42 (m, 3 H, H15, OH), 2.22 (m, 2 H, H18) 2.00 (t, J = 1.1 Hz, 3 H, 
H17), 1.63-1.45 (m, 3 H, H13, H20'), 1.25 (m, 1 H, H20''), 1.04-0.80 (m, 12 
H) 
13C NMR: (125 MHz, CDCl3) 
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201.98 (C(5)), 144.69 (C(8)), 143.03 (C(7)), 139.70 (C(6)), 139.68 (C(3)), 
137.56 (C(4)), 135.24 (C(9)), 135.11 (C(Ph)), 132.84 (C(11)), 129.15 
(C(12)), 128.48 (2 C, Ph), 127.05 (C(Ph)), 126.01 (2 C, Ph), 65.95 (C(1)), 
43.62 (C(10)), 43.23 (C(2)), 28.68 (C(13)), 24.28 (C(18)), 24.11 (C(20)), 
21.22 (C(15)), 14.31 (C(17)), 13.51 (C(19)), 13.48 (C(16)). 11.91 (C(21)), 
11.88 (C(14)) 
HRMS: (EI) m/z calcd for C19H23O [(M-C8H15O)+] 267.1740, found 267.1743 
(2E,6E,8E,11E)-2,4,8,10-Tetraethyl-6-methyl-5-oxo-12-phenyldodeca-2,6,8,11-
tetraenal (2.39) 
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Oxalyl chloride ((COCl)2, 16 µL, 0.18 mmol, 3.5 equiv) was dissolved in 
dichloromethane (2.0 mL) and cooled to -78°C.  Dimethylsulfoxide (17 µL, 0.26 mmol, 
5.0 equiv) was added dropwise and the solution stirred for an additional 30 min at -78°C.  
A precooled (-78°C) solution of alcohol 2.38 (20 mg, 0.052 mmol) in DCM (0.5 mL) was 
added by cannula and the white and opaque mixture was stirred for 1 h.  Triethylamine 
(73 µL, 0.52 mmol, 10 equiv) was added and the thick slurry was slowly warmed to r.t. 
overnight.  H2O (2 mL) was added to quench, followed by extraction with EtOAc (3 x 5 
mL).  The organic phase was dried over MgSO4 and filtered.  After evaporation in vacuo 
the oil was purified by column chromatography (20% EtOAc-hexanes) affording a 
mixture of aldehyde 2.39, and uncharacterized stereroisomers (20 mg, 0.052 mmol, 
100%). 
Analytical data for 2.39 
M.W.: 392.57 
TLC (Rf): 0.67 (20% EtOAc-hexanes) 
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1H NMR: (500 MHz, CDCl3) 
9.38 (s, 1 H, H1), 7.17-7.35 (m, 5 H, PhH), 6.97 (d, J = 1.1 Hz, 1 H, H7), 
6.46 (d, J = 10.5 Hz, 1 H, H3), 6.37 (dd, J = 16.2, 3.3 Hz, 1 H, H12), 6.08 
(dd, J = 15.9, 7.4 Hz, 1 H, H11), 5.40 (d, J = 9.8 Hz, 1 H, H9), 4.29 (m, 1 
H, H4), 3.13 (bp, J = 7.7 Hz, 1 H, H10), 2.28 (m, 4 H, H15, H20), 1.95 (d, 
J = 0.9 Hz, 3 H. H17), 1.66-1.46 (m, 2 H), 1.25 (m, 2 H), 1.01-0.80 (m, 12 
H) 
 
2.5.3.  References 
1. Frigerio, M.; Santagostino, M.; Sputore, S., A User-Friendly Entry to 2-
Iodoxybenzoic Acid (IBX). J. Org. Chem. 1999, 64 (12), 4537-4538. 
2. House, H. O.; Rasmusson, G. H., Stereoselective Synthesis of α-Substituted α,β-
Unsaturated Esters. J. Org. Chem. 1961, 26 (11), 4278-4281. 
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2.5.4.  Selected 1D and 2D NMR spectra 
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CHAPTER 3.  Regiochemistry and stereochemistry of thioesterase catalyzed   
 macrocyclizations in polyketides 
3.1.  Introduction 
The development of intramolecular cyclization techniques for the synthesis of natural 
products has been a lively area of research.1  The great complexity and variety of these 
structures have served as inspiration for the development of a plethora of methodologies.  
These large structures are rife with synthetic challenges owing to case-specific 
thermodynamic considerations of size, entropy and strain of the macrocycle and its 
acyclic counterpart.  Historically, a large portion of the methodologies developed has 
been for the synthesis of macrolactone-containing natural products.  The approaches 
taken have commonly been classified by the mode of activation of the alcohol or acid 
involved in the reaction.  Both strategies involve chemoselective reactions that polarize 
the targeted moiety and consequently increase their reactivity.  Some common acid 
activation methodologies involve formation of mixed anhydrides2 (3.1), thioesters3 (3.2), 
and O-acylisoureas4 (3.3) (Figure 3.1-A).  Although less prevalent, alcohol activation 
methodologies are also employed, and they generally involve its conversion to leaving 
groups such as oxyphosphonium ions5 (3.4), bromides6 (3.5), and methanesulfonates7 
(3.6) (Figure 3.1-B). 
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FIGURE 3.1.  Macrolactones can be synthesized by numerous (A) acid activation and (B) alcohol activation 
methods. 
Regiochemical selectivity, however, remains at best an elusive proposition to attain 
synthetically.  The common approach is to include extra atom-inefficient steps to protect 
and chemoselectively deprotect the requisite functionality prior to macrocyclizing, a 
process that lengthens routes and minimizes yields.  Few compounds in the literature with 
multiple unprotected groups undergo regioselective macrocyclizations.8, 9  Enzymatic 
processes may provide a viable alternative towards this important objective, in particular 
the thioesterase domains of polyketide biosynthesis. 
3.1.1.  Macrolide polyketides 
Macrolide polyketides (Figure 3.2), are an economically important class of natural 
products that have found widespread applications as therapeutic agents.10  Molecules 
such as spiramycin and pimaricin have been clinically relevant in the treatment and 
prevention of common human and animal microbial ailments.11-16  Others, such as the 
epothilone family of natural products and their synthetic analogs, represent a class of 
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novel anticancer agents that exhibit greater effectiveness and lower toxicity than the 
common taxane diterpenoids employed in therapy17-25. 
 
FIGURE 3.2.  Macrolide polyketides share a common biosynthetic origin which is capable of generating 
molecules of great structural diversity and assorted therapeutic applications. 
Macrolides are biosynthesized by type I modular polyketide synthase (PKS) 
pathways.2-8  Erythromycin, the canonical macrolide system, and its core precursor 6-
deoxyerythronolide B (6dEB, 3.7), derive from a biosynthetic gene cluster comprised of 
three large open reading frames each coding for the homodimeric megaproteins DEBS1, 
DEBS2 and DEBS3.26  Each megaprotein includes separate modules with multiple 
catalytic domains that mediate the stepwise thio-Claisen condensations of acetate 
equivalents, and reductively tailor the newly formed keto functional group (Figure 3.3). 
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FIGURE 3.3.  Erythromycin biosynthesis is performed by a polyketide synthase (PKS).  Domains 
represented: KS (ketosynthase), ACP (acyl carrier protein), AT (acyltransferase), DH (dehydratase), KR 
(ketoreductase), (KR) (inactive ketoreductase), ER (enoylreductase), and TE (thioesterase). 
3.1.2.  Thioesterases catalyze regioselective macrocyclizations 
A fundamental step in the biosynthesis of erythromycin, and of other macrolides by 
extension, is that catalyzed by the DEBS thioesterase domain (TE).27-29  The enzyme 
assures substrate turnover from the PKS, delivering it in its bioactive conformation.  Its 
crystal structure27 exhibits a two-fold symmetric homodimer configuration with a 
molecular mass of 66kDa and a tertiary structure characterized by an α,β-hydrolase fold 
(Figure 3.4).30  The active site of the DEBS TE is contained within a hydrophobic 
substrate channel that effectively traverses the monomer, a feature that is in contrast to 
the homologous fatty acid thioesterases (FA TEs)31.  The presence of a substrate channel 
was shown to not be an isolated example, but a conserved element of PKS TEs, and has 
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been seen in structures of the picromycin32 and curacin33 thioesterases.  The function of 
the substrate channel is a topic of debate; a widely viewed hypothesis27 predicts the 
channel-substrate interaction to possess directionality, that is the transfer of the mature 
polyketide from its ACP-bound state to the TE active site takes place at one end of the 
channel, while exit of the macrocyclic or hydrolytic product occurs at the opposite end.  
Computational docking studies27 support this hypothesis by pointing to an Arg-rich site in 
the DEBS-TE in close proximity to the substrate channel that presumably serves as a 
region of non-covalent interaction with DEBS ACP6. 
 
 
FIGURE 3.4.  DEBS TE crystal structure (PDB ID: 1KEZ). (A) Secondary structure representation of the 
homodimer. (B) Van der Waals space-filling model.  The substrate channel traversing the enzyme is 
conspicuous. (C) Topographical map of DEBS TE.  The connectivity of the enzyme's α-helices (red rods) 
and β-strands (yellow arrows) is shown.  The catalytic residue (red dots) and their approximate location is 
also shown. 
The DEBS TE active site is comprised of the conserved catalytic triad Ser-142, Asp-
169, His-259.34  In a classic charge-relay mechanism (Figure 3.5), key residue Ser-142 in 
the active site is deprotonated to generate a strong O-nucleophile that attacks the 
incoming S-acyl-ACP, cleaving the thioester bond.35  In vivo, this new O-acyl-TE 
A. B. 
C. 
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intermediate exclusively undergoes a regioselective intramolecular cyclization.  
However, under in vitro conditions hydrolysis is also routinely observed. 
 
FIGURE 3.5.  Canonical mechanism of the TE domain.  Common among α/β hydrolase family, it involves a 
charge relay mechanism.  The active site serine is deprotonated in the loading step, and a new O-acyl-
enzyme intermediate is formed upon its attack on the upstream S-acyl-ACP.  The conformation of the 
substrate in the channel may lead to either a regioselective intramolecular macrocyclization or 
intermolecular attack by a molecule of water to yield a seco-acid.  The latter has been observed as an 
occurrence of in vitro experiments. 
3.1.3. The factors influencing thioesterase regioselectivity remain unclear 
Very little is known about the underlying factors that determine the regioselectivity of 
macrocyclization of thioesterase domains.  The DEBS TE has shown to be remarkably 
tolerant of a broad range of substrate lengths by ably generating 6, 8, 12, 14 and 16 
member rings (Figure 3.6).36-40 
 
FIGURE 3.6.  DEBS TE competently loads a wide range of linear chain lengths. 
Results from site-directed mutagenesis studies support enzyme-substrate hydrophobic 
interactions as the main stabilizing forces of the substrate in the channel,41 likely inducing 
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the substrate into a favorable conformation towards a regioselective intramolecular 
macrocyclization, while shielding it from hydrolysis by exogenous water molecules.  A 
weak hydrophilic barrier at the PICS TE channel’s exit consisting of bulk water and a 
glutamine residue has been proposed to explain the substrate’s bent arrangement in the 
channel and the proximity of the proper O-nucleophile to the active site.32 
A recent study of serine hydrolases and acyltransferases42, both belonging to the α,β-
fold class, correlated differences in the type of β-turn present between helix A and B in 
their respective active sites to hydrolysis or esterification activity.  Depending on the 
configuration of this element, Kazlauskas et al. propose it can either increase the 
nucleophilicity of ordered water in the active site by hydrogen bonding interactions, or 
make way for a nucleophile to gain access to the O-acyl enzyme intermediate.  This turn 
is, however, substantially different in macrolide-forming TEs, generally possessing 
multiple additional residues, dramatically limiting the predictability of TE activity based 
on sequence data. 
No systematic study has been yet conducted with a full length substrate where the 
molecular basis of regioselectivity of polyketide TE macrocyclizations can be rigorously 
investigated.  The stereochemical complexity of 6dEB (3.7), its native substrate, 
combined with its challenging multistep synthesis,43-47 has been an impediment to this 
goal.  An approach involving a systematic modification of the native substrate, resulting 
in several structural variants for the examination of their interaction with the enzyme, 
would be out of the question because of its intricacy and inefficiency.  Furthermore, a 
thioester such as 3.10 would be susceptible to multiple side reactions that would impede 
their utility in such a study (Figure 3.7).  For example, the δ-hydroxy ketone structure in 
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3.10 is known to undergo hemiketalization in aqueous buffers.48, 49  In addition, formation 
of a δ-lactone would be a highly favorable step, yielding structure 3.11.  These examples 
serve to highlight the important role the binding cavity has in stabilizing the 
intermediates in the enzyme. 
 
FIGURE 3.7.  Putative side reactions of NAC-6dEB substrate 3.10 meant to illustrate the difficulties 
associated with its use as a probe for thioesterase macrocyclization.  Under thermodynamic control, 
hemiketalization (structures 3.8 and 3.9) would likely take place.  In addition, formation of a δ-lactone 
would be kinetically favored to yield structure 3.11. 
3.1.4.  Discovery of a full length peptidyl substrate analog 
Our lab recently reported the ability of wild-type, heterologously expressed DEBS TE 
to hydrolyze short thioester-containing substrates with greater catalytic efficiency than 
their polyketide analogs (Figure 3.8).50 
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FIGURE 3.8.  Substrate analogs designed by Wang et al. to probe the kinetics of the loading step with wild-
type polyketide thioesterases (Deb, Pim, Epo). 7-Aminoheptanoate (3.12) is highlighted. 
Informed by this discovery, we recognized the potential of the 7-aminoheptanoate 
NAC-thioester (3.15) as an element in a convergent synthesis of a linear analog of 6dEB 
(3.7, Figure 3.9).  The other half of our envisioned analog, a phenylhexanoic acid moiety 
(3.14), was designed to be quickly prepared by simple chemical transformations.51 
 
FIGURE 3.9.  6dEB analog 3.13 designed to explore the DEBS TE regiochemistry of cyclization.  Linear 
6dEB is shown for ease of comparison with our synthetic target. 
Among the salient features in the design of the substrate is the inclusion of a phenyl 
chromophore on the backbone.  The DEBS TE has shown to be amenable to this 
structural element,52 and its presence is expected to simplify the analysis of UV traces 
obtained by LC/MS.  Retaining the native substrate's 1,3 diol would be key in providing 
answers to the DEBS TE regiochemistry of cyclization: the presence of both nucleophiles 
may yield 12 and 14-membered macrolactones.  Furthermore, assuming the analog's 
effective macrocyclization, enantioselective methodologies applied to the synthetic route 
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would aid in correlating stereo- and regioselectivity of the enzyme.  Lastly, the 
compound would be the first example of a polyketide TE mediated cyclization of a non-
native substrate. 
Initial work with the racemic and diastereoisomeric mixture of isomers, substrate 3.13 
showed considerable potential.51  Upon treatment of DEBS TE with NAC-thioester 3.13, 
we were pleased to observe a mixture of products (Figure 3.10) by LCMS analysis, 
including two peaks that suggested either the presence of macrolactone regioisomers 3.16 
and 3.17 or that of cyclic diastereoisomers. 
 
 
FIGURE 3.10.  Treatment of isolated DEBS TE with analog 3.13 generated  a mixture of products (as 
monitored by LCMS). 
Effectively interpreting these results required us to look into the individual 
contributions of all stereoisomers to the observed product distribution.  For this purpose, 
a stereocontrolled synthetic route was designed and a suitable hypothesis was formulated 
to guide and inform our discoveries.  We have based the latter on a stereochemical 
pattern observed on numerous substrates ably cyclized by a DEBS TE.  We believe that 
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the regiochemical outcome of TE-mediated macrocyclization is predetermined by the 
substrate's terminal O-nucleophile of R absolute stereochemistry (Figure 3.11). 
 
FIGURE 3.11.  We propose that the absolute stereochemistry of the terminal O-nucleophile (highlighted in 
red) determines the outcome of the TE-catalyzed macrolactonization. 
Herein we present: (1) the total synthesis of four enantioenriched substrates; (2) the 
total synthesis of authentic macrolactone standards; (3) results of our enzymatic assays; 
and (4) a brief synopsis of our future efforts towards this project. 
3.2.  Results and discussion 
3.2.1.  Retrosyntheses 
3.2.1.1.  Enantioenriched NAC thioesters substrates 
To evaluate the contribution each discrete stereoisomer of 3.13 made to the product 
mixture observed upon treatment with the DEBS TE (Figure 10), we developed a general 
stereoselective route that would allow us to efficiently synthesize them.  The salient 
features of this strategy are summarized in Scheme 3.1. 
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SCHEME 3.1.  Retrosynthesis of enantioenriched NAC substrates.  For simplicity, only isomer 3.29 is 
shown. 
 
Our analysis begins with thioester 3.29, one of four stereoisomers necessary for our 
enzymatic assays.  Embedded in the design is the inclusion of a NAC-thioester as it is a 
convenient and broadly employed methodology for mimicking CoA and ACP-bound 
thioesters, enabling the incorporation of substrates onto polyketide and fatty acid 
synthases.  Disconnection of 3.29 at the amide bond (shown), reveals the NAC-thioester 
of methyl-7-aminoheptanoate 3.15, a compound obtained from coupling of commercially 
available HSNAC and seco-acid 3.33.  The chiral dihydroxyacid coupling partner of 
amine 3.15 can be obtained from terminal olefin 3.25 through oxidative cleavage of the 
latter.  Establishment of the homoallylic stereocenter can be accomplished from a 
regioselective vinyl cuprate addition to chiral epoxide 3.22.  The latter is a product of a 
Jacobsen's salen(Co)-catalyzed hydrolytic kinetic resolution (HKR)53 of the epoxide 
mixture derived from mCPBA epoxidation of the chiral olefin 3.21.  Disconnection of 
this intermediate, as shown, reveals commercially available phenylacetaldehyde 3.20 as a 
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suitable starting material, and clearly suggests an asymmetric allylation methodology, 
such as the Brown allylboration,54 to set the first stereocenter of the route. 
3.2.1.2.  12 and 14-membered standards 
Full spectroscopic characterization of the products formed in each enzymatic reaction 
would be possible only if a set of standards was also synthesized.  Toward this goal, we 
designed a route adapted from the stereoselective methodology employed in the synthesis 
of our NAC-thioester substrates.  The standard's retrosynthetic analysis was simplified 
since only diastereopurity (not enantiopurity) was needed (Scheme 3.2).  Two racemic, 
diastereomerically pure 1,3-diols (syn and anti) are at the centerpiece of our design.  
Cleavage of syn macrolactones syn-3.42 and syn-3.43 reveals diprotected methyl ester 
syn-3.41, their common intermediate.  We predicted that the absence of obvious 
conformational bias and large number of degrees of freedom of these linear molecules 
would provide access to both ring sizes in about equal amounts.55  Macrolactonization 
studies with substrates containing multiple unprotected nucleophiles have shown 
selectivity dependent on the conformation of the chains and energies of the transition 
state.  The enthalpy differences between 12- and 14-membered rings56 suggest of a slight 
preference toward formation of the 14-membered ring, however, the difference is 
sufficiently small to lead us to believe a mixture of products may be observed.  
Disconnection at the bond shown yields intermediates syn-3.40 and 3.34, both easily 
accessed from simple precursors and chemical steps.  In the forward sense oxidative 
cleavage of the terminal olefin of syn-3.40 is expected to procure the carboxylic acid 
coupling partner of 3.34 which, in turn, can be assembled by protecting group 
manipulations of 7-aminoheptanoic acid (3.35).  Our preliminary studies indicated that 
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the separation of the diastereomers of olefin 3.38 would not be possible without prior 
removal of the TBS protecting group.  Removal afforded only limited success with the 
various chromatographic separations performed.  The decision was taken to incorporate a 
preparative HPLC step to cleanly separate the mixture. At this juncture, olefin 3.38 would 
be accessible even more readily than homochiral analog 3.25 (Scheme 3.1), starting from 
phenylacetaldehyde (3.20), using non-selective allylation, and omitting HKR of the 
intermediate epoxide 3.37. 
SCHEME 3.2.  Retrosynthesis of the racemic 12 and 14-membered macrolactone standards syn-3.42 and 
syn-3.43.  For simplicity, only the route of the syn-standards is shown. 
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3.2.2. Syntheses 
3.2.2.1. Enantioenriched NAC thioester substrates 
The synthesis of our four enantioenriched analogs was accomplished by two 
complementary routes in under nine linear steps.  Our enantioselective route was initiated 
by an asymmetric allylation of phenylacetaldehyde (3.20).  3.20 was treated separately 
with both optical isomers of allyldiisopinocampheylborane (Ipc2BAllyl)54 in a Et2O/N2(l) 
bath at -100 °C for 30 minutes (Scheme 3.3) furnishing homoallylic alcohols 3.21 and 
ent-3.21 in 63% and 44% yield respectively.  Epoxidation of each enantiomer with a 
buffered solution of mCPBA produced a 1:1 mixture of diastereomers, as confirmed by 
1H NMR.  These were independently silylated to produce two inseparable mixtures, each 
consisting of epoxides 3.22-3.23, and ent-3.22-ent-3.23. 
SCHEME 3.3.  Synthesis of enantioenriched epoxides 3.22, 3.23, ent-3.22 and ent-3.23.a 
 
a Reagents and conditions: (a) (-)-Ipc2BAllyl, Et2O, -100°C, 30 min, 63%; (b) (+)-Ipc2BAllyl, Et2O, -
100°C, 30 min, 44%;  (c) m-CPBA, NaHCO3, CH2Cl2, r.t., 12hr; TBSCl, Imidazole, DMF, r.t., 24hr; 
(R,R)-Salen, H2O, THF, 16hr, 39% over three steps; (d) m-CPBA, NaHCO3, CH2Cl2, r.t., 12hr; TBSCl, 
Imidazole, DMF, r.t., 24hr; (S,S)-Salen, H2O, THF, 16hr, 51% over three steps; (e) Bu2SnO, TsCl, 
CH2Cl2, 4hr; NaH, THF, overnight, 100% over two steps; (f) Bu2SnO, TsCl, CH2Cl2, 4hr; NaH, 
overnight, THF, 58% over two steps. 
All four epoxide stereisomers were obtained by using the Jacobsen hydrolytic kinetic 
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resolution.53  This methodology diastereoselectively hydrolyzed epoxides 3.23 and ent-
3.23, and yielded enantioenriched epoxides 3.22 and ent-3.22 (50%, 38% yield 
respectively), and triols 3.24 and ent-3.24 (42%, 36% yield respectively).  The triols were 
easily recycled into epoxides 3.23 and ent-3.23 by selective monosulfonylation57 
followed by intramolecular nucleophilic displacement58 in 100% and 58% yields 
respectively (over two steps).  This straightforward route provided access to our four key 
diastereo- and enantiopure epoxides. 
With all four epoxide isomers in hand, we selected 3.22 to examine the steps leading 
to all four NAC-thioester substrates (Scheme 3.4).  Vinylation of 3.22 proceeded 
smoothly (85%) to produce olefin 3.25 in 85% yield.  The final steps to our key acid 
began by the silylation of alcohol 3.25, which was immediately followed by the oxidative 
cleavage of its terminal olefin with a buffered KMnO4-NaIO4 mixture.  This step, after 
workup and aqueous extraction, gratifyingly yielded the expected acid as confirmed by 
1H NMR of the crude product mixture.  The key acid's coupling partner, NAC-
aminothioester 3.12, was synthesized from commercially available 3.33 (87%).  
Regrettably, standard deprotection conditions of 3.12’s terminal amino group (20% TFA 
in CH2Cl2) led, upon quenching, to substrate decomposition which forced us to modify 
our approach to the synthesis. 
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SCHEME 3.4.  First attempt towards the synthesis of substrate 3.29.a  Failure to cleanly deprotect 3.12 
hindered our progress. 
 
a Reagents and conditions: (a) VinylMgBr, CuI, THF, -78°C, 85%; (b) HSNAC, EDC, DMAP, THF, r.t., 
87%. 
To solve this problem, we examined a longer route relying on the amino acid methyl 
ester 3.34 as our coupling substrate (Scheme 3.5).  3.34 was synthesized by esterification 
of 7-aminoheptanoic acid (3.35) with TMSCl/MeOH (100% yield)59.  Protection was 
followed by KMnO4/NaIO4 cleavage of olefin 3.25.  The crude acid was immediately 
treated with EDC and coupled with 3.34 to yield bis-silylated substrate 3.31 in 28% yield 
over three steps.   Hydrolysis with LiOH in MeOH/THF/H2O, followed by EDC coupling 
with HSNAC yielded thioester 3.27 in 53% yield over two steps.  Deprotection in an 
acetonitrile solution of HF/Pyridine completed the synthesis of enantioenriched substrate 
3.29 in 35% yield. 
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SCHEME 3.5.  End game for the synthesis of NAC enantioenriched substrate 3.29.a 
 
aReagents and conditions: (a) TMSCl, MeOH, r.t., overnight, 100%; (b) TBSCl, Imidazole, DMF, r.t., 
overnight; KMnO4, NaIO4, 1:1 t-BuOH-buffer (pH 7), r.t., 1 h; 3.34, EDC, DMAP, CH2Cl2, r.t. overnight, 
28% over three steps; (c) LiOH, 3:2:1 MeOH/H2O/THF, r.t., 6h; HSNAC, EDC, DMAP, CH2Cl2, r.t., 
overnight, 53% over two steps; (d) HF, Pyridine, MeCN, r.t., 5hrs, 35%. 
To shorten our synthesis and improve our overall yield, we explored the literature for 
methodologies to remove Boc protecting groups of amines in the presence of thioesters.  
We came across the work of Kokotos et al.60 that reported an efficient removal of this 
group by treatment with an anhydrous HCl/Dioxane solution.  Upon treatment of our 
protected amine 3.12 with this solution, we were pleased to observe clean and 
quantitative deprotection to amine 3.15.  The synthesis of the remaining substrates is 
presented in Scheme 3.6; it differs only from our first attempt in the use of amine 3.15 in 
the convergent step of our route. 
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SCHEME 3.6.  Synthesis of the remaining enantioenriched substrates.a 
a 
Reagents and conditions: a) VinylMgBr, CuI, THF, -78°C, 85%; (b) 3.12, HCl/Dioxane, r.t., 45 min;c) 
TBSCl, Imidazole, DMF, r.t., overnight; KMnO4, NaIO4, 1:1 t-BuOH-buffer (pH 7), r.t., 1 h; 3.15, EDC, 
DMAP, CH2Cl2, r.t. overnight; HSNAC, EDC, DMAP, CH2Cl2, r.t., overnight; (d) HF, Pyridine, MeCN, 
r.t., 5hrs. 
3.2.2.2.  12 and 14-membered standards 
In a manner analogous to our enantiopure NAC-thioester substrates, the route to our 
racemic diastereomerically pure macrolactone standards featured a short sequence of 
transformations from phenylacetaldehyde (3.20).  As shown in Scheme 3.7, the synthesis 
commences with the addition of allylmagnesium bromide to 3.20, cleanly converting it to 
racemic homoallylic alcohol rac-3.21.  Treatment of olefin rac-3.21 with mCPBA61-63 
furnished epoxide 3.36 (77% yield) as evidenced by the loss of the signature olefinic 
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NMR signals between 5-6 ppm.  Predictably, the NMR integration ratios point towards 
the formation of a 1:1 mixture of diastereomers. 
SCHEME 3.7.  Synthesis of macrolactone standards.a 
 
aReagents and conditions: (a) AllylMgBr, Et2O, 0°C, 30 min, 100%; (b) mCPBA, CH2Cl2, r.t., 12hr, 
77%; (c) TBSCl, Imidazole, DMF, r.t., 24hr, 100%; (d) VinylMgBr, CuI, THF, -20°C, 35%; (e) PTSA, 
EtOH, r.t., overnight, 60%; (f) TBSCl, Imidazole, DMF, r.t., overnight; (g) KMnO4, NaIO4, 1:1 t-BuOH-
buffer (pH 7), r.t., 1 h; 3.34, EDC, DMAP, CH2Cl2, r.t; (h) LiOH, THF/H2O, r.t.; HF/MeCN/Pyr, 5h, r.t.; 
(i) (PyS)2, PPh3, THF, r.t.; dilute by syringe pump addition to toluene at 80°C. 
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The regioselective vinylation of epoxide 3.36 required the protection of the alcohol 
moiety.  This was accomplished with TBSCl64 to produce epoxide 3.37 in quantitative 
yield.  Vinylation65 of 3.37 proceeded smoothly to generate 3.38 as a 1:1 mixture of 
homoallylic alcohols in 35% yield.  Attempts to separate 3.38 into its diastereomeric 
components by reverse-phase PHPLC were initially unsuccessful.  From many test runs, 
a compromise was reached, requiring the removal of all protective groups from the 
mixture by treatment with p-TsOH, to furnish the more polar 1,3-diol 3.39 in 60% yield.  
We cleanly separated both diastereomers of the compound mixture by silica gel 
chromatography; however, we determined that a scale-up of the diol mixture would 
benefit from purification by reverse-phase preparative high pressure liquid 
chromatography (PHPLC).  The mixture was found to separate well under the conditions 
stated, providing pure diols syn-3.39 and anti-3.39, both in 32% yield.  Their 
stereochemistry was unambiguously established by 13C NMR from their respective syn- 
and anti-acetonides (Scheme 3.8).66  Treatment of each diol with a solution of p-TsOH in 
acetone provided syn-3.44 (83% yield) and anti-3.44 (33% yield). 
SCHEME 3.8.  Rychnovsky's acetonide methodology was used to determine the relative stereochemistry of 
racemic 1,3-diols separated by PHPLC.a 
 
a Reagents and conditions: (a) Acetone, PTSA, r.t., overnight. 
With the carbodiimide coupling of our synthetic intermediates in mind, we treated 
both anti-3.39 and syn-3.39 to a sequence comprised of a silylation with TBSCl under 
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standard conditions, followed by treatment with a buffered solution of potassium 
permanganate67 in tert-butanol, and lastly, EDC coupling with free amine 3.34 to provide 
full length chain esters anti-3.41 and syn-3.41 in 32% and 36% yields, respectively 
(Scheme 3.7).  The endgame route to our macrocycle standards was initiated by the basic 
hydrolysis of each anti-3.41 and syn-3.41 ester.  The crude acids were individually 
desilylated in a solution of HF/MeCN/pyridine, and after extraction with EtOAc, the 
crude dihydroxyacid products were macrocyclized using the Corey-Nicolaou conditions3 
by treatment with 2,2'-dipyridyl disulfide and triphenylphosphine in THF to form reactive 
2-pyridinethioesters.  These were slowly added by syringe pump to hot toluene (80 °C) to 
effect the high dilution conditions necessary to minimize intermolecular reactivity.  The 
reactions were monitored by LC/MS and after no more than 10 days the products anti-
3.42, anti-3.43, syn-3.42, syn-3.43 were purified by PHPLC and isolated (2%, 0.1%, 
18%, 7% respectively). 
3.2.3.  Enzymatic assay of enantioenriched NAC-thioester substrates 
To determine the outcome of the TE-catalyzed macrolactonization in vitro, we set up 
four simultaneous enzyme assays with recombinant DEBS TE and each of our 
enantiopure NAC-thioester substrates.  Wild type DEBS TE (213 μM) employed in our 
assays was expressed and purified as previously described.51  Our four enzymatic 
reactions, each with a different enantiopure standard, were prepared by incubating 5 μM 
DEBS TE with 2.5 mM substrate in 50 mM phosphate buffer (pH 7.4) at 20°C with 
DMSO (5% v/v) as a solubility additive.  After 18 hrs, the reaction was diluted 4-fold and 
analyzed for product formation by LCMS ESI (Figure 3.12). 
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FIGURE 3.12.  LC traces and product distribution from enzymatic assays with wild type DEBS TE and 
enantioenriched NAC substrates. 
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The results from syn NAC-substrates 3.29 and ent-3.29 are fully consistent with our 
initial stereochemical working hypothesis.  The enzyme competently and predominantly 
cyclizes substrate 3.29.  Comparison of the retention time from the assay's macrocyclic 
product and the syn-3.42 standard confirms that DEBS TE regioselectively generates the 
14-membered ring macrolactone product from 3.29.  Substrate ent-3.29 is not converted 
to a macrocycle under the assay conditions. 
However, our assay results for the anti NAC-substrates 3.30 and ent-3.30 did not 
fully agree with our working hypothesis.  While substrate ent-3.30 underwent hydrolysis 
exclusively, consistent with our hypothesis, unexpectedly 3.30 also produced a seco-acid.  
Because macrocyclization possesses a late transition state geometry, we expect the 
macrocyclic product of 3.30 to be highly analogous to the reaction's transition state, and 
thus bind tightly in the active site.  This will favor restoration of the acyl-enzyme 
intermediate.  Subsequent hydrolysis will rapidly release the seco-acid of 3.30 from the 
site.  This hypothesis is supported by an earlier study68 where the epothilone 
macrolactone was competently loaded on to the Epo TE and hydrolyzed to form the seco 
acid.  We thus set to examine if this mode of reactivity was operative within the DEBS 
TE. 
3.2.4.  Hydrolysis of macrolactone standard 3.42 
To determine if the DEBS TE hydrolyzes the 14-membered macrolactone (R,S)-3.42, 
we treated DEBS TE with authentic standard anti-3.42.  We followed the reaction 
progress at various times by monitoring the occurrence of seco-acid by analytical HPLC 
(Figure 3.13).  Hydrolysis was not observed even under reaction conditions and 
incubation times identical to those used for macrocyclization formation.  This result 
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unambiguously confirms the DEBS TE's inability to open the macrocycle.  Furthermore, 
it is clear that the DEBS TE does not macrocyclize substrate 3.30. 
 
FIGURE 3.13.  Results of the enzymatic hydrolysis assay of macrolactone standard 3.42 by the DEBS TE.  
(A) Standard anti-seco-3.41; (B) Hydrolysis assay at180 min; (C) negative control with no enzyme. 
3.3.  Conclusions 
Our systematic study of our substrate analogs and their relationship with the DEBS 
TE provides a glimpse of the importance absolute stereochemistry has on the selectivity 
of macrocyclization.  The effect these small changes have on the substrate-enzyme 
interactions show them to be sufficiently significant to change their product distribution.  
Our initial hypothesis stated that the absolute stereochemistry of the nucleophilic alcohol 
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needed to be in the R configuration for macrocyclization.  This hypothesis was based on 
the observation that all isolated macrocyclic products from the DEBS TE have 
nucleophilic alcohols of the R configuration.  The inability of the DEBS TE to 
macrocyclize substrate 3.30 which possesses the R configuration on the terminal 
nucleophilic alcohol, demonstrates that absolute configuration is not sufficient to predict 
the ability of the DEBS TE to macrocyclize. 
3.3.1.  Absolute stereochemistry is a key factor driving enzyme specificity 
It is clear that our initial stereochemical hypothesis is insufficient in explaining the 
macrocyclization selectivity of the DEBS TE.  The hydrolysis of substrate 3.30, was 
surprising, as it possesses an absolute and relative stereochemistry at C11 and C13 
analogous to the native substrate.  This implies that additional interactions between the 
enzyme and the native substrate not captured in our analog are required for the proper 
positioning of the nucleophile to effect macrocyclization.  To understand the precise 
enzyme-substrate interactions necessary for macrocyclization, high-resolution structural 
analysis of the acyl-enzyme intermediate will be required.  Ongoing work in the 
laboratory is engaged in the synthesis of non-hydrolysable phosphonate-based acyl-
enzyme intermediates of substrates 3.29 and 3.30.  This system is expected to provide 
contrasting detailed enzyme-substrate interactions between a macrocyclization-competent 
substrate and a substrate that undergoes hydrolysis exclusively. 
Our data demonstrates that substrate 3.30 does not model all the native features of the 
6dEB substrate.  Previous work hypothesized the importance of the C9 carbonyl to effect 
the bent conformation of the native substrate.32  In addition, our hypothesis underlines the 
importance of the absolute stereochemistry of the substrate's terminal O-nucleophile to 
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effect macrocyclization.  Both these features are likely complementary, yet insufficient in 
explaining the macrocyclization specificity of the DEBS TE.  Previous examples show 
that methyl side chains close to the O-nucleophiles are highly conserved.36-40  Due to the 
hydrophobic nature of the substrate-enzyme interactions, these methyl side chains may 
play an important role in dictating the conformation of the substrate in the enzyme active 
site, and thus its reactivity.  Ongoing work in our lab is focusing on introducing these key 
side chains into our substrates, to evaluate if they are sufficient to make substrate 3.30 
macrocyclization competent.  The ultimate goal of this effort is to identify substrate 
functional groups that are necessary and sufficient to predict the macrocyclization 
activity with the DEBS TE. 
3.3.2.  Applications of DEBS TE in synthesis and biosynthesis 
The DEBS TE has been used as a critical feature in numerous engineered PKS 
pathways to produce macrocycles.  However, for each of these published success stories 
there are countless examples of engineered chimeric systems which did not produce 
macrocyclic products.  Our systematic examination of the DEBS TE macrocyclization 
activity suggests that its exquisite and as yet unpredictable substrate specificity may limit 
its utility as an enzyme in engineered systems for macrolactone production.  However, 
because of its reliable hydrolytic activity, it is ideally suited for applications where a 
carboxylic acid metabolite is desired.  For example, a recent study relied on engineered 
PKS enzymes terminating in the DEBS TE to hydrolyze key metabolite intermediates for 
characterization of the double bond geometry in the monensin A pathway, which 
ultimately confirmed the Cane-Celmer-Westley mechanism of polyether biosynthesis.69 
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Broadly substrate-tolerant macrocyclizing TEs may have an enormous impact on the 
synthesis of macrolactone natural products and their analogs.  Current methodologies 
employed in the macrocyclization of natural products remain limited in their scope and 
selectivity.  Our studies underline this by demonstrating how the Corey-Nicolaou 
macrocyclization produced an equimolar mixture of 12 and 14 membered ring 
macrolactone regioisomers.  A clear advantage of the thioesterase can be seen in our 
highly regioselective macrocyclization of substrate 3.29,which produced exclusively the 
14 membered ring macrolactone.  While this enhanced regioselectivity is enticing, in the 
case of the DEBS TE its unpredictable substrate specificity is a serious liability to 
chemoenzymatic macrocyclization approaches.  A highly regioselective thioesterase 
would be ideal in examples where macrolactonization steps have been problematic, such 
as Woodward's synthesis of erythronolide A,45, 70 and White's synthesis of 
polycavernoside A.8  A thioesterase with broad substrate tolerance and high 
regioselectivity would be ideal for the development of chemoenzymatic syntheses of 
macrocyclic natural products. 
Broadly substrate-tolerant TEs would be of great benefit to both engineered PKS 
pathways and chemoenzymatic syntheses of macrocyclic natural products.  Two 
approaches can be devised to find them.  The first approach involves screening known 
native TEs from a variety of PKS pathways in the hope of finding one with broad 
substrate tolerance.  The polyfunctionality of polyketide natural products such as 6dEB 
have likely influenced TEs to retain stringent substrate selectivity, likely rendering this 
approach ineffective.  The second approach involves protein engineering of a known TE 
to relax its substrate tolerance.  As protein engineering based on high-resolution 
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structural data has been reliably used to modify substrate specificity71, 72, this approach is 
perhaps best suited to producing broadly substrate tolerant TEs for multiple applications. 
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3.5.  Experimental section 
3.5.1.  General methods 
Reactions were carried out under an argon atmosphere with dry solvents and oven-
dried glassware under anhydrous conditions unless specified otherwise.  All reactions 
were carried out under an inert argon atmosphere with dry tetrahydrofuran, diethyl ether, 
and DCM solvents by passing them through activated alumina columns.  Toluene, 
benzene, and triethylamine were freshly distilled over calcium hydride.  Reagents were 
purchased at the highest commercial quality and used without further purification, unless 
otherwise stated.  Yields refer to chromatographically and spectroscopically (1H NMR) 
homogeneous materials. 
Reactions were monitored by analytical thin-layer chromatography (TLC) and carried 
out on 0.25 mm E. Merck silica gel plates (60F-254) using UV light as a visualizing 
agent and/or ceric ammonium molybdate (CAM), p-anisaldehyde (PA), and potassium 
permanganate (KMnO4) staining solutions.  Flash column chromatography was 
performed with E. Merck silica gel (60, particle size 0.040-0.063 mm).  Preparative thin-
layer chromatography (PTLC) separations were carried out on 0.25 mm E. Merck silica 
gel plates (60F-254). 
1H NMR, 13C NMR, COSY, HSQC, HMQC and HMBC spectra were recorded on the 
Bruker DPX-300 or AMX-300, AMX-400, DRX-500, and Varian Inova 500 
spectrometers and calibrated using residual undeuterated solvent as an internal reference.  
Data are reported as follows: chemical shifts in ppm (δ); multiplicities are indicated by 
the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, dd 
= doublet of doublets, dt = doublet of triplets, td = triplet of doublets, ddd = doublet of 
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doublet of doublets, m = multiplet, b = broad; coupling constants in Hz (J). 
Analytical capillary gas chromatography (GC) analyses were obtained from an 
Agilent 6890 fitted with a flame ionization detector (He carrier gas, 3 mL/min).  The 
column used was a J&W Scientific chiral Cyclosil B column (30m x 0.25mm x 0.25µm).  
The injector temperature was 250°C, the detector temperature was 320°C.  Retention 
times (tR) and integrated ratios were obtained from the Agilent Technologies GC 
Chemstation software.  The temperature program used for the analytical GC was as 
follows: initial temperature = 110°C; ramp = 0.2°C/min; final temperature = 120°C. 
Analytical high pressure liquid chromatography (HPLC) was performed on an 
Agilent 1100 series HPLC-DAD system equipped with a reversed-phase analytical scale 
Gemini 250 × 21.2 mm column, particle size 10 µm.  Preparative high pressure liquid 
chromatography (PHPLC) was carried out on an Agilent 1200 series system comprising a 
reversed-phase Gemini Axia 250 × 21.2 mm column, particle size 10 µm (Phenomenex 
Inc., Torrance, CA).  All ESI-LC-MS/MS analyses were collected on an API2000 
LC/MS/MS System (Applied Biosystems) equipped with a turbo-ion spray ESI probe 
interfaced with a Prominence UFLC (Shimadzu) equipped with a reverse phase BDS 
Hypersil C18 100 × 2.1 mm column, particle size 3 µm (Thermo Scientific).  
HPLC/LCMS UV absorption was monitored at 210 nm.  HRMS were obtained on a 
Kratos Analytical Concept instrument (University of Ottawa Mass Spectrum Centre). 
E. coli BL21(DE3) was grown in sterile LB media supplemented with ampicillin 
using standard protocols.  IPTG was purchased from Sigma-Aldrich, nickel-nitrotriacetic 
acid resin (Ni-NTA) from QIAGEN, while antibiotics and media/buffer components were 
purchased from Fisher Scientific.  Bacterial concentration (OD600) was monitored with a 
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GENESYS 20 spectrophotometer (Thermo Electron Corporation) and 1 mL cuvettes 
(BrandTech). 
3.5.2.  Experimental procedures 
3.5.2.1.  Macrolactone standards 
1-Phenylpent-4-en-2-ol (rac-3.21) 
rac-3.213.20
OH
O
5
4
3
2
1
 
Phenylacetaldehyde (3.20, +90% purity) (1.12 mL, 10.0 mmol) was dissolved in 
diethyl ether (Et2O, 100 mL, 0.1 M) and cooled to 0°C while vigorously stirring under an 
argon atmosphere.  After 20 minutes, allylmagnesium bromide (10.5 mL, 10.5 mmol, 
1.05 equiv) was added dropwise over 5 min. The reaction was monitored by TLC and 
after 30 min. it was quenched with an aqueous saturated solution of NH4Cl (50 mL).  
Diluted mixture with EtOAc (50 mL) and extracted aqueous layer with EtOAc (4x30 
mL).  The combined EtOAc fractions were washed brine (2x100 mL) and subsequently 
dried over anhydrous Na2SO4.  The slurry was filtered through a plug of cotton and the 
filtrate evaporated in vacuo.  Crude oil was purified by silica gel chromatography (20% 
EtOAc-hexanes) affording homoallylic alcohol rac-3.21 (1.62 g, 10.0 mmol, 100%) as a 
clear oil. 
Analytical data for rac-3.21a 
M.W.: 162.23 
TLC (Rf): 0.38 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
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7.38-7.24 (m, 5 H, PhH), 5.88 (m, 1 H, H2), 5.21 (m, 1 H, H1'), 5.16 (m, 1 
H, H1''), 3.90 (m, 1 H, H4), 2.80 (m, 2 H, H5), 2.32 (m, 2 H, H3), 1.94 (bs, 
1 H, OH) 
13C NMR: (75 MHz, CDCl3) 
138.59 (C(Ph)), 134.87 (C(2)), 129.56 (2 C, C(Ph)), 128.61 (2 C, C(Ph)), 
126.56 (C(Ph)), 118.10 (C(1)), 71.83 (C(4)), 43.41 (C(5)), 41.28 (C(3)) 
Reference: Kumar, A. N.; Bhatt, S.; Chattopadhyay, S., Chemoenzymatic asymmetric 
synthesis of harzia lactone A stereomers. Tetrahedron: Asymmetry 2009, 
20 (2), 205-209 
a Alcohol rac-3.21 was identical to its previously reported spectroscopic values 
1-Oxiranyl-3-phenyl-propan-2-ol (3.36)  
3.36rac-3.21
OH OH
O
5
4
3
2
1
 
Alcohol rac-3.21 (1.62 g, 10.0 mmol) and mCPBA (3.20 g, 13 mmol, 1.3 eq) were 
dissolved in dry dichloromethane (DCM, 100 mL) and stirred under an argon atmosphere 
at room temperature.  After 12 h., the reaction was quenched with an aqueous saturated 
solution of NaHCO3 followed by extraction with EtOAc (4x60 mL).  The organic 
fractions were combined and extracted in addition with NaHCO3 (3x50 mL) and 
repeatedly washed with brine (6x30 mL).  The organic layer was dried over Na2SO4 and 
filtered, after which the solvent was evaporated in vacuo.  The residual oil was purified 
by silica gel chromatography (200% EtOAc-hexanes) affording the 1:1 diastereomeric 
mixture of epoxides 3.36 (1.38 g, 77%) as a colorless oil. 
Analytical data for 3.36 (syn & anti mixture)a 
M.W.: 178.23 
TLC (Rf): 0.27 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
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7.36-7.22 (m, 10 H, PhH), 4.08 (m, 2 H, H4), 3.19-3.10 (m, 2 H, H2), 2.89-
2.72 (m, 6 H, H5, H1'), 2.61 (dd, J = 2.8, 2.0 Hz, 1 H, H1''), 2.51 (dd, J = 
2.8, 2.0 Hz, 1 H, H1''), 2.17 (d, J = 3.1 Hz, 1 H, OH), 2.14 (d, J = 3.1 Hz, 1 
H, OH), 1.90 (m, 2 H, H3), 1.64 (m, 2 H, H3) 
13C NMR: (75 MHz, CDCl3) 
138.16 (2 C, C(Ph)), 129.64 (2 C, C(Ph)), 129.62 (2 C, C(Ph)), 128.80 (4 
C, C(Ph)), 126.81 (2 C, C(Ph)), 71.37 (C(4)), 70.37(C(4)), 50.53 (C(1)), 
50.30 (C(1)), 47.16 (C(2)), 46.76 (C(2)), 44.33 (C(5)), 44.11 (C(5)), 39.10 
(C(3)), 38.88 (C(3)) 
(1-Benzyl-2-oxiranylethoxy)-tert-butyldimethylsilane (3.37) 
3.373.36
OH O
OO
5
4
3
2
1
Si
7
9
8
6
 
Epoxide 3.36 (3.34 g, 18.9 mmol), tert-butyldimethylchlorosilane (4.28 g, 28.4 mmol, 
1.5 eq) and imidazole (9.39 g, 32.1 mmol, 1.7 equiv) were dissolved in 
dimethylformamide (DMF, 200 mL, 0.1 M) while stirring at room temperature for 1 h 20 
min.  Quenched with NH4Cl (100 mL) and extracted with EtOAc (4x100 mL).  Washed 
combined organic fractions with brine (6x60 mL) and dried with Na2SO4, followed by 
the evaporation of the solvent in vacuo.  Purified residual oil by silica gel 
chromatography (5% EtOAc-hexanes) affording an inseparable 1:1 (syn/anti) mixture of 
silylated epoxide diastereomers 3.37 (5.53 g, 18.9 mmol, 100%) as a colorless oil. 
Analytical data for 3.37 (syn & anti mixture) 
M.W.: 292.49 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.28-7.17 (m, 10 H, PhH), 4.13-4.04 (m, 2 H, H4), 3.14-3.12 (m, 1 H, H2), 
3.05-3.03 (m, 1 H, H2), 2.89-2.75 (m, 6 H, H5, H1'), 2.48-2.42 (m, 2 H, 
H1''), 1.70 (t, J = 5.5 Hz, 2 H, H3), 1.65-1.58 (m, 2 H, H3), 0.89 (s, 9 H, 
H9), 0.87 (s, 9 H, H9), 0.05 (s, 3 H, H6), -0.02 (s, 3 H, H6), -0.10 (s, 3 H, 
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H7), -0.19 (s, 3 H, H7) 
13C NMR: (75 MHz, CDCl3) 
139.09 (C(Ph)), 138.68 (C(Ph)), 130.01 (2 C, C(Ph))), 129.96 (2 C, 
C(Ph))), 128.44 (2 C, C(Ph))), 128.41 (2 C, C(Ph))), 126.47 (C(Ph)), 
126.41 (C(Ph)), 72.22 (C(4)), 71.63 (C(4)), 49.98 (C(2)), 49.57 (C(2)), 
47.95 (C(1)), 46.90 (C(1)), 44.99 (C(5)), 44.21 (C(5)), 40.31 (C(2)), 40.03 
(C(2)), 26.06 (3 C, C(9)), 26.03 (3 C, C(9)), 18.25 (2 C, C(8)), -4.61 (C(6)), 
-4.67 (2 C, C(6), C(7)), -4.85 (C(7)) 
HRMS: (EI) m/z calcd for C13H19O2Si [(M-C4H9)+] 235.1149, found 235.0973 
6-(tert-Butyldimethylsilyloxy)-7-phenylhept-1-en-4-ol (3.38) 
3.383.37
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A heterogeneous solution in THF (200 mL) of CuI (3.9 g, 21 mmol, 1 equiv) was 
cooled to -20°C over 30 min., under an argon atmosphere.  To this suspension, 
vinylmagnesium bromide (63 mL, 63 mmol, 3 equiv) was added and stirred for an 
additional 30 min., producing a brown solution.  Epoxide 3.37 (6.0 g, 21 mmol) was 
dissolved in THF (100 mL) and added by canula over 20 min., and stirred vigorously for 
2.5 hrs.  Quenching with NH4Cl (50 mL), immediately produced a brown precipitate, 
which was filtered and the organic layer extracted with excess water.  Organic extract 
was washed with brine (2x50 mL), dried over Na2SO4 and the solvent evaporated in 
vacuo.  Purification of the residual oil was accomplished by silica gel chromatography 
(10% EtOAc-hexanes) affording an inseparable mixture of alcohol diastereomers 3.38 
(2.3 g, 7.2 mmol, 35%) as a yellow oil. 
Analytical data for 3.38 (syn & anti mixture) 
M.W.: 320.54 
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TLC (Rf): 0.45 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.28-7.12 (m, 10 H, PhH), 5.86-5.67 (m, 2 H, H2), 5.09-5.01 (m, 4 H, H1), 
4.19 (m, 1 H, H6), 4.03 (m, 2 H, H4, H6), 3.77 (m, 1 H, H4), 3.33 (s, 1 H, 
OH), 2.94-2.76 (m, 4 H, H7), 2.23-2.15 (m, 4 H, H3), 1.63-1.55 (m, 4 H, 
H5), 0.88 (s, 9 H, H11), 0.86 (s, 9 H, H11), 0.08 (s, 3 H, H8), 0.03 (s, 3 H, 
H8), -0.01 (s, 3 H, H9), -0.16 (s, 3 H, H9) 
13C NMR: (75 MHz, CDCl3) 
138.60 (C(Ph)), 138.29 (C(Ph)), 134.88 (C(2)), 134.74 (C(2)), 129.56 (2 C, 
(C(Ph)), 129.55 (2 C, (C(Ph)), 128.31 (2 C, (C(Ph)), 128.27 (2 C, (C(Ph)), 
126.28 (C(Ph)), 126.27 (C(Ph)), 117.50 (C(1)), 117.34 (C(1)), 73.94 (C(6)), 
73.08 (C(6)), 69.75 (C(4)), 67.69 (C(4)), 44.84 (C(7)), 43.00 (C(7)), 42.42 
(C(5)), 42.33 (C(5)), 42.08 (C(3)), 40.76 (C(3)), 25.82 (6 C, (C(11)), 17.92 
(2 C, C(10)), -4.37 (C(8)), -4.73 (C(9)), -4.97 (C(8)), -5.11 (C(9)) 
HRMS: (EI) m/z calcd for C15H23O2Si [(M-C4H9)+] 263.1462, found 263.1445 
1-Phenylhept-6-ene-2,4-diols (syn-3.39/anti-3.39) 
3.38
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A solution in EtOH (10 mL) of monoprotected diol 3.38 (1.3 g, 4.2 mmol) and PTSA 
(5.6 g, 29 mmol, 7 equiv) was stirred under argon for 4 hrs.  After checking by TLC, the 
reaction was quenched with a saturated NaHCO3 solution (5 mL) and extracted with 
EtOAc (4 x 10 mL).  Washed the organic extract with brine (2 x 20 mL), dried over 
MgSO4 and the solvent was evaporated in vacuo.  Purification by silica gel 
chromatography (20% EtOAc-hexanes to 100% EtOAc gradient) furnished the racemic 
diastereomeric mixture of diols 3.39 (520 mg, 2.5 mmol, 60%). 
To rapidly and efficiently separate, HPLC conditions were optimized on a reversed 
phase analytical scale Gemini 250 × 21.2 mm column, particle size 10 µm by applying 
water with methanol, acetonitrile and their 50:50 combination as organic modifiers using 
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an Agilent 1100 series HPLC-DAD system.  The final method with optimal binary linear 
gradient conditions was transferred and upscaled on an Agilent 1200 series preparative 
HPLC system comprising a binary pump (ﬂow rate range 5-100 mL/min), an autosampler 
with a 2 mL loop, a diode array detector with a ﬂow cell (path length 3 mm and 
maximum pressure limit 120 bar) and a fraction collector (40 mL collection tubes).  
Preparative scale separations were performed on a reverse-phase Gemini Axia 250 × 21.2 
mm column, particle size 10 µm (Phenomenex Inc., Torrance, CA) using a linear gradient 
of 30-100% acetonitrile in 20 min at a flow rate of 31.5 mL/min at room temperature.  
Fractions were collected, combined, and the solvent evaporated in vacuo to yield anti-
3.39 (163 mg, 0.79 mmol, 32%) as a crystalline solid and syn-3.39 (160 mg, 0.78 mmol, 
32%) as a pale yellow oil. 
Analytical data for anti-3.39 
M.W.: 206.13 
TLC (Rf): 0.67 (100% EtOAc) 
1H NMR: (400 MHz, CDCl3) 
7.32-7.19 (m, 5 H, PhH), 5.83-5.74 (m, 1 H, H2), 5.14-5.10 (m, 2 H, H1), 
4.17 (p, J = 7.4 Hz, 1 H, H6), 4.02 (p, J = 6.8 Hz, 1 H, H4), 2.78 (m, 2 H, 
H7), 2.25 (m, 2 H, H3), 2.25 (bs, 2 H, OH), 1.68 (dd, J = 6.1, 5.4 Hz, 2 H, 
H5) 
13C NMR: (100 MHz, CDCl3) 
138.27 (C(Ph)), 134.63 (C(2)), 129.38 (2 C, C(Ph)), 128.65 (2 C, C(Ph)), 
126.59 (C(Ph)), 118.29 (C(1)), 70.11 (C(6)), 68.11 (C(4)), 44.07 (C(7)), 
42.03 (C(5)), 41.56 (C(3)) 
HRMS: (EI) m/z calcd for C6H11O2 [(M-C7H7)+] 115.0754, found 115.0772 
Analytical data for syn-3.39 
M.W.: 206.13 
TLC (Rf): 0.71 (100% EtOAc) 
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1H NMR: (400 MHz, CDCl3) 
7.32-7.19 (m, 5 H, PhH), 5.84-5.73 (m, 1 H, H2), 5.14-5.08 (m, 2 H, H1), 
4.05 (m, 1 H, H6), 3.87 (m, 1 H, H4), 2.89 (bs, 1 H, OH), 2.76 (d, J = 6.5 
Hz, 2 H, H7), 2.22 (m, 2 H, H3), 1.69 (dt, J = 14.4, 2.3 Hz, 1 H, H5'), 1.54 
(m, 1 H, H5'') 
13C NMR: (100 MHz, CDCl3) 
137.97 (C(Ph)), 134.34 (C(2)), 129.46 (2 C, C(Ph)), 128.63 (2 C, C(Ph)), 
126.60 (C(Ph)), 118.30 (C(1)), 73.72 (C(6)), 71.66 (C(4)), 44.52 (C(7)), 
42.41 (C(5)), 41.82 (C(3)) 
HRMS: (EI) m/z calcd for C6H11O2 [(M-C7H7)+] 115.0754, found 115.0768 
anti-4-Allyl-6-benzyl-2,2-dimethyl-1,3-dioxane (anti-3.44) 
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In an acetone solution (0.1 mL, 1.4 mmol, 50 equiv), PTSA (1.6 mg, 0.008 mmol, 0.3 
equiv) and anti-3.39 (5.5 mg, 0.027 mmol) were stirred overnight under an argon 
atmosphere.  Quenched with TEA (5.0 µL 0.04 mmol, 1.3 equiv) and after evaporating 
solvent in vacuo, purified by flash chromatography (20% EtOAc-hexanes) affording 
acetonide anti-3.44 (2.2 mg, 0.0089 mmol, 33%) as a clear oil. 
Analytical data for anti-3.44 
M.W.: 246.34 
TLC (Rf): 0.78 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.29-7.16 (m, 5 H, PhH), 5.82-5.69 (m, 1 H, H2), 5.08-4.99 (m, 2 H, H1), 
4.04 (m, 1 H, H6), 3.86 (m, 1 H, H4), 2.88 (dd, J = 14.0, 7.0 Hz, 1 H, H7'), 
2.65 (dd, J = 14.0, 6.4 Hz, 1 H, H7''), 2.28-2.08 (m, 2 H, H3), 1.70-1.48 (m, 
2 H, H5), 1.35 (s, 3 H, H8(eq)), 1.29 (s, 3 H, H9(ax)) 
13C NMR: (75 MHz, CDCl3) 
138.34 (C(Ph)), 134.43 (C(2)), 129.18 (2 C, C(Ph)), 128.16 (2 C, C(Ph)), 
126.14 (C(Ph)), 116.78 (C(1)), 100.34 (C(10)), 67.43 (C(6)), 66.24 (C(4)), 
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42.08 (C(7)), 40.07 (C(5)), 37.51 (C(3)), 24.84 (2 C, C(8), C(9)) 
HRMS: (EI) m/z calcd for C15H19O2 [(M-CH3)+] 231.1380, found 231.1388 
syn-4-Allyl-6-benzyl-2,2-dimethyl-1,3-dioxane (syn-3.44) 
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In an acetone solution (0.1 mL, 1.4 mmol, 50 equiv), PTSA (1.0 mg, 0.005 mmol, 0.2 
equiv) and syn-3.39 (5.5 mg, 0.027 mmol) were stirred overnight under an argon 
atmosphere.  Quenched with TEA (5.0 µL 0.04 mmol, 1.3 equiv) and after evaporating 
solvent in vacuo, purified by flash chromatography (20% EtOAc-hexanes) affording 
acetonide syn-3.44 (5.5 mg, 0.022 mmol, 83%) as a clear oil. 
Analytical data for syn-3.44 
M.W.: 246.34 
TLC (Rf): 0.78 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.30-7.17 (m, 5 H, PhH), 5.80-5.68 (m, 1 H, H2), 5.07-4.98 (m, 2 H, H1), 
4.00 (m, 1 H, H6), 3.78 (m, 1 H, H4), 2.90 (dd, J = 13.4, 5.8 Hz, 1 H, H7'), 
2.60 (dd, J = 13.4, 7.4 Hz, 1 H, H7''), 2.30-2.08 (m, 2 H, H3), 1.44-1.40 (m, 
1 H, H5'), 1.41 (s, 3 H, H8(eq)), 1.40 (s, 3 H, H9(ax)), 1.17 (m, 1 H, H5'') 
13C NMR: (75 MHz, CDCl3) 
137.93 (C(Ph)), 134.19 (C(2)), 129.42 (2 C, C(Ph)), 128.22 (2 C, C(Ph)), 
126.22 (C(Ph)), 116.96 (C(1)), 98.57 (C(10)), 70.06 (C(6)), 68.63 (C(4)), 
43.02 (C(7)), 40.77 (C(5)), 35.82 (C(3)), 30.17 (C(8)), 19.80 (C(9)) 
HRMS: (EI) m/z calcd for C15H19O2 [(M-CH3)+] 231.1380, found 231.1375 
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anti-5-Allyl-7-benzyl-2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-disilaundecane (anti-
3.40) 
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Diol anti-3.39 (155 mg, 0.75 mmol) was dissolved by stirring in anhydrous DMF (3.8 
mL, 0.2M) at r.t. under an argon atmosphere.  Imidazole (116 mg, 1.7 mmol, 2.2 equiv) 
was added followed by TBSCl (256 mg, 1.7 mmol, 2.2 equiv) and the reaction was 
allowed to proceed overnight.  After checking by TLC for completion, extracted product 
with hexanes (4x2 mL), dried over MgSO4 and the solvent was evaporated in vacuo.  
Purification of the residual oil was accomplished by silica gel chromatography (10% 
EtOAc-hexanes) affording bis-silylated diol anti-3.40 (326 mg, 0.75 mmol, 100%) as a 
clear and viscous oil. 
Analytical data for anti-3.40 
M.W.: 434.30 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.25-7.13 (m, 5 H, PhH), 5.82-5.72 (m, 1 H, H2), 5.05-5.00 (m, 2 H, H1), 
3.92 (p, J = 6.4 Hz, 1 H, H6), 3.80 (p, J = 6.3 Hz, 1 H, H4), 2.72 (dddd, J = 
6.4, 3.4 Hz, 2 H, H7), 2.21 (m, 2 H, H3), 1.57 (m, 2 H, H5), 0.82 (s, 9 H, 
H11), 0.81 (s, 9 H, H15), -0.01 (s, 3 H, H8), -0.02 (s, 3 H, H12), -0.04 (s, 3 
H, H9), -0.17 (s, 3 H, H13) 
13C NMR: (100 MHz, CDCl3) 
139.01 (C(Ph)), 135.08 (C(2)), 129.70 (2 C, C(Ph)), 128.13 (2 C, C(Ph)), 
126.05 (C(Ph)), 116.90 (C(1)), 71.58 (C(6)), 69.93 (C(4)), 44.92 (C(5)), 
44.67 (C(7)), 42.45 (C(3)), 25.91 (3 C, C(11)), 25.88 (3 C, C(15)), 18.07 
C(10)), 18.05 (C(14)), -3.99 (C(8)), -4.28 (C(12)), -4.44 (2 C, C(9), C(13)) 
HRMS: (EI) m/z calcd for C21H37O2Si2 [(M-C4H9)+] 377.2327, found 377.2306 
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syn-5-Allyl-7-benzyl-2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-disilaundecane (syn-
3.40) 
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Diol syn-3.39 (157 mg, 0.76 mmol) was dissolved by stirring in anhydrous DMF (3.8 
mL, 0.2M) at r.t. under an argon atmosphere.  Imidazole (116 mg, 1.7 mmol, 2.2 equiv) 
was added followed by TBSCl (256 mg, 1.7 mmol, 2.2 equiv) and the reaction was 
allowed to proceed overnight.  After checking by TLC for completion, extracted product 
with hexanes (4x2 mL), dried over MgSO4 and the solvent was evaporated in vacuo.  
Purification of the residual oil was accomplished by silica gel chromatography (10% 
EtOAc-hexanes) affording bis-silylated diol syn-3.40 (330 mg, 0.76 mmol, 100%) as a 
clear and viscous oil. 
Analytical data for syn-3.40 
M.W.: 434.30 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.25-7.13 (m, 5 H, PhH), 5.78-5.67 (m, 1 H, H2), 4.98-4.92 (m, 2 H, H1), 
3.89 (p, J = 6.5 Hz, 1 H, H6), 3.84 (p, J = 6.2 Hz, 1 H, H4), 2.75 (dd, J = 
13.3, 5.6 Hz, 1 H, H7'), 2.66 (dd, J = 13.3, 6.8 Hz, 1 H, H7''), 2.16 (m, 2 H, 
H3), 1.59 (m, 2 H, H5), 0.87 (s, 9 H, H11), 0.82 (s, 9 H, H15), 0.05 (s, 3 H, 
H8), 0.04 (s, 3 H, H12), -0.07 (s, 3 H, H9), -0.21 (s, 3 H, H13) 
13C NMR: (100 MHz, CDCl3) 
139.04 (C(Ph)), 134.85 (C(1)), 129.86 (2 C, C(Ph)), 128.07 (2 C, C(Ph)), 
126.03 (C(Ph)), 116.98 (C(2)), 70.88 (C(6)), 69.16 (C(4)), 44.45 (C(5)), 
44.17 (C(7)), 41.91 (C(3)), 25.91 (6 C, C(11), C(15)), 18.09 (C(10)), 18.03 
(C(14)), -4.21 (C(8)), -4.38 (C(12)), -4.71 (C(9)), -4.79 (C(13)) 
HRMS: (EI) m/z calcd for C21H37O2Si2 [(M-C4H9)+] 377.2327, found 377.2318 
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Methyl 7-aminoheptanoate hydrochloride (3.34) 
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7-Aminoheptanoic acid (3.35) (150 mg, 1.03 mmol) was dissolved in MeOH (1.0 mL, 
24.7 mmol, 24 equiv) at r.t. under argon.  To the solution, trimethylsilyl chloride 
(TMSCl, 0.13 mL, 1.03 mmol, 1.0 equiv) was added and stirred overnight.  The solvent 
was evaporated in vacuo yielding crude methyl ester 3.34 (202 mg, 1.03 mmol, 100%) as 
a pale green solid. 
Analytical data for 3.34a 
M.W.: 195.69 
1H NMR: (300 MHz, D2O) 
3.55 (s, 3 H, H8), 2.85 (bt, J = 7.5 Hz, 2 H, H7), 2.26 (t, J = 7.5 Hz, m, 2 
H, H2), 1.48 (m, 4 H, H3, H6), 01.22 (m, 4 H, H4, H5) 
13C NMR: (75 MHz, D2O) 
177.60 (C(1)), 51.99 (C(8)), 39.31 (C(7)), 33.44 (C(2)), 27.51 (C(6)), 26.40 
(C(4)), 25.09 (C(5)), 23.88 (C(3)) 
Reference: Gros, L.; Orenes Lorente, S.; Jimenez Jimenez, C.; Yardley, V.; Rattray, 
L.; Wharton, H.; Little, S.; Croft, S. L.; Ruiz-Perez, L. M.; Gonzalez-
Pacanowska, D.; Gilbert, I. H., Evaluation of azasterols as anti-parasitics. 
J. Med. Chem. 2006, 49 (20), 6094-6103 
a Aminoester 3.34 was identical to its previously reported spectroscopic values 
Methyl 7-anti-3,5-bis(tert-butyldimethylsilyloxy)-6-phenylhexanamido)heptanoate 
(anti-3.41) 
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In a flask, NaIO4 (780 mg, 1.4 mmol, 8.0 equiv) and KMnO4 (34 mg, 0.22 mmol, 1.2 
equiv) were dissolved in pH 7.24 phosphate buffer (1.0 mL, 0.05M) and stirred 
vigorously at r.t.  Olefin anti-3.40 (80 mg, 0.18 mmol) was dissolved in t-BuOH (1.8 
mL) while stirring.  After 15 min, the dark purple permanganate solution was transferred 
by Pasteur pipette to the olefin solution and stirred overnight.  Two buffer washes (0.4 
mL) were employed to quantitatively transfer the oxidant mixture.  Upon contact, the 
new heterogeneous solution changed coloration to a pale brown/purple.  Quenched with a 
saturated solution of sodium thiosulfate (1.0 mL), stirred for 30 min and extracted with 
EtOAc (4x1.5 mL).  The organic extract was washed with brine (2x2 mL), dried over 
MgSO4 and the solvent evaporated in vacuo.  The isolated crude oil (42 mg) was 
dissolved in DCM (1.9 mL, 0.05M) and, while stirring under argon, added: EDC (27 mg, 
0.14 mmol, 1.5 equiv), DMAP (1.1 mg, 0.009 mmol, 0.1 equiv) and amine 3.34 (22 mg, 
0.11 mmol, 1.2 equiv).  After 5 min, TEA was added (31 μL, 0.22 mmol, 2.4 equiv) and 
the solution was stirred overnight.  Quenched with NH4Cl (1.0 mL) and extracted with 
EtOAc (5x2 mL).  Organic extracts were washed with brine (2x5 mL) and dried over 
MgSO4.  After solvent evaporation, the oil obtained was purified by flash column 
chromatography (30% EtOAc-hexanes) furnishing amide anti-3.41 (34 mg, 0.058 mmol, 
32% over two steps) as an amber oil. 
Analytical data for anti-3.41 
M.W.: 593.99 
TLC (Rf): 0.26 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
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7.25-7.13 (m, 5 H, PhH), 6.33 (bt, J = 5.5 Hz, 1 H, NH), 4.04 (m, 1 H, H3), 
3.87 (p, J = 6.3 Hz, 1 H, H5), 3.64 (s, 3 H, H14), 3.26-3.07 (m, 2 H, H7), 
2.70 (d, J = 6.4 Hz, 2 H, H6), 2.50 (dd, J = 15.1, 4.0 Hz, 1 H, H2'), 2.28 (m, 
3 H, H12, H2''), 1.68 (m, 2 H, H4), 1.58 (m, 2 H, H11), 1.41 (m, 2 H, H8), 
1.28 (m, 4 H, H9, H10), 0.82 (s, 9 H, H22), 0.81 (s, 9 H, H18), 0.00 (s, 6 H, 
H15, H19), -0.03 (s, 3 H, H16), -0.18 (s, 3 H, H20) 
13C NMR: (100 MHz, CDCl3) 
174.08 (C(13)), 170.55 (C(1)), 138.55 (C(Ph)), 129.71 (2 C, C(Ph)), 128.17 
(2 C, C(Ph)), 126.19 (C(Ph)), 71.30 (C(5)), 67.64 (C(3)), 51.44 (C(14)), 
44.33 (C(4)), 44.15 (C(6)), 44.14 (C(2)), 39.14 (C(7)), 33.96 (C(12)), 29.36 
(C(8)), 28.76 (C(9)), 26.68 (C(10)), 25.88 (3 C, C(18)), 25.74 (3 C, C(22)), 
24.80 (C(11)), 17.98 (C(17)), 17.85 (C(21)), -4.52 (C(15)), -4.56 (C(19)), -
4.60 (C(18)), -4.68 (C(20)) 
HRMS: (EI) m/z calcd for C28H50NO5Si2 [(M-C4H9)+] 536.3222, found 536.3251 
Methyl 7-syn-3,5-bis(tert-butyldimethylsilyloxy)-6-phenylhexanamido)heptanoate 
(syn-3.41) 
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In a flask, NaIO4 (780 mg, 1.4 mmol, 8.0 equiv) and KMnO4 (34 mg, 0.22 mmol, 1.2 
equiv) were dissolved in pH 7.24 phosphate buffer (1.0 mL, 0.05M) and stirred 
vigorously at r.t.  Olefin syn-3.40 (80 mg, 0.18 mmol) was dissolved in t-BuOH (1.8 mL) 
while stirring.  After 15 min, the dark purple permanganate solution was transferred by 
Pasteur pipette to the olefin solution and stirred overnight.  Two buffer washes (0.4 mL) 
were employed to quantitatively transfer the oxidant mixture.  Upon contact, the new 
heterogeneous solution changed coloration to pale brown.  Quenched with a saturated 
solution of sodium thiosulfate (1.0 mL), stirred for 30 min and extracted with EtOAc 
(4x1.5 mL).  The organic extract was washed with brine (2x2 mL), dried over MgSO4 
and the solvent evaporated in vacuo.  The isolated crude oil (51 mg) was dissolved in 
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DCM (2.2 mL, 0.05M) and added while stirring under argon: EDC (33 mg, 0.17 mmol, 
1.5 equiv), DMAP (1.2 mg, 0.01 mmol, 0.1 equiv) and amine 3.34 (25 mg, 0.13 mmol, 
1.2 equiv).  After 5 min, TEA was added (36 μL, 0.26 mmol, 2.4 equiv) and the solution 
was stirred overnight.  Quenched with NH4Cl (1.0 mL) and extracted with EtOAc (5 x 2 
mL).  Organic extracts were washed with brine (2x5 mL) and dried over MgSO4.  After 
solvent evaporation, the oil obtained was purified by flash column chromatography (30% 
EtOAc-hexanes) furnishing amide syn-3.41 (34 mg, 0.065 mmol, 36% over two steps) as 
an amber oil. 
Analytical data for syn-3.41 
M.W.: 593.99 
TLC (Rf): 0.24 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.24-7.10 (m, 5 H, PhH), 6.28 (bt, J = 5.4 Hz, 1 H, NH), 4.17 (m, 1 H, H3), 
3.93 (m, 1 H, H5), 3.63 (s, 3 H, H14), 3.21-3.00 (m, 2 H, H7), 2.76 (dd, J = 
13.5, 6.3 Hz, 1 H, H6'), 2.67 (dd, J = 13.4, 6.7 Hz, 1 H, H6''), 2.43 (dd, J = 
14.9, 4.3 Hz, 1 H, H2'), 2.26 (t, J = 7.5 Hz, 2 H, H12), 2.20 (dd, J = 14.9, 
5.2 Hz, 1 H, H2''), 1.60 (m, 4 H, H4, H11), 1.35 (m, 2 H, H8), 1.25 (m, 4 H, 
H9, H10), 0.85 (s, 9 H, H22), 0.84 (s, 9 H, H18), 0.05 (s, 3 H, H15), 0.04 
(s, 3 H, H19), -0.01 (s, 3 H, H16), -0.13 (s, 3 H, H20) 
13C NMR: (100 MHz, CDCl3) 
174.09 (C(13)), 170.62 (C(1)), 138.42 (C(Ph)), 129.66 (2 C, C(Ph)), 128.19 
(2 C, C(Ph)), 126.17 (C(Ph)), 70.54 (C(5)) , 67.17 (C(3)), 51.45 (C(14)), 
44.41 (C(6)), 43.58 (C(4)), 43.45 (C(2)), 39.09 (C(7)), 33.97 (C(12)), 29.35 
(C(11)), 28.75 (C(9)), 26.65 (C(10)), 25.90 (3 C, C(18)), 25.81 (3 C, 
C(22)), 24.80 (C(10)), 18.00 (C(17)), 17.89 (C(21)), -4.57 (3 C, C(15), 
C(16), C(19)), -4.76 (C(20)) 
HRMS: (EI) m/z calcd for C28H50NO5Si2 [(M-C4H9)+] 536.3222, found 536.3256 
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General procedure for the deprotection and Corey-Nicolaou macrocyclization of 
bis-silylated diols anti-3.41 and syn-3.41 
Hydrolysis.  The methyl ester and LiOH (10 equiv) are dissolved and vigorously 
stirred in a 5:1 solution of MeOH:H2O (0.02M) at r.t. for 6 hr.  Solvent was evaporated 
off and the crude was acidified to a pH of 3 units by the dropwise addition of 1M HCl.  
Extracted with EtOAc (4x0.25 volumes), dried with brine and MgSO4, and evaporated in 
vacuo.  Silyl deprotection.  In an Eppendorf tube the crude acid was dissolved in MeCN 
(0.1 M) and vortexed for 10 sec to homogeneity.  To this solution, pyridine (10 equiv) 
and hydrofluoric acid (HF, 50 equiv) were added and, following mixing by vortexing 10 
sec, the mixture was left to react 6 hr.  The mixture was diluted with H2O, extracted with 
EtOAc (5 x 0.5 volumes) and the organic phase was dried with MgSO4 and evaporated in 
vacuo.  Macrolactonization.  The crude hydroxyacid, 2,2'-dithiopyridine (DTP, 1.5 
equiv), and PPh3 (1.5 equiv) were dissolved in THF (0.01 M) and stirred at r.t. for 5.5 hr.  
The bright yellow solution was quantitatively transferred and diluted into a syringe by 
portionwise addition of toluene (~0.005 M).  The solution was transferred dropwise by 
syringe pump (0.6 mL/hr) into a round bottom flask fitted with a reflux condenser 
containing toluene (~0.0005 M) heated to 85°C under an argon atmosphere.  The reaction 
was stirred for 5 to 8 days while monitoring for completion by LC/MS, at which time the 
solvent was evaporated in vacuo and the crude partially purified by chromatographic 
techniques (PTLC and/or FCC) employing a 5%MeOH/EtOAc solvent system.  The 
presence of macrocycle in the eluted fractions was checked by LC/MS.  After pooling the 
fractions of interest and evaporating the solvent in vacuo, purified by PHPLC on a 
reverse phase Eclipse XDB-C18 150 × 4.6 mm column, particle size 5 µm (Agilent 
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Technologies, Inc., Santa Clara, CA) using a linear gradient of 0-40% 95% 
acetonitrile:water in 30 min at a flow rate of 2.2 mL/min at 40°C. 
anti-2-Benzyl-4-hydroxy-1-oxa-7-azacyclotetradecane-6,14-dione (anti-3.42) 
anti-2-(2-Hydroxy-3-phenylpropyl)-1-oxa-5-azacyclododecane-4,12-dione (anti-3.43) 
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Hydrolysis.  Methyl ester anti-3.41 (117 mg, 0.20 mmol) was treated with LiOH 
(84 mg, 2.0 mmol, 10 equiv) and dissolved in MeOH:H2O (12 mL, 0.02 M) at r.t.  Upon 
acidification of aqueous layer, extracted with EtOAc (4x3 mL) and dried with brine (1 x 
1 mL) and MgSO4.  Filtered and evaporated solvent in vacuo.  Silyl deprotection. The 
isolated crude oil (~114 mg) was dissolved in MeCN (2 mL) and vortexed to 
homogeneity (10-20 sec).  Pyridine (145 μL, 2.0 mmol, 10 equiv) followed by HF (174 
μL, 10 mmol, 50 equiv) were added and after vortexing thoroughly, the reaction was left 
undisturbed for 6 hr.  Diluted with H2O (1.5 mL) and extracted with EtOAc (5x1 mL).  
The organic layers were combined, dried with MgSO4 and, after evaporation in vacuo, a 
crude white solid was isolated (~60 mg).  Macrolactonization.  Crude hydroxyacid (3.5 
mg, 0.010 mmol) was dissolved in THF (0.8 mL, 0.01 M) followed by DTP (3.3 mg, 
0.015 mmol, 1.5 equiv) and PPh3 (3.9 mg, 0.015 mmol, 1.5 equiv).  After 5.5 hr, diluted 
with toluene (5 mL, 0.002 M) and added via syringe pump (0.6 mL/hr) to hot toluene.  
After 5 days at 86°C, solvent was evaporated and the crude was purified by PHPLC.  
Two fractions were collected and lyophilized to yield 1) spectroscopically pure anti-3.42 
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(0.5 mg, 2 μmol, 2% after three steps) and 2) a crude mixture of anti-3.42 and anti-3.43 
(0.05 mg, 0.15 μmol, 0.1% after three steps) as white solids.  The latter mixture was 
repurified by LC/MS and regrettably its yield was insufficient for full spectroscopic 
characterization. 
Analytical data for anti-3.42 
M.W.: 333.42 
TLC (Rf): 0.23 (100% EtOAc) 
LCMS: tR, 17.24 min 
1H NMR: (500 MHz, CDCl3) 
7.28-7.15 (m, 5 H, PhH), 6.15 (bd, J = 4.4 Hz, 1 H, NH), 5.21 (dq, J = 8.3, 
5.6 Hz, 1 H, H12), 3.83 (bs, 2 H, H10, OH), 3.52 (m, 1 H, H7'), 3.02 (m, 1 
H, H7''), 2.95 (dd, J = 14.3, 8.4 Hz, 1 H, H13'), 2.88 (dd, J = 14.2, 5.4 Hz, 
1 H, H13''), 2.44 (m, 2 H, H9), 2.25 (m, 2 H, H2), 1.95 (m, 1 H, H11'), 1.79 
(m, 1H, H3'), 1.75 (m, 1 H, H11''), 1.59 (1 H, H3''), 1.53 (2 H, H6), 1.37 
(m, 2 H, H4', H5'), 1.30 (m, 1 H, H4''), 1.19 (m, 1 H, H5'') 
 
Note: Protons on C3, C4, C5, C6 are covered by H2O peak and solvent.  
Peaks were assigned from COSY and HSQC correlation spectra 
13C NMR: (75 MHz, CDCl3) 
174.62 (C(1)), 171.80 (C(8)), 136.91 (C(Ph)), 129.11 (2 C, C(Ph)), 128.53 
(2 C, C(Ph)), 126.78 (C(Ph)), 72.11 (C(12)), 66.29 (C(10)), 41.94 (C(9)), 
40.98 (C(11)), 40.42 (C(13)), 39.11 (C(7)), 34.24 (C(2)), 29.12 (C(4)), 
27.35 (C(6)), 25.59 (C(5)), 23.20 (C(3)) 
HRMS: (EI) m/z calcd for C19H27NO4 [(M)+] 333.1940, found 333.1951 
Analytical data for anti-3.43 
M.W.: 333.42 
TLC (Rf): 0.23 (100% EtOAc) 
LCMS: tR, 16.54 min 
1H NMR: (500 MHz, CDCl3) 
7.28-7.15 (m, 5 H, PhH), 5.50 (m, 1 H, H10), 5.30 (bd, J = 9.0 Hz, 1 H, 
NH), 3.73 (m, 2 H, H12) 
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Peaks picked from mixture of products are unambiguously from anti-3.43.  
Insufficient quantities of anti-3.43 limited our spectroscopic analysis. 
LRMS: (ESI) m/z calcd for C19H28NO4 [(M+H)+] 334, found 334 
syn-2-Benzyl-4-hydroxy-1-oxa-7-azacyclotetradecane-6,14-dione (syn-3.43) 
syn-2-(2-Hydroxy-3-phenylpropyl)-1-oxa-5-azacyclododecane-4,12-dione (syn-3.43) 
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Hydrolysis.  Methyl ester syn-3.41 (99 mg, 0.17 mmol) was treated with LiOH (71 
mg, 1.7 mmol, 10 equiv) and dissolved in MeOH:H2O (12 mL, 0.014 M) at r.t.  Upon 
acidification of aqueous layer, extracted with EtOAc (4 x 3 mL) and dried with brine (1 x 
1 mL) and MgSO4.  Filtered and evaporated solvent in vacuo.  Silyl deprotection. The 
isolated crude oil (~94 mg) was dissolved in MeCN (1.6 mL) and vortexed to 
homogeneity (10-20 sec).  Pyridine (116 μL, 2.0 mmol, 10 equiv) followed by HF (140 
μL, 10 mmol, 50 equiv) were added and after vortexing thoroughly, the reaction was left 
undisturbed for 6 hr.  Diluted with H2O (1.5 mL) and extracted with EtOAc (5 x 1 mL).  
The organic layers were combined, dried with MgSO4 and, after evaporation in vacuo, a 
crude white solid was isolated (~50 mg).  Macrolactonization.  Crude hydroxyacid (30 
mg, 0.085 mmol) was dissolved in THF (0.85 mL, 0.1 M) followed by DTP (29 mg, 0.13 
mmol, 1.5 equiv) and PPh3 (34 mg, 0.13 mmol, 1.5 equiv).  After 5.5 hr, diluted with 
toluene (10 mL, ~0.009 M) and added via syringe pump (0.6 mL/hr) to hot toluene.  After 
10 days at 85°C, solvent was evaporated and the crude was partially purified by FCC 
(5%MeOH/EtOAc); the macrolactone-containing fractions were combined and the crude 
obtained (~10 mg) was purified by PHPLC.  Two fractions were collected and 
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lyophilized to yield 1) spectroscopically pure syn-3.42 (5.0 mg, 15 μmol, 18% after three 
steps) and 2) syn-3.43 (2.0 mg, 6 μmol, 7% after three steps) as white solids. 
Analytical data for syn-3.42 
M.W.: 333.42 
TLC (Rf): 0.46 (100% EtOAc) 
LCMS: tR, 17.28 min 
1H NMR: (500 MHz, CDCl3) 
7.28-7.14 (m, 5 H, PhH), 5.90 (bd, J = 8.4 Hz, 1 H, NH), 5.24 (m, 1 H, 
H12), 3.80 (m, 1 H, H10), 3.66 (m, 1 H, H7'), 2.88 (m, 3 H, H7'', H13), 
2.56 (dd, J = 13.7, 2.2 Hz, 1 H, H9'), 2.24 (m, 2 H, H2), 2.10 (dd, J = 
13.7, 7.7 Hz, 1 H, H9''), 1.95 (m, 1 H, H11'), 1.76 (m, 2 H, H3', H11''), 
1.52 (m, 2 H, H3'', H5'), 1.43 (m, 2 H, H5'', H6'), 1.23 (m, 3 H, H4, H6'') 
13C NMR: (75 MHz, CDCl3) 
174.96 (C(1)), 172.49 (C(8)), 136.85 (C(Ph)), 129.25 (2 C, C(Ph)), 128.45 
(2 C, C(Ph)), 126.73 (C(Ph)), 71.60 (C(12)), 67.38 (C(10)), 42.44 (C(9)), 
41.57 (C(13)), 40.13 (C(11)), 39.51 (C(7)), 34.06 (C(2)), 28.83 (C(6)), 
26.59 (C(5)), 26.05 (C(4)), 22.37 (C(3)) 
HRMS: (EI) m/z calcd for C19H27NO4 [(M)+] 333.1940, found 333.1947 
Analytical data for syn-3.43 
M.W.: 333.42 
TLC (Rf): 0.46 (100% EtOAc) 
LCMS: tR, 15.55 min 
1H NMR: (500 MHz, CDCl3) 
7.31-7.18 (m, 5 H, PhH), 5.52 (m, 1 H, H10), 5.36 (bd, J = 6.9 Hz, 1 H, 
NH), 3.91 (m, 1 H, H12), 3.67 (m, 1 H, H7'), 3.06 (dd, J = 13.4, 2.7 Hz, 1 
H, H7''), 2.89 (dd, J = 13.4, 4.4 Hz, 1 H, H13'), 2.65 (dd, J = 13.5, 8.5 Hz, 
1 H, H13''), 2.55 (dd, J = 13.5, 2.9 Hz, 1 H, H9'), 2.37 (m, 2 H, H2', H9'), 
2.27 (m, 1 H, H2''), 1.83 (m, 3 H, H3', H11), 1.58 (m, 4 H, H3'', H4, H6'), 
1.29 (m, 3 H, H5, H6'') 
13C NMR: (75 MHz, CDCl3) 
173.35 (C(1)), 169.55 (C(2)), 137.84 (C(Ph)), 129.41 (2 C, C(Ph)), 128.64 
(2 C, C(Ph)), 126.65 (C(Ph)), 69.86 (2 C, C(10), C(12)), 44.07 (C(13)), 
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42.91 (C(9)), 41.41 (C(11)), 37.37 (C(7)), 33.51 (C(2)), 25.81 (C(4)), 24.63 
(C(5)), 23.99 (C(6)), 23.63 (C(3)) 
HRMS: (EI) m/z calcd for C19H27NO4 [(M)+] 333.1940, found 333.1932 
3.5.2.2.  Enantioenriched NAC thioesters 
General procedure for the Brown allylation of phenylacetaldehyde (3.20) 
In a round bottomed flask (r.b.f.), Ipc2BAllyl (5 mL, 1M in pentanes) was cooled to -
100°C in a Et2O/N2(l) bath.  To this, a solution of phenylacetaldehyde in 10 mL Et2O was 
slowly cannulated over 5 min. After 30 min and warming to -78°C, quenched with 2 mL 
MeOH and slowly allowed mixture to warm up to r.t., at which point 2 mL of a 15% 
NaOH solution was added followed by 4 mL of 30% H2O2.  This mixture was equipped 
with a water condenser and refluxed for 30 min.  Purification was accomplished by 
extracting with EtOAc (3x15 mL), and drying with brine and Na2SO4.  The organic 
fractions were combined and solvent evaporated in vacuo.  The residual clear oil was 
purified by flash column chromatography (50% DCM-Hexanes). 
(S)-1-Phenylpent-4-en-2-ol (3.21) 
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The procedure outlined above was employed in the conversion of aldehyde 3.20 to 
homoallylic alcohol 3.21 (460 mg, 2.8 mmol, 63%, 90% ee) with (-)-Ipc2BAllyl. 
Analytical data for 3.21a 
M.W.: 162.23 
TLC (Rf): 0.38 (20% EtOAc-hexanes) 
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1H NMR: (300 MHz, CDCl3) 
7.33-7.19 (m, 5 H, PhH), 5.81 (m, 1 H, H2), 5.16 (m, 1 H, H1'), 5.12 (t, J = 
1.2 Hz, 1 H, H1''), 3.86 (m, 1 H, H4), 2.75 (m, 2 H, H5), 2.29 (m, 2 H, H3), 
1.65 (d, J = 10 Hz, 1 H, OH) 
13C NMR: (75 MHz, CDCl3) 
138.39 (C(Ph)), 134.70 (C(2)), 129.44 (2 C, C(Ph)), 128.57 (2 C, C(Ph)), 
126.51 (C(Ph)), 118.18 (C(1)), 71.69 (C(4)), 43.32 (C(5)), 41.21 (C(3)) 
GC: tR, 41.45 min (95%) 
Reference: Kumar, A. N.; Bhatt, S.; Chattopadhyay, S., Chemoenzymatic asymmetric 
synthesis of harzia lactone A stereomers. Tetrahedron: Asymmetry 2009, 
20 (2), 205-209 
a Alcohol 3.21 was identical to its previously reported spectroscopic values 
(R)-1-Phenylpent-4-en-2-ol (ent-3.21) 
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The general procedure previously outlined was employed in the conversion of 
aldehyde 3.20 to homoallylic alcohol ent-3.21 (320 mg, 1.97 mmol, 44%, 90% ee) with 
(+)-Ipc2BAllyl. 
Analytical data for ent-3.21a 
M.W.: 162.23 
TLC (Rf): 0.38 (20% EtOAc-hexanes) 
1H NMR: (300 MHz, CDCl3) 
7.38-7.20 (m, 5 H, PhH), 5.82 (m, 1 H, H2), 5.15 (m, 1 H, H1'), 5.12 (t, J = 
1.2 Hz, 1 H, H1''), 3.87 (m, 1 H, H4), 2.75 (m, 2 H, H5), 2.33-2.18 (m, 2 H, 
H3) 
13C NMR: (75 MHz, CDCl3) 
138.43 (C(Ph)), 134.73 (C(2)), 129.46 (2 C, C(Ph)), 128.56 (2 C, C(Ph)), 
126.51 (C(Ph)), 118.14 (C(1)), 71.72 (C(4)), 43.32 (C(5)), 41.21 (C(3)) 
GC: tR, 42.62 min (95%) 
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Reference: Kumar, A. N.; Bhatt, S.; Chattopadhyay, S., Chemoenzymatic asymmetric 
synthesis of harzia lactone A stereomers. Tetrahedron: Asymmetry 2009, 
20 (2), 205-209 
a Alcohol ent-3.21 was identical to its previously reported spectroscopic values 
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General procedure for the synthesis of enantioenriched epoxides 3.22 and ent-3.22 
The purified chiral Brown allylation product was treated to the following sequence:  
Epoxidation.  The chiral olefin was dissolved at 0°C in DCM (0.05M conc.) along with 
mCPBA (2.1 equiv, 77% purity) and NaHCO3(s) (4.2 equiv) and vigorously stirred 
overnight and allowing the mixture to gradually warm up to r.t.  Quenching was carried 
out by addition of 0.5 volumes of a saturated NH4Cl solution and extraction performed 
with EtOAc, H2O and copious amounts of saturated NaHCO3 solution.  Dried organic 
layer with Na2SO4 and the solvent was evaporated in vacuo.  The crude oil was filtered 
through a plug of silica with EtOAc.  Silylation.  The crude oil was dissolved in DMF at 
r.t. to which imidazole and TBSCl were added sequentially.  The solution was vigorously 
stirred for 24 hrs and subsequently quenched with NH4Cl and diluted with EtOAc and 
H2O.  Extracted 8-10 times with brine and after solvent evaporation, the residual oil was 
filtered through a plug of silica with hexanes.  Jacobsen's hydrolytic kinetic resolution.  
The catalysts employed were prepared according to a previously reported literature 
method1.  The epoxide and catalyst were dissolved in THF and cooled to 0°C while 
ent-3.21 
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stirring in a round bottomed flask.  H2O was added and warmed up to r.t. while stirring 
for 16 h.  The solvent was evaporated and the oil purified by flash column 
chromatography (100% hexanes – 50% EtOAc-hexanes). 
tert-Butyldimethyl((R)-1-((R)-oxiran-2-yl)-3-phenylpropan-2-yloxy)silane (3.22) 
(2S,4R)-4-(tert-Butyldimethylsilyloxy)-5-phenylpentane-1,2-diol (3.24) 
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Epoxidation.  General procedure outlined above was employed with homoallylic 
alcohol 3.21 (460 mg, 2.8 mmol), mCPBA (1.33 g, 5.9 mmol, 2.1 equiv, 77% pure), 
NaHCO3 (991 mg, 11.8 mmol, 4.2 equiv) in DCM (56 mL).  The reaction yielded a crude 
oil (273 mg, ~1.5 mmol) that was used without further purification on the next step.  
Silylation.  Crude epoxide (273 mg, ~1.5 mmol), imidazole (177 mg, 2.6 mmol, 1.7 
equiv), TBSCl (347 mg, 2.3 mmol, 1.5 equiv) was stirred in DMF (30 mL).  The crude 
oil (341 mg, ~1.2 mmol) obtained was used in the hydrolytic kinetic resolution step.  
Jacobsen's hydrolytic kinetic resolution.  Crude silylated oil (341 mg, ~1.2 mmol), 
R,R-Salen catalyst (692.8 mg/mmol, 17 mg, 0.024 mmol, 2 mol%), H2O (12 μL, 0.66 
mmol, 0.55 equiv), THF (1 mL).  After careful purification epoxide 3.22 (175 mg, 0.60 
mmol, 90% de, 21% overall) and vicinal diol 3.24 (156 mg, 0.50 mmol, 18% overall) 
were isolated.  The three step sequence furnished 3.22 and 3.24 in a 39% overall yield. 
Analytical data for 3.22 
M.W.: 292.49 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
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1H NMR: (400 MHz, CDCl3) 
7.27-7.15 (m, 5 H, PhH), 4.02 (dt, J = 5.6, 1.2 Hz, 1 H, H4), 3.09 (m, 1 H, 
H2), 2.83 (d, J = 2.4, 2 H, H5), 2.74 (m, 1 H, H1'), 2.40 (m, 1 H, H1''), 1.66 
(t, J = 5.6 Hz, 2 H, H3), 0.83 (s, 9 H, H9), -0.05 (s, 3 H, H6), -0.22 (s, 3 H, 
H7) 
13C NMR: (100 MHz, CDCl3) 
138.87 (C(Ph)), 129.80 (2 C, C(Ph)), 128.20 (2 C, C(Ph)), 126.20 (C(Ph)), 
72.00 (C(4)), 49.38 (C(2)), 46.71 (C(1)), 43.99 (C(5)), 39.81 (C(2)), 25.82 
(3 C, C(9)), 18.02 (C(8)), -4.90 (C(6), -5.07 (C(7)) 
HRMS: (EI) m/z calcd for C13H19O2Si [(M-C4H9)+] 235.1149, found 235.0922 
 
Analytical data for 3.24 
M.W.: 310.49 
TLC (Rf): 0.14 (30% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.28-7.13 (m, 5 H, PhH), 4.21 (m, 1 H, H4), 4.15 (m, 1 H, H2), 3.57 (m, 1 
H, H1'), 3.38 (m, 1 H, H1''), 2.93 (dd, J = 13.2, 6.8 Hz, 1 H, H5'), 2.80 (dd, 
J = 13.6, 7.2 Hz, 1 H, H5''), 2.0 (m, 1 H, OH), 1.70 (m, 1H, H3'), 1.46 (m, 
1H, H3''), 0.87 (s, 9 H, H9), 0.03 (s, 3 H, H6), -0.15 (s, 3 H, H7) 
13C NMR: (100 MHz, CDCl3) 
138.41 (C(Ph)), 129.54 (2 C, C(Ph)), 128.45 (2 C, C(Ph)), 126.45 (C(Ph)), 
72.95 (C(4)), 68.84 (C(2)), 67.14 (C(1)), 42.90 (C(5)), 36.97 (C(2)), 25.83 
(3 C, C(9)), 17.95 (C(8)), -4.97 (C(6), -5.08 (C(7)) 
HRMS: (EI) m/z calcd for C10H23O3Si [(M-C7H7)+] 219.1411, found 219.1397 
tert-Butyldimethyl((S)-1-((S)-oxiran-2-yl)-3-phenylpropan-2-yloxy)silane (ent-3.22) 
(2R,4S)-4-(tert-Butyldimethylsilyloxy)-5-phenylpentane-1,2-diol (ent-3.24) 
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Epoxidation. General procedure outlined above was employed with homoallylic 
alcohol ent-3.21 (320 mg, 1.97 mmol), mCPBA (928 mg, 4.14 mmol, 2.1 equiv, 77% 
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pure), NaHCO3 (696 mg, 8.28 mmol, 4.2 equiv) in DCM (40 mL).  The reaction yielded 
a crude oil (301 mg, ~1.69 mmol) that was used without further purification on the next 
step.  Silylation.  Crude epoxide (301 mg, ~1.69 mmol), imidazole (195 mg, 2.87 mmol, 
1.7 equiv), TBSCl (383 mg, 2.54 mmol, 1.5 equiv) was stirred in DMF (34 mL).  The 
crude oil (405 mg, ~1.38 mmol) obtained was used in the hydrolytic kinetic resolution 
step.  Jacobsen's hydrolytic kinetic resolution.  Crude silylated oil (405 mg, ~1.38 
mmol), S,S-Salen catalyst (692.8 mg/mmol, 19 mg, 0.030 mmol, 2 mol%), H2O (14 μL, 
0.76 mmol, 0.55 equiv), THF (0.3 mL).  After purification epoxide ent-3.22 (152 mg, 
0.52 mmol, 90% de, 26% overall) and vicinal diol ent-3.24 (151 mg, 0.49 mmol, 25% 
overall) were isolated.  The three step sequence furnished ent-3.22 and ent-3.24 in a 51% 
overall yield. 
Analytical data for ent-3.22 
M.W.: 292.49 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.27-7.15 (m, 5 H, PhH), 4.02 (dt, J = 5.6, 1.2 Hz, 1 H, H4), 3.09 (m, 1 H, 
H2), 2.83 (d, J = 2.4, 2 H, H5), 2.74 (m, 1 H, H1'), 2.40 (m, 1 H, H1''), 1.66 
(t, J = 5.6 Hz, 2 H, H3), 0.83 (s, 9 H, H9), -0.05 (s, 3 H, H6), -0.22 (s, 3 H, 
H7) 
13C NMR: (100 MHz, CDCl3) 
138.88 (C(Ph)), 129.80 (2 C, C(Ph)), 128.21 (2 C, C(Ph)), 126.20 (C(Ph)), 
72.00 (C(4)), 49.38 (C(2)), 46.71 (C(1)), 43.99 (C(5)), 39.81 (C(2)), 25.82 
(3 C, C(9)), 18.02 (C(8)), -4.90 (C(6), -5.07 (C(7)) 
HRMS: (EI) m/z calcd for C13H19O2Si [(M-C4H9)+] 235.1149, found 235.1110 
 
Analytical data for ent-3.24 
M.W.: 310.49 
TLC (Rf): 0.14 (30% EtOAc-hexanes) 
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1H NMR: (400 MHz, CDCl3) 
7.28-7.13 (m, 5 H, PhH), 4.21 (m, 1 H, H4), 4.15 (m, 1 H, H2), 3.57 (m, 1 
H, H1'), 3.38 (m, 1 H, H1''), 2.93 (dd, J = 13.2, 6.8 Hz, 1 H, H5'), 2.80 (dd, 
J = 13.6, 7.2 Hz, 1 H, H5''), 2.0 (m, 1 H, OH), 1.70 (m, 1H, H3'), 1.46 (m, 
1H, H3''), 0.87 (s, 9 H, H9), 0.03 (s, 3 H, H6), -0.15 (s, 3 H, H7) 
13C NMR: (100 MHz, CDCl3) 
138.41 (C(Ph)), 129.54 (2 C, C(Ph)), 128.45 (2 C, C(Ph)), 126.45 (C(Ph)), 
72.95 (C(4)), 68.84 (C(2)), 67.13 (C(1)), 42.90 (C(5)), 36.98 (C(2)), 25.83 
(3 C, C(9)), 17.95 (C(8)), -4.96 (C(6), -5.08 (C(7)) 
HRMS: (EI) m/z calcd for C10H23O3Si [(M-C7H7)+] 219.1411, found 219.1405 
General procedure for the conversion of vicinal diols to epoxides 3.23 and ent-3.23 
The purified vicinal diol was stirred along with dibutyltin oxide (Bu2SnO, 0.2 equiv), 
p-toluene sulfonate chloride (TsCl, 1 equiv) and triethylamine (Et3N, 1 equiv) in DCM 
(0.15M conc) at r.t. under an argon atmosphere. After 3h, filtered through a plug of 
cotton and evaporated solvent.  The oil was redissolved in THF (0.2M conc) and added 
dropwise to an ice-cold suspension of sodium hydride (NaH, 2 equiv, 60% in oil) in THF 
(0.4M conc).  Stirred overnight and quenched with NH4Cl (1 mL).  Extracted with 
EtOAc (3x2 volumes), dried organic layer with brine and Na2SO4 and after filtration and 
evaporation of the solvent, purified by flash column chromatography (100% hexanes). 
tert-butyldimethyl((R)-1-((S)-oxiran-2-yl)-3-phenylpropan-2-yloxy)silane (3.23) 
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The above general procedure was employed with vicinal diol 3.24 (136 mg, 0.44 
mmol), Bu2SnO (21.7 mg, 0.087 mmol, 20 mol%), TsCl (83.9 mg, 0.44 mmol, 1.0 
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equiv), Et3N (61.4 μL, 0.44 mmol, 1.0 equiv) in DCM (2.9 mL).  The reaction furnished 
a crude oil (205 mg, ~0.44 mmol) that was redissolved in THF (3.5 mL) and added to a 
suspension of NaH ( 35.2 mg, 0.88 mmol, 2.0 equiv) in THF (1 mL).  Isolated 3.23 as an 
amber oil (129 mg, 0.44 mmol, 90% de, 100% over two steps). 
Analytical data for 3.23 
M.W.: 292.49 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.27-7.13 (m, 5 H, PhH), 4.07 (m, 1 H, H4), 3.00 (m, 1 H, H2), 2.84-2.71 
(m, 3 H, H5, H1'), 2.43 (m, 1 H, H1''), 1.56 (m, 2 H, H3), 0.85 (s, 9 H, H9), 
0.01 (s, 3 H, H6), -0.14 (s, 3 H, H7) 
13C NMR: (100 MHz, CDCl3) 
138.47 (C(Ph)), 129.75 (2 C, C(Ph)), 128.24 (2 C, C(Ph)), 126.26 (C(Ph)), 
71.41 (C(4)), 49.79 (C(2)), 47.76 (C(1)), 44.78 (C(5)), 40.09 (C(2)), 25.85 
(3 C, C(9)), 18.04 (2 C, C(8)), -4.83 (C(6), -4.88 (C(7)) 
HRMS: (EI) m/z calcd for C13H19O2Si [(M-C4H9)+] 235.1149, found 235.1057 
tert-Butyldimethyl((S)-1-((R)-oxiran-2-yl)-3-phenylpropan-2-yloxy)silane (ent-3.23) 
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The general procedure was employed with vicinal diol ent-3.23 (151 mg, 0.49 mmol), 
Bu2SnO (25 mg, 0.10 mmol, 20 mol%), TsCl (93 mg, 0.49 mmol, 1.0 equiv), Et3N (68 
μL, 0.49 mmol, 1.0 equiv) in DCM (3.3 mL).  The reaction produced a crude oil that was 
redissolved in THF (4.0 mL) and added to a suspension of NaH (39 mg, 0.98 mmol, 2.0 
equiv) in THF (1 mL).  Isolated ent-3.24 as an amber oil (83 mg, 0.28 mmol, 90% de, 
58% over two steps). 
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Analytical data for ent-3.24 
M.W.: 292.49 
TLC (Rf): 0.71 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.27-7.13 (m, 5 H, PhH), 4.06 (m, 1 H, H4), 3.00 (m, 1 H, H2), 2.80-2.73 
(m, 3 H, H5, H1'), 2.43 (m, 1 H, H1''), 1.55 (m, 2 H, H3), 0.85 (s, 9 H, H9), 
0.01 (s, 3 H, H6), -0.14 (s, 3 H, H7) 
13C NMR: (75 MHz, CDCl3) 
138.42 (C(Ph)), 129.71 (2 C, C(Ph)), 128.19 (2 C, C(Ph)), 126.22 (C(Ph)), 
71.37 (C(4)), 49.75 (C(2)), 47.72 (C(1)), 44.73 (C(5)), 40.04 (C(2)), 25.81 
(3 C, C(9)), 18.00 (C(8)), -4.87 (C(6)), -4.93 (C(7)) 
HRMS: (EI) m/z calcd for C13H19O2Si [(M-C4H9)+] 235.1149, found 235.1110 
General procedure for the vinyl cuprate opening of chiral epoxides 
A mixture of purified epoxide, copper (I) iodide (CuI, 0.1 equiv) in THF (1.0M conc) 
was vigorously stirred under argon at -78°C for 20 min.  Vinyl magnesium bromide 
(VinylMgBr, 1.3 equiv) was added dropwise and the mixture allowed to slowly warm up 
to r.t. overnight.  The dark brown solution was quenched with NH4Cl (0.5 volumes) and 
extracted with EtOAc (3x2 volumes).  After drying the organic layer with brine (2 
volumes) and Na2SO4, the mixture was filtered and the solvent evaporated.  Purification 
was performed by flash column chromatography (10% ethyl acetate-hexanes). 
(4S,6R)-6-(tert-Butyldimethylsilyloxy)-7-phenylhept-1-en-4-ol (3.25) 
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The general procedure was employed with epoxide 3.22 (60.2 mg, 0.21 mmol), CuI 
(4.4 mg, 0.023 mmol, 0.1 equiv), THF (0.14 mL) and vinylmagnesium bromide (0.27 
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mL, 0.27 mmol, 1.3 equiv).  After work up and purification of the crude organic extract, 
homoallylic alcohol 3.25 (57.2 mg, 0.18 mmol, 85%) was isolated as an amber oil. 
Analytical data for 3.25 
M.W.: 320.54 
TLC (Rf): 0.45 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.28-7.13 (m, 5 H, PhH), 5.75 (m, 1 H, H2), 5.07-5.01 (m, 2 H, H1), 4.08 
(m, 1 H, H6), 3.76 (m, 1 H, H4), 2.89 (bs, 1 H, OH), 2.85 (dd, J = 13.2, 5.6 
Hz, 1 H, H7'), 2.71 (dd, J = 13.2, 7.6 Hz, 1 H, H7''), 2.14 (m, 2 H, H3), 1.53 
(m, 2 H, H5), 0.88 (s, 9 H, H11), 0.08 (s, 3 H, H8), -0.01 (s, 3 H, H9) 
13C NMR: (100 MHz, CDCl3) 
138.32 (C(Ph)), 134.77 (C(2)), 129.61 (2 C, (C(Ph)), 128.32 (2 C, (C(Ph)), 
126.31 (C(Ph)), 117.54 (C(1)), 73.97 (C(6)), 69.79 (C(4)), 44.87 (C(7)), 
42.46 (C(5)), 42.12 (C(3)), 25.87 (3 C, C(11)), 17.96, (C(10)), -4.33 (C(8)), 
-4.69 (C(9)) 
HRMS: (EI) m/z calcd for C12H25O2Si [(M-C7H7)+] 229.1618, found 229.1514 
(4R,6R)-6-(tert-Butyldimethylsilyloxy)-7-phenylhept-1-en-4-ol (3.26) 
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The general procedure was employed with epoxide 3.23 (35.1 mg, 0.12 mmol), CuI 
(2.3 mg, 0.023 mmol, 0.1 equiv), THF (0.12 mL) and vinylmagnesium bromide (0.16 
mL, 0.16 mmol, 1.3 equiv).  After work up and purification of the crude organic extract, 
homoallylic alcohol 3.26 (20 mg, 0.062 mmol, 52%) was isolated as an amber oil. 
Analytical data for 3.26 
M.W.: 320.54 
TLC (Rf): 0.48 (20% EtOAc-hexanes) 
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1H NMR: (400 MHz, CDCl3) 
7.25-7.07 (m, 5 H, PhH), 5.78 (m, 1 H, H2), 5.09-5.00 (m, 2 H, H1), 4.19 
(m, 1 H, H6), 4.10 (m, 1 H, H4), 2.90 (dd, J = 13.2, 6.4 Hz, 1 H, H7'), 2.79 
(dd, J = 13.2, 7.2 Hz, 1 H, H7''), 2.13 (m, 2 H, H3), 1.54 (m, 2 H, H5), 0.86 
(s, 9 H, H11), 0.02 (s, 3 H, H8), -0.16 (s, 3 H, H9) 
13C NMR: (100 MHz, CDCl3) 
138.64 (C(Ph)), 134.92 (C(2)), 129.59 (2 C, (C(Ph)), 128.36 (2 C, (C(Ph)), 
126.33 (C(Ph)), 117.39 (C(1)), 73.12 (C(6)), 67.73 (C(4)), 43.04 (C(7)), 
42.37 (C(5)), 40.78 (C(3)), 25.87 (3 C, (C(11))), 17.97 (C(10)), -4.93 
(C(8)), -5.07 (C(9)) 
HRMS: (EI) m/z calcd for C12H25O2Si [(M-C7H7)+] 229.1618, found 229.1617 
(4R,6S)-6-(tert-Butyldimethylsilyloxy)-7-phenylhept-1-en-4-ol (ent-3.25) 
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The general procedure was employed with epoxide ent-3.22 (152.0 mg, 0.52 mmol), 
CuI (10.0 mg, 0.052 mmol, 0.1 equiv), THF (0.52 mL) and vinylmagnesium bromide 
(0.68 mL, 0.68 mmol, 1.3 equiv).  After work up and purification of the crude organic 
extract, homoallylic alcohol ent-3.25 (39.3 mg, 0.12 mmol, 23%) was isolated as an 
amber oil. 
Analytical data for ent-3.25 
M.W.: 320.54 
TLC (Rf): 0.45 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.26-7.13 (m, 5 H, PhH), 5.75 (m, 1 H, H2), 5.08-5.02 (m, 2 H, H1), 4.08 
(m, 1 H, H6), 3.76 (m, 1 H, H4), 2.89 (bs, 1 H, OH), 2.85 (dd, J = 13.2, 5.6 
Hz, 1 H, H7'), 2.71 (dd, J = 13.2, 7.6 Hz, 1 H, H7''), 2.14 (m, 2 H, H3), 1.53 
(m, 2 H, H5), 0.88 (s, 9 H, H11), 0.07 (s, 3 H, H8), -0.03 (s, 3 H, H9) 
13C NMR: (100 MHz, CDCl3) 
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138.27 (C(Ph)), 134.73 (C(2)), 129.56 (2 C, C(Ph)), 128.28 (2 C, C(Ph)), 
126.27 (C(Ph)), 117.50 (C(1)), 73.95 (C(6)), 69.75 (C(4)), 44.83 (C(7)), 
42.39 (C(5)), 42.07 (C(3)), 25.83 (3 C, (C(11)), 17.91 (C(10)), -4.37 (C(8)), 
-4.73 (C(9)) 
HRMS: (EI) m/z calcd for C12H25O2Si [(M-C7H7)+] 229.1618, found 229.1616 
(4S,6S)-6-(tert-Butyldimethylsilyloxy)-7-phenylhept-1-en-4-ol (ent-3.26) 
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The general procedure was employed with epoxide ent-3.23 (83.0 mg, 0.28 mmol), 
CuI (6.0 mg, 0.030 mmol, 0.1 equiv), THF (0.28 mL) and vinylmagnesium bromide (0.36 
mL, 0.36 mmol, 1.3 equiv).  After work up and purification of the crude organic extract, 
homoallylic alcohol ent-3.26 (42.6 mg, 0.13 mmol, 46%) was isolated as an amber oil. 
Analytical data for ent-3.26 
M.W.: 320.54 
TLC (Rf): 0.48 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.27-7.06 (m, 5 H, PhH), 5.78 (m, 1 H, H2), 5.09-5.02 (m, 2 H, H1), 4.19 
(m, 1 H, H6), 4.09 (m, 1 H, H4), 2.90 (dd, J = 13.2, 6.4 Hz, 1 H, H7'), 2.78 
(dd, J = 13.2, 7.2 Hz, 1 H, H7''), 2.14 (m, 2 H, H3), 1.54 (m, 2 H, H5), 0.86 
(s, 9 H, H11), 0.02 (s, 3 H, H8), -0.16 (s, 3 H, H9). 
13C NMR: (100 MHz, CDCl3) 
138.64 (C(Ph)), 134.92 (C(2)), 129.59 (2 C, (C(Ph)), 128.36 (2 C, (C(Ph)), 
126.33 (C(Ph)), 117.39 (C(1)), 73.12 (C(6)), 67.73 (C(4)), 43.04 (C(7)), 
42.37 (C(5)), 40.78 (C(3)), 25.87 (3 C, C(11)), 17.97 (C(10)), -4.93 (C(8)), 
-5.07 (C(9)) 
HRMS: (EI) m/z calcd for C12H25O2Si [(M-C7H7)+] 229.1618, found 229.1604 
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Methyl 7-((3R,5R)-3,5-bis(tert-butyldimethylsilyloxy)-6-phenylhexanamido) 
heptanoate (3.31) 
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Homoallylic alcohol 3.25 (57.2 mg, 0.18 mmol), tert-butyldimethylchlorosilane (55.0 
mg, 0.36 mmol, 2.0 equiv) and imidazole (26.0 mg, 0.38 mmol, 2.1 equiv) were 
dissolved in dimethylformamide (DMF, 0.42 mL, 0.4 M) while stirring at room 
temperature overnight.  Diluted with water (1 mL) and extracted with hexanes (4x2 mL); 
dried with Na2SO4 and followed by evaporating solvent in vacuo. The crude bis-silylated 
olefin (45.8 mg, ~0.11 mmol) was used in the next step without purification. 
In a r.b.f. sodium metaperiodate (NaIO4, 455.0 mg, 0.84 mmol, 8.0 equiv) and 
potassium permanganate (KMnO4, 18.7 mg, 0.12 mmol, 1.1 equiv) were dissolved in pH 
7.0 buffer (0.5 mL, 0.05M) and stirred vigorously at r.t.  The crude olefin was dissolved 
in t-BuOH (0.5 mL) while stirring.  After 15 min, the dark purple permanganate solution 
was transferred by Pasteur pipette to the olefin solution.  Two buffer washes (0.1 mL) 
were employed to quantitatively transfer of the oxidant.  Upon contact, the mixture 
changed coloration to a pale brown.  The solution was stirred overnight.  Quenched with 
a saturated solution of sodium thiosulfate (0.5 mL), diluted with 1 mL of water and 
extracted with EtOAc (3x1 mL).  The organic extract was washed with brine (2x0.5 mL), 
dried over Na2SO4 and the solvent evaporated in vacuo.  The isolated crude oil was used 
in the next step without purification. 
Dissolved crude oil in DCM (1.0 mL) and added while stirring under argon: 
EDC•HCl (29.9 mg, 0.16 mmol, 1.5 equiv), DMAP (1.2 mg, 0.010 mmol, 0.1 equiv) and 
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amine 3.34 (28.6 mg, 0.15 mmol, 1.4 equiv).  After 5 min, TEA was added (21.7 μL, 0.16 
mmol, 1.5 equiv) and the solution was stirred overnight.  Quenched with NH4Cl (1.0 mL) 
and extracted with EtOAc (3x1 mL).  Organic extracts were washed with brine (2x1 mL) 
and dried over Na2SO4.  Upon solvent evaporation, the oil obtained was purified by flash 
column chromatography (20% EtOAc-hexanes - 50% EtOAc) furnishing amide 3.31 (30 
mg, 0.051 mmol, 28% over three steps) as an amber oil. 
Analytical data for 3.31 
M.W.: 593.99 
TLC (Rf): 0.24 (20% EtOAc-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.25-7.11 (m, 5 H, PhH), 6.27 (t, J = 5.2 Hz, 1 H, NH), 4.18 (m, 1 H, H3), 
3.93 (m, 1 H, H5), 3.64 (s, 3 H, H14), 3.16 (m, 1 H, H7'), 3.05 (m, 1 H, 
H7''), 2.76 (dd, J = 13.2, 6.4 Hz, 1 H, H6'), 2.69 (dd, J = 13.2, 6.4 Hz, 1 H, 
H6''), 2.42 (dd, J = 14.8, 4.4 Hz, 1 H, H2'), 2.27 (t, J = 7.6 Hz, 2 H, H12), 
2.21 (dd, J = 14.8, 5.2 Hz, 1 H, H2''), 1.59 (m, 4 H, H11), 1.36 (m, 2 H, 
H8), 1.27 (m, 4 H, H10), 0.85 (s, 9 H, H22), 0.84 (s, 9 H, H18), 0.05 (s, 3 
H, H19), 0.04 (s, 3 H), -0.01 (s, 3 H, H16), -0.13 (s, 3 H, H20). 
13C NMR: (100 MHz, CDCl3) 
174.12 (C(13)), 170.62 (C(1)), 138.43 (C(Ph)), 129.67 (2 C, C(Ph)), 128.20 
(2 C, C(Ph)), 126.17 (C(Ph)), 70.54 (C(5)), 67.18 (C(3)), 51.47 (C(14)), 
44.42 (C(6)), 43.57 (C(4)), 43.44 (C(2)), 39.10 (C(7)), 33.98 (C(12)), 29.35 
(C(11)), 28.76 (C(9)), 26.66 (C(10)), 25.91 (3 C), 25.81 (3 C), 24.81 
(C(10)), 18.00 (C(17)), 17.90 (C(21)), -4.57 (3 C, C(15), C(16), C(19)), -
4.75 (C(20)) 
7-(2-Acetamidoethylthio)-7-oxoheptan-1-ammonium chloride (3.15) 
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Boc-protected aminothioester 3.122 (102 mg, 0.29 mmol) was dissolved and stirred in 
HCl/Dioxane (0.73 mL, 2.9 mmol, 10 equiv) at r.t. under argon.  After 45 min, the 
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solvent was evaporated in vacuo and free amine 3.15 was isolated (82 mg, 0.29 mmol, 
100%) as a white paste. 
Analytical data for 3.15 
M.W.: 282.83 
1H NMR: (300 MHz, D2O) 
3.24 (t, J = 6.2 Hz, 2 H, H3), 2.91 (t, J = 6.5 Hz, 2 H, H4), 2.85 (bt, J = 7.4 
Hz, 2 H, H11), 2.52 (t, J = 7.4 Hz, 2 H, H6), 1.82 (s, 3 H, H1), 1.52 (m, 4 
H, H7, H10), 1.23 (m, 4 H, H8, H9). 
13C NMR: (75 MHz, D2O) 
204.70 (C(5)), 174.18 (C(2)), 43.20 (C(11)), 39.33 (C(3)), 38.60 (C(4)), 
27.92 (C(6)), 27.31 (C(10)), 26.39 (C(1)), 25.10 (C(7)), 24.91 (C(8)), 21.75 
(C(9)) 
S-2-Acetamidoethyl 7-((3R,5R)-3,5-bis(tert-butyldimethylsilyloxy)-6-
phenylhexanamido)heptanethioate (3.27) 
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Hydrolysis.  Ester 3.31 (30 mg, 0.051 mmol) and LiOH (21 mg, 0.51 mmol, 10 
equiv) were dissolved in a 3:2:1 solution of MeOH:H2O:THF (0.6 mL, 0.4 mL and 0.2 
mL respectively) and stirred vigorously at r.t. for 6 hr.  Quenched with 1M HCl (0.5 mL), 
and adjusted pH to approximately 3 units by adding HCl dropwise.  Extracted with 
EtOAc (6x0.5 mL) and dried with brine (3x0.5 mL) and MgSO4.  Coupling.  After 
evaporating the solvent in vacuo, the crude acid was dissolved in DCM (0.5 mL) and, 
while stirring under argon at r.t., added: EDC (14.8 mg, 0.077 mmol, 1.5 equiv), DMAP 
(0.6 mg, 0.005 mmol, 0.1 equiv) and HSNAC (9.0 μL, 0.085 mmol, 1.7 equiv).  After 
stirring overnight, the solution was diluted with water (0.5 mL) and EtOAc (0.5 mL), and 
extracted with EtOAc (3x1 mL).  The organic phase was washed with brine (2x1 mL) and 
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dried over Na2SO4.  Purified crude mixture by flash column chromatography (30% 
Acetone-hexanes) furnishing NAC thioester 3.27 (18.4 mg, 0.027 mmol, 53% over two 
steps) as a clear oil. 
Analytical data for 3.27 
M.W.: 681.13 
TLC (Rf): 0.33 (30% Acetone-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.25-7.11 (m, 5 H, PhH), 6.30 (t, J = 5.6 Hz, 1 H, NH), 5.98 (bs, 1 H, 
NHAc), 4.18 (m, 1 H, H3), 3.93 (m, 1 H, H5), 3.39 (q, J = 6.4 Hz, 2 H, 
H15), 3.16 (m, 1 H, H7'), 3.06 (m, 1 H, H7''), 3.00 (t, J = 6.4 Hz, 2 H, 
H14), 2.76 (dd, J = 13.2, 6 Hz, 1 H, H6'), 2.68 (dd, J = 13.2, 6.8 Hz, 1 H, 
H6''), 2.53 (t, J = 7.2 Hz, 2 H, H12), 2.43 (dd, J = 14.8, 4.4 Hz, 1 H, H2'), 
2.19 (dd, J = 14.8, 5.2 Hz, 1 H, H2''), 1.94 (s, 3 H, H17), 1.59 (m, 4 H, H4, 
H11), 1.35 (m, 2 H, H8), 1.27 (m, 4 H, H9, H10), 0.85 (s, 9 H, H25), 0.84 
(s, 9 H, H21), 0.05 (s, 3 H, H22), 0.04 (s, 3 H, H18), -0.01 (s, 3 H, H23), -
0.13 (s, 3 H, H19) 
13C NMR: (100 MHz, CDCl3) 
199.94 (C(13)), 170.70 (C(1)), 170.31 (C(16)), 138.42 (C(Ph)), 129.67 (2 
C, C(Ph)), 128.21 (2 C, C(Ph)), 126.19 (C(Ph)), 70.54 (C(5)), 67.18 (C(3)), 
44.42 (C(6)), 43.94 (C(12)), 43.58 (C(4)), 43.44 (C(2)), 39.73 (C(15)), 
38.95 (C(7)), 29.28 (C(8)), 28.55 (C(14)), 28.40 (C(9)), 26.50 (C(10)), 
25.91 (3 C, C(21)), 25.82 (3 C, C(25)), 25.46 (C(11)), 23.20 (C(17)), 18.01 
(C(20)), 17.91 (C(24)), -4.55 (2 C, C(18), C(22)), -4.57 (C(19)), -4.75 
(C(23)) 
General procedure for the oxidative cleavage of bis-silylated homoallylic alcohols 
and their carbodiimide coupling with NAC thioester 3.15 
Silylation.  Purified monoprotected homoallylic alcohol, TBSOTf (1.1 equiv) and 
2,6-lutidine (2.2 equiv) were dissolved in DCM (to a 0.1 M conc.) while stirring in an ice 
bath overnight.  The mixture was quenched with a saturated aqueous NH4Cl solution (1 
volume) and extracted with hexanes (4x1 volumes); dried with brine and Na2SO4, and 
evaporated solvent in vacuo.  Oxidative cleavage.  The weighed crude bis-silylated 
olefin is dissolved in t-BuOH (0.05M) and stirred under argon at r.t. In a separate flask, 
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NaIO4 (8.0 equiv) and KMnO4 (1.2 equiv) were vigorously stirred  in a 0.2M pH 7.0 
phosphate buffer (0.05M) at r.t.  After 15 min, the dark purple permanganate solution was 
transferred quantitatively by Pasteur pipette to the olefin-containing solution and stirred 
overnight.  Quenched with a saturated solution of sodium thiosulfate (0.5 volumes), 
diluted with water and extracted thrice with EtOAc (1 volume).  The organic extract was 
washed twice with brine, dried over Na2SO4 and the solvent evaporated in vacuo.  
Coupling.  The isolated crude oil was dissolved in DCM (0.1M) along EDC (1.5 equiv), 
DMAP (0.1 equiv) and NAC thioester 3.15 (1.2 equiv) was added while stirring under 
argon.  After 5 min, TEA was added (1.5 equiv) and the solution stirred overnight.  
Quenched with NH4Cl (0.5 volumes) and extracted thrice with EtOAc (1 volume).  The 
organic extract was washed twice with brine and dried over Na2SO4.  Following solvent 
evaporation, the crude product obtained was purified by flash column chromatography 
(30% acetone-hexanes). 
S-2-acetamidoethyl 7-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-6-
phenylhexanamido)heptanethioate (3.28) 
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Silylation.  The general procedure was employed as described with homoallylic 
alcohol 3.26 (20.0 mg, 0.062 mmol), TBSOTf (30 µL, 0.13 mmol, 2.1 equiv), and 2,6-
lutidine (22 µL, 0.19 mmol, 3.0 equiv) in DCM (0.62 mL, 0.1M).  Oxidative cleavage.  
The bis-silylated crude was dissolved in t-BuOH (0.6 mL) and oxidatively cleaved by 
reaction with KMnO4 (12.0 mg, 0.074 mmol, 1.2 equiv), NaIO4 (270 mg, 0.5 mmol, 8.0 
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equiv) dissolved in pH 7.0 buffer (0.6 mL).  Coupling.  The crude acid obtained was 
dissolved in DCM (1.2 mL, 0.05M) and combined with NAC aminothioester 3.15 (21.0 
mg, 0.074 mmol, 1.2 equiv), EDC (18.0 mg, 0.093 mmol, 1.5 equiv), DMAP (1.0 mg, 
0.006 mmol, 0.1 equiv), and TEA (13 µL, 0.093 mmol, 1.5 equiv). Following purification 
NAC substrate 3.28 (9.0 mg, 0.013 mmol, 21% over three steps) was isolated. 
Analytical data for 3.28 
M.W.: 681.13 
TLC (Rf): 0.33 (30% Acetone-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.25-7.13 (m, 5 H, PhH), 6.32 (t, J = 5.2 Hz, 1 H, NH), 5.94 (bs, 1 H, 
NHAc), 4.06 (m, 1 H, H3), 3.89 (m, 1 H, H5), 3.40 (q, J = 6 Hz, 2 H, H15), 
3.14 (m, 2 H, H7), 3.01 (t, J = 6.6 Hz, 2 H, H14), 2.70 (dd, J = 6.4, 2.4 Hz, 
2 H, H6), 2.54 (t, J = 7.5 Hz, 2 H, H12), 2.48 (dd, J = 15.0, 4.0 Hz, 1 H, 
H2'), 2.24 (dd, J = 15.0, 5.3 Hz, 1 H, H2''), 1.94 (s, 3 H, H17), 1.61 (m, 4 H, 
H4, H11), 1.39 (p, J = 7 Hz, 2 H, H8), 1.25 (m, 4 H, H9, H10), 0.83 (s, 18 
H, H21, H25), 0.00 (s, 6 H, H18, H22), -0.03 (s, 3 H, H23), -0.18 (s, 3 H, 
H19) 
13C NMR: (100 MHz, CDCl3) 
199.99 (C(13)), 170.65 (C(1)), 170.29 (C(16)), 138.55 (C(Ph)), 129.72 (2 
C, C(13)), 128.21 (2 C, C(13)), 126.23 (C(Ph)), 71.32 (C(5)), 67.66 (C(3)), 
44.30 (C(4)), 44.18 (C(6)), 44.12 (C(2)), 43.95 (C(12)), 39.70 (C(15)), 
39.00 (C(7)), 29.30 (C(8)), 28.57 (C(14)), 28.42 (C(9)), 26.53 (C(10)), 
25.90 (3 C, C(21)), 25.76 (3 C, C(25)), 23.23 (C(17)), 18.01 (C(20)), 17.88 
(C(24)), -4.49 (C(18)), -4.54 (C(22)), -4.56 (C(19)), -4.66 (C(23)) 
S-2-Acetamidoethyl 7-((3S,5S)-3,5-bis(tert-butyldimethylsilyloxy)-6-
phenylhexanamido)heptanethioate (ent-3.27) 
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Silylation.  The general procedure was employed as described with homoallylic 
alcohol ent-3.25 (39.3 mg, 0.12 mmol), TBSOTf (30 µL, 0.13 mmol, 1.1 equiv), and 2,6-
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lutidine (31 µL, 0.27 mmol, 2.2 equiv) in DCM (1.2 mL, 0.1M).  Oxidative cleavage.  
The bis-silylated crude (21.2 mg) was dissolved in t-BuOH (0.4 mL) and oxidatively 
cleaved by reaction with KMnO4 (9.2 mg, 0.058 mmol, 1.2 equiv), NaIO4 (209 mg, 0.39 
mmol, 8.0 equiv) dissolved in pH 7.0 buffer (0.4 mL).  Coupling.  The crude acid 
obtained (18.3 mg) was dissolved in DCM (0.8 mL, 0.05M) and combined with NAC 
aminothioester 3.15 (13.9 mg, 0.049 mmol, 1.2 equiv), EDC (11.7 mg, 0.061 mmol, 1.5 
equiv), DMAP (0.5 mg, 0.004 mmol, 0.1 equiv), and TEA (8.5 µL, 0.061 mmol, 1.5 
equiv). Following purification NAC substrate ent-3.27 (16.0 mg, 0.023 mmol, 19% over 
three steps) was isolated. 
Analytical data for ent-3.27 
M.W.: 681.13 
TLC (Rf): 0.33 (30% Acetone-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.25-7.11 (m, 5 H, PhH), 6.29 (t, J = 5.6 Hz, 1 H, NH), 5.95 (bs, 1 H, 
NHAc), 4.17 (m, 1 H, H3), 3.93 (m, 1 H, H5), 3.40 (q, J = 6.4 Hz, 2 H, 
H15), 3.16 (m, 1 H, H7'), 3.06 (m, 1 H, H7''), 3.00 (t, J = 6.4 Hz, 2 H, 
H14), 2.76 (dd, J = 13.2, 6 Hz, 1 H, H6'), 2.68 (dd, J = 13.2, 6.8 Hz, 1 H, 
H6''), 2.53 (t, J = 7.2 Hz, 2 H, H12), 2.43 (dd, J = 14.8, 4.4 Hz, 1 H, H2'), 
2.19 (dd, J = 14.8, 5.2 Hz, 1 H, H2''), 1.94 (s, 3 H, H17), 1.59 (m, 4 H, H4, 
H11), 1.35 (m, 2 H, H8), 1.27 (m, 4 H, H9, H10), 0.85 (s, 9 H, H25), 0.84 
(s, 9 H, H21), 0.05 (s, 3 H, H22), 0.04 (s, 3 H, H18), -0.01 (s, 3 H, H23), -
0.13 (s, 3 H, H19) 
13C NMR: (100 MHz, CDCl3) 
199.97 (C(13)), 170.69 (C(1)), 170.29 (C(16)), 138.42 (C(Ph)), 129.67 (2 
C, C(Ph)), 128.21 (2 C, C(Ph)), 126.19 (C(Ph)), 70.54 (C(5)), 67.17 (C(3)), 
44.42 (C(6)), 43.95 (C(12)), 43.57 (C(4)), 43.44 (C(2)), 39.73 (C(15)), 
38.95 (C(7)), 29.28 (C(8)), 28.56 (C(14)), 28.40 (C(9)), 26.50 (C(10)), 
25.91 (3 C, C(21)), 25.82 (3 C, C(25)), 25.47 (C(11)), 23.21 (C(17)), 18.01 
(C(20)), 17.91 (C(24)), -4.55 (2 C, C(18), C(22)), -4.57 (C(19)), -4.75 
(C(23)) 
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S-2-Acetamidoethyl 7-((3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-6-
phenylhexanamido)heptanethioate (ent-3.28) 
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Silylation.  The general procedure was employed as described with homoallylic 
alcohol ent-3.26 (42.6 mg, 0.13 mmol), TBSOTf (34 µL, 0.15 mmol, 1.1 equiv), and 2,6-
lutidine (35 µL, 0.30 mmol, 2.2 equiv) in DCM (1.3 mL, 0.1M).  Oxidative cleavage.  
The bis-silylated crude was dissolved in t-BuOH (0.43 mL) and oxidatively cleaved by 
reaction with KMnO4 (25.0 mg, 0.16 mmol, 1.2 equiv), NaIO4 (542 mg, 1.0 mmol, 8.0 
equiv) dissolved in pH 7.0 buffer (0.87 mL).  Coupling.  The crude acid obtained (48 
mg) was dissolved in DCM (1.1 mL, 0.1M) and combined with NAC aminothioester 3.15 
(37.0 mg, 0.13 mmol, 1.2 equiv), EDC (33.0 mg, 0.17 mmol, 1.5 equiv), DMAP (1.3 mg, 
0.011 mmol, 0.1 equiv), and TEA (24 µL, 0.17 mmol, 1.5 equiv). Following purification 
NAC substrate ent-3.28 (59.5 mg, 0.088 mmol, 68% over three steps) was isolated. 
Analytical data for ent-3.28 
M.W.: 681.13 
TLC (Rf): 0.33 (30% Acetone-hexanes) 
1H NMR: (400 MHz, CDCl3) 
7.24-7.12 (m, 5 H, PhH), 6.33 (t, J = 5.2 Hz, 1 H, NH), 6.03 (bs, 1 H, 
NHAc), 4.05 (m, 1 H, H3), 3.88 (m, 1 H, H5), 3.39 (q, J = 6 Hz, 2 H, H15), 
3.13 (m, 2 H, H7), 3.00 (t, J = 6.6 Hz, 2 H, H14), 2.70 (dd, J = 6.4, 2.4 Hz, 
2 H, H6), 2.53 (t, J = 7.5 Hz, 2 H, H12), 2.48 (dd, J = 15.0, 4.0 Hz, 1 H, 
H2'), 2.24 (dd, J = 15.0, 5.3 Hz, 1 H, H2''), 1.93 (s, 3 H, H17), 1.62 (m, 4 
H, H4, H11), 1.38 (p, J = 7 Hz, 2 H, H8), 1.25 (m, 4 H, H9, H10), 0.81 (s, 
18 H, H21, H25), -0.01 (s, 6 H, H18, H22), -0.05 (s, 3 H, H23), -0.18 (s, 3 
H, H19) 
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13C NMR: (100 MHz, CDCl3) 
199.99 (C(13)), 170.65 (C(1)), 170.29 (C(16)), 138.55 (C(Ph)), 129.72 (2 
C, C(Ph)), 128.21 (2 C, C(Ph)), 126.23 (C(Ph)), 71.32 (C(5)), 67.66 (C(3)), 
44.30 (C(4)), 44.18 (C(6)), 44.12 (C(2)), 43.95 (C(12)), 39.70 (C(15)), 
39.00 (C(7)), 29.30 (C(8)), 28.57 (C(14)), 28.42 (C(9)), 26.53 (C(10)), 
25.90 (3 C, C(21)), 25.76 (3 C, C(25)), 23.23 (C(17)), 18.01 (C(20)), 17.88 
(C(24)), -4.49 (C(18)), -4.54 (C(22)), -4.56 (C(19)), -4.66 (C(23)) 
General procedure for the deprotection of enantioenriched NAC thioesters 
The purified NAC substrate contained in an Eppendorf tube was dissolved in MeCN 
(0.1M) at r.t..  To this solution pyridine (10 equiv) was added, followed by HF (50 
equiv).  The mixture was vortexed to homogeneity for 10 sec and the reaction was 
allowed to proceed without stirring for 5 hr, at which time the reaction was diluted with 
water (0.2 volumes) and extracted with EtOAc (5 x 0.2 volumes).  The organic extracts 
were pooled and dried with MgSO4, and the crude purified by flash chromatography (5% 
MeOH-DCM). 
S-2-Acetamidoethyl 7-((3R,5R)-3,5-dihydroxy-6-phenylhexanamido)heptanethioate 
(3.29) 
O
3.27
O
Si
O
N
H
Si
SNAC
OH OH O
N
H
S
O H
N
OO
6
3.29
1
2
3
4
5
6
13
12
11
10
9
8
147
15 16
17
 
The general procedure was employed as described with bis-silylated NAC substrate 
3.27 alcohol (16 mg, 0.023 mmol), pyridine (14 µL, 0.23 mmol, 10 equiv), and HF (99 
µL, 2.3 mmol, 100 equiv) in MeCN (800 µL, 0.03M).  Following purification, free diol 
3.29 (3.6 mg, 0.008 mmol, 35%) was isolated. 
Analytical data for 3.29 
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M.W.: 452.61 
TLC (Rf): 0.10 (5% MeOH-DCM) 
1H NMR: (500 MHz, CDCl3) 
7.30-7.18 (m, 5 H, PhH), 6.07 (bt, J = 5.2 Hz, 1 H, NH), 5.88 (bs, 1 H, 
NHAc), 4.59 (bs, 1 H, OH), 4.19 (m, 1 H, H3), 4.10 (m, 1 H, H5), 3.40 (q, 
J = 6.0 Hz, 2 H, H15), 3.21 (q, J = 6.6 Hz, 2 H, H7), 3.17 (bs, 1 H, OH), 
2.99 (t, J = 6.4 Hz, 2 H, H14), 2.76 (dddd, J = 13.6, 13.6, 7.3, 6.0 Hz, 2 H, 
H6), 2.55 (t, J = 7.2 Hz, 2 H, H12), 2.30 (m, 2 H, H2), 1.94 (s, 3 H, H17), 
1.61 (m, 4 H, H4, H11), 1.47 (m, 2 H, H8), 1.31 (m, 4 H, H9, H10) 
13C NMR: (125 MHz, CDCl3) 
200.09 (C(13)), 171.86 (C(1)), 170.35 (C(16)), 137.82 (C(Ph)), 129.41 (2 
C, C(Ph)), 128.59 (2 C, C(Ph)), 126.58 (C(Ph)), 73.43 (C(5)), 69.46 (C(3)), 
44.34 (C(6)), 43.79 (C(12)), 42.86 (C(2)), 41.52 (C(4)), 39.67 (C(15)), 
39.03 (C(7)), 29.10 (C(8)), 28.49 (C(14)), 28.22 (C(9)), 26.24 (C(10)), 
25.38 (C(11)), 23.18 (C(17)) 
HRMS: (EI) m/z calcd for C16H29N2O5S [(M-C7H7)+] 361.1792, found 361.1831 
S-2-acetamidoethyl 7-((3S,5R)-3,5-dihydroxy-6-phenylhexanamido)heptanethioate 
(3.30) 
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The general procedure was employed as described with bis-silylated NAC substrate 
3.28 alcohol (3 mg, 0.004 mmol), pyridine (3 µL, 0.04 mmol, 10 equiv), and HF (7 µL, 
0.20 mmol, 50 equiv) in MeCN (40 µL, 0.1M).  Following purification, free diol 3.30 
(900 µg, 2 µmol, 50%) was isolated. 
Analytical data for 3.30 
M.W.: 452.61 
TLC (Rf): 0.39 (10% MeOH-DCM) 
1H NMR: (400 MHz, CDCl3) 
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7.32-7.18 (m, 5 H, PhH), 5.99 (bs, 1 H, NH), 5.89 (bs, 1 H, NHAc), 4.32 
(m, 1 H, H3), 4.15 (m, 1 H, H5), 3.40 (q, J = 6.0 Hz, 2 H, H15), 3.22 (q, J = 
6.6 Hz, 2 H, H7), 3.00 (t, J = 6.3 Hz, 2 H, H14), 2.78 (d, J = 6.6 Hz, 2 H, 
H6), 2.55 (t, J = 7.5 Hz, 2 H, H12), 2.34 (m, 2 H, H2), 1.94 (s, 3 H, 17), 
1.66 (m, 4 H, H4, H11), 1.51 (m, 2 H, H8), 1.31 (m, 4 H, H9, H10) 
13C NMR: (100 MHz, CDCl3) 
200.13 (C(13)), 172.29 (C(1)), 129.34 (2 C, C(Ph)), 128.58 (2 C, C(Ph)), 
126.53 (C(Ph)), 69.92 (C(5)), 66.39 (C(3)), 43.96 (C(6)), 43.78 (C(12)), 
42.29 (C(2)), 41.59 (C(4)), 39.65 (C(15)), 39.03 (C(7)), 29.13 (C(8)), 28.50 
(C(14)), 28.21 (C(9)), 26.23 (C(10)), 25.38 (C(11)), 23.21 (C(17)) 
HRMS: (EI) m/z calcd for C19H28NO4 [(M-C4H8NOS)+] 334.2013, found 
334.2054 
S-2-acetamidoethyl 7-((3S,5S)-3,5-dihydroxy-6-phenylhexanamido)heptanethioate 
(ent-3.27) 
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The general procedure was employed as described with bis-silylated NAC substrate 
ent-3.27 alcohol (16.0 mg, 0.023 mmol), pyridine (17 µL, 0.23 mmol, 10 equiv), and HF 
(42 µL, 1.15 mmol, 50 equiv) in MeCN (250 µL, 0.1M).  Following purification, free 
diol ent-3.29 (9.6 mg, 0.021 mmol, 92%) was isolated. 
Analytical data for ent-3.29 
M.W.: 452.61 
TLC (Rf): 0.10 (5% MeOH-DCM) 
1H NMR: (400 MHz, CDCl3) 
7.30-7.17 (m, 5 H, PhH), 6.22 (bt, J = 5.2 Hz, 1 H, NH), 6.00 (bs, 1 H, 
NHAc), 4.66 (bs, 1 H, OH), 4.16 (m, 1 H, H3), 4.09 (m, 1 H, H5), 3.38 (q, 
J = 6.2 Hz, 2 H, H15), 3.34 (bs, 1 H, OH), 3.20 (q, J = 6.6 Hz, 2 H, H7), 
2.99 (t, J = 6.4 Hz, 2 H, H14), 2.75 (dddd, J = 13.6, 13.6, 7.3, 6.0 Hz, 2 H, 
H6), 2.54 (t, J = 7.2 Hz, 2 H, H12), 2.30 (m, 2 H, H2), 1.93 (s, 3 H, H17), 
1.61 (m, 4 H, H4, H11), 1.47 (m, 2 H, H8), 1.31 (m, 4 H, H9, H10) 
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13C NMR: (100 MHz, CDCl3) 
200.11 (C(13)), 171.87 (C(1)), 170.43 (C(16)), 137.93 (C(Ph)), 129.45 (2 
C, C(Ph)), 128.60 (2 C, C(Ph)), 126.58 (C(Ph)), 73.40 (C(5)), 69.48 (C(3)), 
44.40 (C(6)), 43.84 (C(12)), 43.01 (C(2)), 41.59 (C(4)), 39.67 (C(15)), 
39.06 (C(7)), 29.16 (C(8)), 28.52 (C(14)), 28.28 (C(9)), 26.30 (C(10)), 
25.42 (C(11)), 23.21 (C(17)) 
HRMS: (EI) m/z calcd for C16H29N2O5S [(M-C7H7)+] 361.1792, found 361.1745 
S-2-acetamidoethyl 7-((3R,5S)-3,5-dihydroxy-6-phenylhexanamido)heptanethioate 
(ent-3.30) 
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The general procedure was employed as described with bis-silylated NAC substrate 
ent-3.28 alcohol (22 mg, 0.032 mmol), pyridine (23 µL, 0.23 mmol, 10 equiv), and HF 
(58 µL, 1.6 mmol, 50 equiv) in MeCN (320 µL, 0.1M).  Following purification free diol 
ent-3.30 (5.7 mg, 0.013 mmol, 40%) was isolated. 
Analytical data for ent-3.30 
M.W.: 452.61 
TLC (Rf): 0.39 (10% MeOH-DCM) 
1H NMR: (400 MHz, CDCl3) 
7.31-7.18 (m, 5 H, PhH), 6.04 (bs, 1 H, NH), 5.92 (bs, 1 H, NHAc), 4.32 
(m, 1 H, H3), 4.15 (m, 1 H, H5), 3.40 (q, J = 6.0 Hz, 2 H, H15), 3.22 (q, J = 
6.6 Hz, 2 H, H7), 2.99 (t, J = 6.2 Hz, 2 H, H14), 2.78 (d, J = 6.7 Hz, 2 H, 
H6), 2.55 (t, J = 7.3 Hz, 2 H, H12), 2.31 (m, 2 H, H2), 1.94 (s, 3 H, H17), 
1.66 (m, 4 H, H4, H11), 1.48 (m, 2 H, H8), 1.32 (m, 4 H, H9, H10) 
13C NMR: (75 MHz, CDCl3) 
200.12 (C(13)), 172.36 (C(1)), 170.39 (C(16)), 138.20 (C(Ph)), 129.34 (2 
C, C(Ph)), 128.57 (2 C, C(Ph)), 126.52 (C(Ph)), 69.90 (C(5)), 66.37 (C(3)), 
43.97 (C(6)), 43.77 (C(12)), 42.29 (C(2)), 41.63 (C(4)), 39.66 (C(15)), 
39.08 (C(7)), 29.09 (C(8)), 28.48 (C(14)), 28.19 (C(9)), 26.22 (C(10)), 
25.37 (C(11)), 23.17 (C(17)) 
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HRMS: (EI) m/z calcd for C16H29N2O5S [(M-C7H7)+] 361.1792, found 361.1783 
3.5.2.3.  Transformation, expression and purification of wild-type DEBS TE 
Transformation.  The expression vector pRSG33 (wild-type DEBS TE)3 was 
transformed into chemical competent E. coli BL21(DE3) for protein expression 
employing standard protocols.4  Recovered cells were spread on LB+Amp plates and 
incubated at 37°C for 12 hr.  Expression.  E. coli BL21(DE3) was grown in 400 mL of 
standard LB medium in a shake flask supplemented with 100 μg mL-1 of ampicillin at 37 
°C.  At OD600 = 0.45, protein expression was induced by addition of 1 mM IPTG, and the 
culture incubated at 20°C with shaking at 250 rpm for 12 h.  Purification.  Protein 
purification was performed at 4°C.  The cells were harvested by centrifugation at 
2.63x103 g for 30 min and promptly resuspended in 80 mL of lysis buffer (100 mM 
sodium phosphate, 300 mM NaCl, 10% (v/v) glycerol, 1 mg/mL lysozyme, 1 µg/mL 
pepstatin A, 1-2 µg/mL leupeptin, pH 8.0). The cells were lysed by sonication on ice and 
the debris was removed by centrifugation at 1.16x104 g for 45 min.  The clarified lysate 
was gently mixed for 3 hr with 1 mL of nickel-nitrilotriacetic acid (Ni-NTA) resin and 
transferred onto a purification column.  The protein was eluted with wash buffer of 
increasing imidazole concentrations: 20 mL x 0 mM imidazole; 20 mL x 20 mM 
imidazole; 2x(10 mL x 100 mM imidazole); 2x(10 mL x 250 mM imidazole).  The 
purified protein was exchanged into dialysis buffer (100 mM Tris, 300 mM NaCl, 30% 
(v/v) glycerol, pH 7.43) and concentrated by centrifugation with an Amicon Ultra 5000 
MWCO (Millipore) at 10°C.  Upon concentration, the protein was flash-frozen in liquid 
nitrogen and stored at -80°C.  Protein concentration was determined by the Bradford 
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assay (Bio-Rad). Approximately 3 mg of purified protein was obtained per L of cell 
culture. 
3.5.2.4.  Kinetic analysis of the DEBS TE 
The TE-catalyzed hydrolysis of thioester substrates were monitored by observation of 
the formation of 5-thio-2-nitrobenzoate by reaction of released N-acetylcysteamine with 
5,5'-dithiobis-2-nitrobenzoic acid (DTNB). A typical kinetic assay mixture consists of 5 
μM DEBS TE, 50 mM phosphate buffer (pH 7.37), 4 % (v/v) saturated solution of DTNB 
in 50 mM phosphate buffer (pH 7.37), x mM substrate (50 mM stock solutions in DMSO, 
where x is the variable amount) and 10 % (v/v) DMSO in total volume of 15 μL reaction. 
The formation of free thiol was quantified by measuring the absorption at 412 nm using a 
Nanodrop 2000 (Pedestal mode) from Thermo Scientific. 
The reactions were monitored for 60 min at room temperature and data points were 
collected at 1, 3, 5, 10, 30, and 60 min intervals.  Initial velocities (v) were determined by 
linear regression analysis of the data.  All steady state kinetic assays were performed with 
five different concentrations of substrates (0.1, 0.2, 0.5, 2, and 5 mM) in duplicate.  The 
kinetic parameter kcat/KM was calculated from the slope of v versus [S].  Because of 
apparent variation in specific activity among protein preparations, a single protein 
preparation was used for determination of the specificity constant for all enantioenriched 
substrates. 
Table 3.1.  Calculated specificity constants (kcat/KM) for the reaction of enantioenriched substrates ent-
3.29, ent-3.30, 3.29 and 3.30 with the DEBS TE (values represent the mean ± standard error). 
Isomer kcat/KM (M·s-1) 
ent-3.29 1.34 ± 1x10-2 
ent-3.30 0.43 ± 6x10-2 
3.30 0.6 ± 4x10-1 
3.20 0.3 ± 1x10-1 
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3.5.2.5.  Hydrolytic assay of anti-3.42 with DEBS TE 
The enzymatic assays were prepared by incubating 5 μM DEBS TE in 50 mM 
phosphate buffer (pH 7.4) with 2.5 mM anti-3.42 macrolactone standard at 20°C. At 
various time points (15, 30, 60, 120, 180, 1620 min), aliquots were taken, diluted 4-fold 
with a 50% MeCN:H2O solution and analyzed for hydrolysis by analytical HPLC 
(Agilent 1100 series). 
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3.5.4.  Selected 1D and 2D NMR spectra 
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